<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">57000</article-id><article-id pub-id-type="doi">10.7554/eLife.57000</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Subcellular sorting of neuregulins controls the assembly of excitatory-inhibitory cortical circuits</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes" id="author-180706"><name><surname>Exposito-Alonso</surname><given-names>David</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-4950-2744</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes" id="author-130620"><name><surname>Osório</surname><given-names>Catarina</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-5228-0599</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-210625"><name><surname>Bernard</surname><given-names>Clémence</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5305-7738</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-180720"><name><surname>Pascual-García</surname><given-names>Sandra</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0536-1185</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-152540"><name><surname>del Pino</surname><given-names>Isabel</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8672-926X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-51310"><name><surname>Marín</surname><given-names>Oscar</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6264-7027</contrib-id><email>oscar.marin@kcl.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund6"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-10432"><name><surname>Rico</surname><given-names>Beatriz</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0581-851X</contrib-id><email>beatriz.rico@kcl.ac.uk</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology and Neuroscience, King’s College London</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff><aff id="aff2"><label>2</label><institution>MRC Centre for Neurodevelopmental Disorders, King’s College London</institution><addr-line><named-content content-type="city">London</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Brose</surname><given-names>Nils</given-names></name><role>Reviewing Editor</role><aff><institution>Max Planck Institute of Experimental Medicine</institution><country>Germany</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Huguenard</surname><given-names>John R</given-names></name><role>Senior Editor</role><aff><institution>Stanford University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>15</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e57000</elocation-id><history><date date-type="received" iso-8601-date="2020-03-17"><day>17</day><month>03</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-12-14"><day>14</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Exposito-Alonso et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Exposito-Alonso et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-57000-v2.pdf"/><abstract><p>The assembly of specific neuronal circuits relies on the expression of complementary molecular programs in presynaptic and postsynaptic neurons. In the cerebral cortex, the tyrosine kinase receptor ErbB4 is critical for the wiring of specific populations of GABAergic interneurons, in which it paradoxically regulates both the formation of inhibitory synapses as well as the development of excitatory synapses received by these cells. Here, we found that Nrg1 and Nrg3, two members of the neuregulin family of trophic factors, regulate the inhibitory outputs and excitatory inputs of interneurons in the mouse cerebral cortex, respectively. The differential role of Nrg1 and Nrg3 in this process is not due to their receptor-binding EGF-like domain, but rather to their distinctive subcellular localization within pyramidal cells. Our study reveals a novel strategy for the assembly of cortical circuits that involves the differential subcellular sorting of family-related synaptic proteins.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>cerebral cortex</kwd><kwd>interneurons</kwd><kwd>synapses</kwd><kwd>neuregulins</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MR/S010785/1</award-id><principal-award-recipient><name><surname>Marín</surname><given-names>Oscar</given-names></name><name><surname>Rico</surname><given-names>Beatriz</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100008236</institution-id><institution>Fondation Roger de Spoelberch</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Marín</surname><given-names>Oscar</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010434</institution-id><institution>“la Caixa” Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Exposito-Alonso</surname><given-names>David</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution>European Union’s Horizon 2020 research and innovation programme</institution></institution-wrap></funding-source><award-id>AIMS-2-TRIALS, 777394</award-id><principal-award-recipient><name><surname>Marín</surname><given-names>Oscar</given-names></name><name><surname>Rico</surname><given-names>Beatriz</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Neuregulins control the integration of specific excitatory and inhibitory synapses through subcellular sorting.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The function of the cerebral cortex relies on dynamic interactions between excitatory and inhibitory neurons. These interactions are governed by precise synaptic connectivity patterns, which are laid down during development and subsequently sculpted by ongoing activity to support neural processes such as learning. What are the molecular and cellular rules that underlie the development of specific connectivity motifs? Neurons use cellular and subcellular strategies for the assembly of specific synapses (<xref ref-type="bibr" rid="bib7">de Wit and Ghosh, 2016</xref>; <xref ref-type="bibr" rid="bib42">Südhof, 2018</xref>; <xref ref-type="bibr" rid="bib56">Yogev and Shen, 2014</xref>). Cellular specificity in synaptic targeting involves the generation of multiple protein isoforms of the same gene family through alternative splicing (<xref ref-type="bibr" rid="bib7">de Wit and Ghosh, 2016</xref>). For instance, the expression of a random combinatory pool of protocadherin isoforms provides a cell-surface recognition code that is mediated by homophilic interactions (<xref ref-type="bibr" rid="bib43">Thu et al., 2014</xref>). The alternative splicing of neurexins, which is regulated in a cell-specific manner, also supports synaptic specificity at the cellular level (<xref ref-type="bibr" rid="bib19">Fuccillo et al., 2015</xref>; <xref ref-type="bibr" rid="bib26">Iijima et al., 2011</xref>). Interestingly, the establishment of specific patterns of subcellular connectivity relies on the expression of complementary molecular programs in presynaptic and postsynaptic neurons, which provide unique address codes for the subcellular targeting of connections (<xref ref-type="bibr" rid="bib2">Apóstolo and de Wit, 2019</xref>; <xref ref-type="bibr" rid="bib14">Favuzzi and Rico, 2018</xref>). For example, expression of latrophilins at specific postsynaptic sites drives the assembly of excitatory inputs into different dendritic compartments in pyramidal cells (<xref ref-type="bibr" rid="bib40">Sando et al., 2019</xref>). Similarly, expression of Cbln4 in a subclass of cortical interneurons is required for the targeting of inhibitory inputs to the dendrites of pyramidal cells (<xref ref-type="bibr" rid="bib13">Favuzzi et al., 2019</xref>).</p><p>The molecular mechanisms underlying subcellular synaptic specificity likely rely on the sorting of specific mRNAs and/or proteins into distinct subcellular compartments. For instance, the localization of certain mRNAs into the somatodendritic or axonal compartments of neurons depends on alternative 3′UTR sequences (<xref ref-type="bibr" rid="bib5">Cioni et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Tushev et al., 2018</xref>). In addition, it has been shown that synaptic proteins localize to different subcellular compartments by either selective retention or selective delivery (<xref ref-type="bibr" rid="bib36">Ribeiro et al., 2018</xref>; <xref ref-type="bibr" rid="bib39">Sampo et al., 2003</xref>). These processes are thought to be mediated by the compartmentalized organization of the cytoskeleton and specific interactions with sorting receptors, adaptors, and motor proteins (<xref ref-type="bibr" rid="bib23">Gumy and Hoogenraad, 2018</xref>; <xref ref-type="bibr" rid="bib37">Ribeiro et al., 2019</xref>).</p><p>The tyrosine kinase receptor ErbB4 is involved in the wiring of specific microcircuits in the cerebral cortex (<xref ref-type="bibr" rid="bib10">Del Pino et al., 2018</xref>). ErbB4 is uniquely expressed by some types of cortical interneurons and absent from pyramidal cells (<xref ref-type="bibr" rid="bib15">Fazzari et al., 2010</xref>; <xref ref-type="bibr" rid="bib46">Vullhorst et al., 2009</xref>). ErbB4 localizes to synaptic contacts in both the somatodendritic (postsynaptic) and/or axonal (presynaptic) compartments of interneurons (<xref ref-type="bibr" rid="bib15">Fazzari et al., 2010</xref>), where it regulates both the number of excitatory synapses received and inhibitory synapses made by different types of interneurons (<xref ref-type="bibr" rid="bib9">Del Pino et al., 2017</xref>; <xref ref-type="bibr" rid="bib8">Del Pino et al., 2013</xref>; <xref ref-type="bibr" rid="bib15">Fazzari et al., 2010</xref>; <xref ref-type="bibr" rid="bib44">Ting et al., 2011</xref>; <xref ref-type="bibr" rid="bib54">Yang et al., 2013</xref>). These observations raise the possibility that presynaptic and postsynaptic ErbB4 receptors may interact with different synaptic partners during the development of cortical circuits.</p><p>Neuregulins comprise a family of growth factors that activate receptor tyrosine kinases of the ErbB family (<xref ref-type="bibr" rid="bib32">Mei and Nave, 2014</xref>). Type III Neuregulin 1 (hereafter referred to as Nrg1) and Neuregulin 3 (Nrg3) are the most abundantly expressed neuregulins in the cerebral cortex during the period of synaptogenesis (<xref ref-type="bibr" rid="bib15">Fazzari et al., 2010</xref>; <xref ref-type="bibr" rid="bib30">Longart et al., 2004</xref>; <xref ref-type="bibr" rid="bib35">Rahman et al., 2019</xref>). Previous studies have suggested that both Nrg1 and Nrg3 are homogeneously distributed in the same subcellular compartments. Nrg1 has been reported to be present in the axons of peripheral and hippocampal neurons in vitro (<xref ref-type="bibr" rid="bib24">Hancock et al., 2008</xref>; <xref ref-type="bibr" rid="bib47">Vullhorst et al., 2017</xref>; <xref ref-type="bibr" rid="bib51">Wolpowitz et al., 2000</xref>), while Nrg3 has been shown to be enriched in axonal varicosities and synaptic puncta contacting interneuron dendrites (<xref ref-type="bibr" rid="bib34">Müller et al., 2018</xref>; <xref ref-type="bibr" rid="bib47">Vullhorst et al., 2017</xref>). Here, we demonstrate that sorting of Nrg1 and Nrg3 into different subcellular compartments of pyramidal cells mediate the formation of specific excitatory and inhibitory synapses in distinct populations of cortical interneurons. Our results unveil a novel strategy for the assembly of cortical circuits mediated by the subcellular sorting of family-related synaptic proteins.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Distinct synaptic deficits in cortical pyramidal cells lacking Nrg1 or Nrg3</title><p>A large proportion of pyramidal cells express <italic>Nrg1</italic> and <italic>Nrg3</italic> across cortical layers 2–6 during postnatal development and into adulthood (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>), suggesting that both neuregulins may play redundant functions as ErbB4 ligands in the regulation of inhibitory and excitatory synapses. To test this hypothesis, we performed genetic loss-of-function experiments using conditional alleles for each of these genes. Since neuregulin signaling in pyramidal cells plays a role in the laminar allocation of neocortical interneurons (<xref ref-type="bibr" rid="bib3">Bartolini et al., 2017</xref>; <xref ref-type="bibr" rid="bib17">Flames et al., 2004</xref>), we deleted <italic>Nrg1</italic> and <italic>Nrg3</italic> from pyramidal cells postnatally to avoid interfering with the function of neuregulins prior to synapse formation. To this end, we bred <italic>Neurod6<sup>CreERT2</sup></italic> (also known as <italic>Nex<sup>CreERT2</sup></italic>) mice, in which a tamoxifen-inducible version of Cre recombinase is under the control of the endogenous regulatory sequences of the pyramidal cell-specific <italic>Neurod6</italic> locus (<xref ref-type="bibr" rid="bib1">Agarwal et al., 2012</xref>), with mice carrying loxP-flanked <italic>Nrg1</italic> or <italic>Nrg3</italic> alleles (<xref ref-type="bibr" rid="bib3">Bartolini et al., 2017</xref>; <xref ref-type="bibr" rid="bib53">Yang et al., 2001</xref>). Recombination of the <italic>Nrg1</italic> locus generates a <italic>Nrg1</italic> null allele in which the EGF domain is missing from all <italic>Nrg1</italic> variants (<xref ref-type="bibr" rid="bib53">Yang et al., 2001</xref>). Since the precise time of full protein depletion from the neuron and therefore any impact in layer migration is difficult to predict, we first assessed Parvalbumin-expressing (PV+) interneuron distribution. We observed that postnatal induction of Cre recombinase in pyramidal cells does not disrupt the density and organization of PV+ interneurons in <italic>Nrg1</italic> and <italic>Nrg3</italic> conditional mutant mice at postnatal (P) day 30 (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>). Therefore, these mice represent ideal models to investigate the precise role of <italic>Nrg1</italic> or <italic>Nrg3</italic> in pyramidal cells during the assembly of cortical circuits.</p><p>We first analyzed the role of <italic>Nrg1</italic> and <italic>Nrg3</italic> in the development of inhibitory synapses onto pyramidal cells. We investigated the two types of inhibitory synapses that are known to be altered in the absence of ErbB4 from interneurons: synapses made by Cholecystokinin (CCK+) basket cells onto the soma and synapses made by chandelier cells on the axon initial segment (AIS) (<xref ref-type="bibr" rid="bib9">Del Pino et al., 2017</xref>; <xref ref-type="bibr" rid="bib8">Del Pino et al., 2013</xref>). We performed immunohistochemistry for pre- and postsynaptic markers to quantify inhibitory synaptic clusters in control and conditional mutant mice. In brief, we used GAD65 and CB1R to label the boutons of CCK+ interneurons, and GAD67 to identify chandelier cell boutons on the AIS of pyramidal cells (<xref ref-type="bibr" rid="bib16">Fish et al., 2011</xref>; <xref ref-type="bibr" rid="bib28">Katona et al., 1999</xref>). Of note, our ability to detect synaptic clusters was very similar independently of the genotype, which indicated that our approach does not introduce any bias in the quantification of synaptic densities (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). To identify Cre-expressing pyramidal cells, we included the conditional reporter allele <italic>Ai9</italic> (tdTomato) in our breeding scheme (<xref ref-type="bibr" rid="bib31">Madisen et al., 2010</xref>). We observed a significant decrease in the density of GAD65+/CB1R+ presynaptic boutons contacting the soma of pyramidal cells in conditional <italic>Nrg1</italic> mutants compared to controls (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>). In contrast, deletion of <italic>Nrg3</italic> from pyramidal cells did not affect the formation of somatic synapses by CCK+ basket cells (<xref ref-type="fig" rid="fig1">Figure 1A–C</xref>). These results suggested that Nrg1, and not Nrg3, is required for the development of CCK+ basket cell synapses on pyramidal cells.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Specific synaptic deficits in cortical pyramidal cells lacking Nrg1 or Nrg3.</title><p>(<bold>A</bold>) Schematic of experimental design. Conditional deletion of <italic>Nrg1</italic> or <italic>Nrg3</italic> in pyramidal cells was achieved by tamoxifen (TM) injection in newly born pups at P0. Two synapses were analyzed in conditional neuregulin mutants: inhibitory synapses formed by CCK+ basket cells onto the soma of pyramidal cells (GAD65, CB1R) and excitatory synapses made by pyramidal cells onto PV+ interneurons (VGlut1, PSD95). (<bold>B</bold>) Confocal images (top three panels) and binary images (bottom panel) illustrating presynaptic GABAergic boutons co-labeled with GAD65 (magenta) and CB1R (cyan) contacting the soma of tdTomato+ pyramidal cells (gray) in controls, <italic>Nrg1</italic> and <italic>Nrg3</italic> conditional mutant mice. (<bold>C</bold>) Quantification of the density of GAD65+/CB1R+ boutons formed onto pyramidal cell somas in <italic>Nrg1</italic> and <italic>Nrg3</italic> conditional mutant mice. Two-tailed Student’s <italic>t</italic>-tests. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg1</italic>, **p&lt;0.01; <italic>n</italic> = 5 mice (73 cells) for controls and 5 mice (94 cells) for mutants. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg3</italic>, p=0.867; <italic>n</italic> = 6 mice (96 cells) for controls and 6 mice (100 cells) for mutants. (<bold>D</bold>) Confocal images (top three panels) and binary images (bottom panel) illustrating presynaptic VGlut1+ puncta (blue) in tdTomato+ axons (red) of pyramidal cells located in close apposition to PSD95+ clusters (green) in PV+ interneurons (gray) in controls, <italic>Nrg1</italic> and <italic>Nrg3</italic> conditional mutant mice. (<bold>E</bold>) Quantification of the density of VGlut1+/PSD95+/tdTomato+ synapses contacting PV+ interneurons in <italic>Nrg1</italic> and <italic>Nrg3</italic> conditional mutant mice. Two-tailed Student’s <italic>t</italic>-tests. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg1</italic>, p=0.993; <italic>n</italic> = 5 mice (101 cells) for controls and 5 mice (110 cells) for mutants. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg3</italic>, **p&lt;0.01; <italic>n</italic> = 6 mice (126 cells) for controls and 6 mice (123 cells) for mutants. Scale bars, 1 µm. Data represent mean ± s.e.m. The averages per animal and genotype are represented in bar graphs, and the distributions of values per cell are shown in cumulative frequency plots. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref> and <xref ref-type="supplementary-material" rid="fig1sdata2">Figure 1—source data 2</xref>.</p><p> <supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Numerical data of inhibitory and excitatory synapses in conditional mutant mice for Nrg1 and Nrg3.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig1-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Summary of data and statistics that are represented in graphs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig1-data2-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Cellular expression of <italic>Nrg1</italic> and <italic>Nrg3</italic> mRNA in the mouse cerebral cortex, related to <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title><p>(<bold>A</bold>) Single-molecule fluorescent in situ hybridization with <italic>Nrg1</italic> and <italic>Nrg3</italic> RNAscope probes in coronal sections through somatosensory cortex at P30. <italic>Nrg1</italic> and <italic>Nrg3</italic> mRNA expression is abundantly detected across layers 2–6 in the mouse cerebral cortex. (<bold>B</bold>) mRNA expression of <italic>Nrg1</italic> and <italic>Nrg3</italic> in pyramidal cells across cortical layers at P56. The violin plots depict single-cell RNA-sequencing data from the RNA-Seq Data Navigator at the Allen Brain Atlas (<ext-link ext-link-type="uri" xlink:href="http://celltypes.brain-map.org/rnaseq/mouse">http://celltypes.brain-map.org/rnaseq/mouse</ext-link>). Scale bars, 50 µm (<bold>A</bold>) and 10 µm (high magnifications).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Postnatal deletion of <italic>Nrg1</italic> or <italic>Nrg3</italic> from cortical pyramidal cells does not affect the density and distribution of PV+ interneurons, related to <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title><p>(<bold>A</bold>) Schematic of experimental design. Conditional deletion of <italic>Nrg1</italic> or <italic>Nrg3</italic> in pyramidal cells was achieved by tamoxifen injection in newly born pups at P0. (<bold>B</bold>) Expression of tdTomato in the cerebral cortex of <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdT</sup></italic> mice at P30 following tamoxifen injection at P0 illustrates the extent of genetic recombination. (<bold>C</bold>) Coronal sections through the somatosensory cortex processed for immunohistochemistry against parvalbumin (PV) (magenta) and counterstained with DAPI (gray) in control and conditional neuregulin mutant mice. (<bold>D</bold>) Quantification of the distribution and density of PV+ cells in pyramidal cell-specific <italic>Nrg1</italic> and <italic>Nrg3</italic> mutant mice and control littermates at P30. Distribution in <italic>Nrg1</italic> mutants: Kruskal-Wallis rank sum test, <italic>F</italic> = 0.018, p=0.894; <italic>n</italic> = 7 mice (63 regions of interest, ROIs) for controls and 5 mice (45 ROIs) for mutants. Density in <italic>Nrg1</italic> mutants: Mann-Whitney <italic>U</italic>-test, p=0.876; <italic>n</italic> = 7 mice (63 ROIs) for controls and 5 mice (45 ROIs) for mutants. Distribution in <italic>Nrg3</italic> mutants: Kruskal-Wallis rank sum test, <italic>F</italic> = 0.059, p=0.824; n = 6 mice (50 ROIs) for controls and 6 mice (51 ROIs) for mutants. Density in <italic>Nrg3</italic> mutants: Two-tailed Student’s <italic>t</italic>-test, p=0.425; <italic>n</italic> = 6 mice (50 ROIs) for controls and 6 mice (51 ROIs) for mutants. Scale bars, 400 µm (<bold>B</bold>) and 50 µm (<bold>C</bold>). Data are shown as mean ± s.e.m. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig1s2sdata1">Figure 1—figure supplement 2—source data 1</xref>.</p><p> <supplementary-material id="fig1s2sdata1"><label>Figure 1—figure supplement 2—source data 1.</label><caption><title>Numerical data of PV+ cell densities in conditional mutant mice for Nrg1 and Nrg3.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig1-figsupp2-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Extended view of synaptic labeling and analysis in brain slices from wild-type and conditional mutant mice.</title><p>(<bold>A</bold>) Coronal sections through the somatosensory cortex processed for immunohistochemistry against GAD65 (magenta) and CB1R (cyan) in control and conditional neuregulin mutant mice. The arrowhead indicates the localization of the synaptic puncta shown in the high-magnification image. (<bold>B</bold>) Quantification of the proportion of CB1R+ puncta that are co-labeled with GAD65. Two-tailed Student’s <italic>t</italic>-tests. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg1</italic>, p=0.329; <italic>n</italic> = 4 mice (40 ROIs) for controls and four mice (40 ROIs) for mutants. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg3</italic>, p=0.461; <italic>n</italic> = 4 mice (40 ROIs) for controls and 4 mice (40 ROIs) for mutants. (<bold>C</bold>) Coronal sections through the somatosensory cortex processed for immunohistochemistry against Synaptotagmin-2 (magenta) and gephyrin (cyan) in control and conditional neuregulin mutant mice. The arrowhead indicates the localization of the synaptic puncta shown in the high-magnification image. (<bold>D</bold>) Quantification of the proportion of Syt2+ puncta that are co-labeled with gephyrin. Two-tailed Student’s <italic>t</italic>-tests. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg1</italic>, p=0.739; <italic>n</italic> = 4 mice (40 ROIs) for controls and 4 mice (40 ROIs) for mutants. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg3</italic>, p=0.799; <italic>n</italic> = 4 mice (40 ROIs) for controls and 4 mice (40 ROIs) for mutants. (<bold>E</bold>) Coronal sections through the somatosensory cortex processed for immunohistochemistry against VGlut1 (green) and PSD95 (red) in control and conditional neuregulin mutant mice. The arrowhead indicates the localization of the synaptic puncta shown in the high-magnification image. (<bold>F</bold>) Quantification of the proportion of VGlut1+ puncta that are co-labeled with PSD95. Two-tailed Student’s <italic>t</italic>-tests. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg1</italic>, p=0.552; <italic>n</italic> = 4 mice (40 ROIs) for controls and 4 mice (40 ROIs) for mutants. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg3</italic>, p=0.741; <italic>n</italic> = 4 mice (40 ROIs) for controls and 4 mice (40 ROIs) for mutants. Scale bars, 5 µm (<bold>A, C, E</bold>) and 0.5 µm (high magnifications). Data from distributions of ROIs are shown as box plots, and the adjacent data points and lines represent the averages per animal and averaged mean per group, respectively. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig1s3sdata1">Figure 1—figure supplement 3—source data 1</xref>.</p><p> <supplementary-material id="fig1s3sdata1"><label>Figure 1—figure supplement 3—source data 1.</label><caption><title>Numerical data of synaptic colocalizations in conditional mutant mice for Nrg1 and Nrg3.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig1-figsupp3-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig1-figsupp3-v2.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>Loss of axo-axonic boutons in cortical pyramidal cells lacking <italic>Nrg1</italic> but not <italic>Nrg3</italic>, related to <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title><p>(<bold>A</bold>) Schematic of experimental design. Conditional deletion of <italic>Nrg1</italic> or <italic>Nrg3</italic> in pyramidal cells (PC) was achieved by tamoxifen (TM) injection in newly born pups at P0. Inhibitory synapses made by chandelier cells (ChC) onto the axon initial segment (AIS) of pyramidal cells (GAD67, pIκBα) were analyzed in these experiments. (<bold>B</bold>) Confocal images (left) and binary images used for quantification (right), showing GAD67+ boutons (magenta, arrowheads) contacting the AIS (cyan) of pyramidal cells in controls, <italic>Nrg1</italic> and <italic>Nrg3</italic> conditional mutant mice. (<bold>C</bold>) Quantification of the density of axo-axonic inhibitory boutons contacting pyramidal cells in controls, <italic>Nrg1</italic> and <italic>Nrg3</italic> conditional mutant mice. Mann-Whitney <italic>U</italic>-test: for <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg1</italic>, **p&lt;0.01; n = 6 mice (178 cells) for controls and six mice (196 cells) for mutants. Two-tailed Student’s <italic>t</italic>-test: for <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg3</italic>, p=0.959; <italic>n</italic> = 5 mice (139 cells) for controls and 5 mice (127 cells) for mutants. ChC, chandelier cell; PC, pyramidal cell. Scale bars, 1 µm. Data are shown as mean ± s.e.m. The averages per animal and genotype are represented in bar graphs, and the distributions of values per cell are shown in cumulative frequency plots. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig1s4sdata1">Figure 1—figure supplement 4—source data 1</xref>.</p><p> <supplementary-material id="fig1s4sdata1"><label>Figure 1—figure supplement 4—source data 1.</label><caption><title>Numerical data of axo-axonic synapses in conditional mutant mice for Nrg1 and Nrg3.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig1-figsupp4-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig1-figsupp4-v2.tif"/></fig><fig id="fig1s5" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 5.</label><caption><title>Density of inhibitory somatic synapses formed by PV+ basket cells onto pyramidal cells in conditional mutant mice for <italic>Nrg1</italic> or <italic>Nrg3</italic>, related to <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title><p>(<bold>A</bold>) Schematic of experimental design. Conditional deletion of <italic>Nrg1</italic> or <italic>Nrg3</italic> in pyramidal cells (PC) was achieved by tamoxifen (TM) injection in newly born pups at P0. Inhibitory synapses made by parvalbumin (PV)+ basket cells onto the soma of pyramidal cells (Syt2, Gephyrin) were analyzed in these experiments. (<bold>B</bold>) Confocal images (top three panels) and binary images (bottom panels) illustrating presynaptic GABAergic boutons labeled with synaptotagmin 2 (Syt2) (magenta) in close apposition to Gephyrin+ clusters (cyan) on the surface of tdTomato+ pyramidal cell somas (gray) in controls and <italic>Nrg1</italic> and <italic>Nrg3</italic> conditional mutant mice. (<bold>C</bold>) Quantification of the density of Syt2+ boutons contacting pyramidal cells in controls and <italic>Nrg1</italic> and <italic>Nrg3</italic> conditional mutant mice. Two-tailed Student’s <italic>t</italic>-tests. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg1</italic>, p=0.803; <italic>n</italic> = 4 mice (108 cells) for controls and four mice (109 cells) for mutants. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg3</italic>, p=0.618; <italic>n</italic> = 3 mice (70 cells) for controls and three mice (80 cells) for mutants. (<bold>D</bold>) Quantification of the density of Syt2+/Gephyrin+ synapses formed onto pyramidal cells in controls and <italic>Nrg1</italic> and <italic>Nrg3</italic> conditional mutant mice. Two-tailed Student’s <italic>t</italic>-tests. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg1</italic>, p=0. 828; <italic>n</italic> = 4 mice (108 cells) for controls and 4 mice (109 cells) for mutants. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg3</italic>, p=0. 609; <italic>n</italic> = 3 mice (70 cells) for controls and 3 mice (80 cells) for mutants. PC, pyramidal cell; PV, parvalbumin+ basket cell. Scale bars, 1 µm. Data are shown as mean ± s.e.m. The averages per animal and genotype are represented in bar graphs, and the distributions of values per cell are shown in cumulative frequency plots. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig1s5sdata1">Figure 1—figure supplement 5—source data 1</xref>.</p><p> <supplementary-material id="fig1s5sdata1"><label>Figure 1—figure supplement 5—source data 1.</label><caption><title>Numerical data of PV+ basket cell synapses in conditional mutant mice for Nrg1 and Nrg3.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig1-figsupp5-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig1-figsupp5-v2.tif"/></fig><fig id="fig1s6" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 6.</label><caption><title>Density of tamoxifen-induced recombined pyramidal cells, related to <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title><p>(<bold>A</bold>) Schematic of experimental design. Conditional deletion of <italic>Nrg1</italic> or <italic>Nrg3</italic> in pyramidal cells (PC) was achieved by tamoxifen (TM) injection in newly born pups at P0. (<bold>B</bold>) Quantification of the density of tdTomato+ pyramidal cells at P30. Two-tailed Student’s <italic>t</italic>-tests. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg1</italic>, p=0.929; <italic>n</italic> = 5 mice (18 regions of interest, ROIs) for controls and 5 mice (18 ROIs) for mutants. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg3</italic>, p=0.869; <italic>n</italic> = 5 mice (18 ROIs) for controls and 5 mice (18 ROIs) for mutants. Data are shown as mean ± s.e.m. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig1s6sdata1">Figure 1—figure supplement 6—source data 1</xref>.</p><p> <supplementary-material id="fig1s6sdata1"><label>Figure 1—figure supplement 6—source data 1.</label><caption><title>Numerical data of tdT+ cell densities in conditional mutant mice for Nrg1 and Nrg3.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig1-figsupp6-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig1-figsupp6-v2.tif"/></fig><fig id="fig1s7" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 7.</label><caption><title>Cell-autonomous requirement of Nrg3 in excitatory synapse formation, related to <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title><p>(<bold>A</bold>) Schematic of experimental design. Conditional deletion of <italic>Nrg1</italic> or <italic>Nrg3</italic> in pyramidal cells (PC) was achieved by tamoxifen (TM) injection in newly born pups at P0. (<bold>B</bold>) Quantification of the density of VGlut1+/PSD95+ synapses that do not arise from tdTomato+ pyramidal cell axons (tdTomato-) at P30. Two-tailed Student’s <italic>t</italic>-tests. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg1</italic>, p=0.360; <italic>n</italic> = 5 mice (101 cells) for controls and 5 mice (110 cells) for mutants. For <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdt</sup>;Nrg3</italic>, p=0.940; <italic>n</italic> = 6 mice (126 cells) for controls and 6 mice (123 cells) for mutants. Data are shown as mean ± s.e.m. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig1s7sdata1">Figure 1—figure supplement 7—source data 1</xref>.</p><p> <supplementary-material id="fig1s7sdata1"><label>Figure 1—figure supplement 7—source data 1.</label><caption><title>Numerical data of tdT-negative excitatory synapses in conditional mutant mice for Nrg1 and Nrg3.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig1-figsupp7-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig1-figsupp7-v2.tif"/></fig></fig-group><p>We next examined the function of neuregulins in the formation of inhibitory synapses by chandelier cells. We observed that the AIS of cortical pyramidal cells lacking <italic>Nrg1</italic> received significantly fewer GAD67+ boutons (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>). In contrast, we observed that the density of axo-axonic boutons is unaltered following deletion of <italic>Nrg3</italic> from pyramidal cells (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>). These results reinforced the idea that Nrg3 function is dispensable for the development of inhibitory synaptic inputs on pyramidal cells, a function that is mediated by Nrg1.</p><p>To establish whether Nrg1 functions in specific inhibitory circuits that are dependent on ErbB4 function (chandelier and CCK+ basket cell synapses) or is generally required for GABAergic synaptogenesis, we analyzed the number of PV+ basket cell synapses contacting pyramidal cells lacking specific neuregulins. We used Synaptotagmin-2 (Syt2) to specifically identify the presynaptic compartment of these synapses (<xref ref-type="bibr" rid="bib41">Sommeijer and Levelt, 2012</xref>). We found no differences in the density of Syt2+ boutons or Syt2+/Gephyrin+ synaptic puncta contacting the soma of pyramidal cells lacking <italic>Nrg1</italic> compared to controls (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5</xref>). These results are consistent with the hypothesis that Nrg1 plays a predominant role in the formation of inhibitory connections between specific types of interneurons (chandelier cells and CCK+ basket cells) and pyramidal cells. In addition, as expected from our previous results which suggest that Nrg3 is not involved in inhibitory synapse formation, we also observed that pyramidal cells lacking <italic>Nrg3</italic> receive a normal complement of PV+ basket cell synapses (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5</xref>).</p><p>We next investigated the potential role of neuregulins in the assembly of excitatory synapses onto PV+ interneurons, since ErbB4 is located at these synapses and is essential for their formation (<xref ref-type="bibr" rid="bib9">Del Pino et al., 2017</xref>; <xref ref-type="bibr" rid="bib8">Del Pino et al., 2013</xref>; <xref ref-type="bibr" rid="bib15">Fazzari et al., 2010</xref>; <xref ref-type="bibr" rid="bib44">Ting et al., 2011</xref>). To this end, we selected regions of interest (ROIs) within layer 2/3 of the somatosensory cortex of control and neuregulin conditional mutant mice that exhibit comparable densities of tdTomato+ pyramidal cells (<xref ref-type="fig" rid="fig1s6">Figure 1—figure supplement 6</xref>). To identify excitatory synapses, we used vesicular glutamate transporter 1 (VGlut1), a characteristic component of excitatory glutamatergic terminals, and PSD95, the major scaffolding protein in the excitatory postsynaptic density. We quantified the density of VGlut1+/PSD95+ synapses within the population of tdTomato<italic>-</italic>expressing axonal terminals contacting PV+ interneurons. We found that conditional deletion of <italic>Nrg1</italic> from pyramidal cells does not alter the density of excitatory synapses these neurons make onto PV+ interneurons (<xref ref-type="fig" rid="fig1">Figure 1A,D–E</xref>). In contrast, we observed a significant reduction in the density of excitatory synapses targeting PV+ interneurons when pyramidal cells lacked <italic>Nrg3</italic> (<xref ref-type="fig" rid="fig1">Figure 1A,D–E</xref>). Of note, quantification of VGlut1+/PSD95+ synapses that did not contain tdTomato (i.e. arising from non-recombined, wild-type pyramidal neurons) revealed comparable values between control and conditional mutant mice (<xref ref-type="fig" rid="fig1s7">Figure 1—figure supplement 7</xref>), which reinforced the notion that synaptic deficits in conditional mutants are cell-autonomous.</p><p>Altogether, these genetic experiments reveal that Nrg1 and Nrg3 control inhibitory (inputs) and excitatory (outputs) synapse formation independently in pyramidal cells. Nrg1 mediates inhibitory synapse formation onto pyramidal cells, whereas Nrg3 controls excitatory synapse formation onto interneurons.</p></sec><sec id="s2-2"><title>Gain-of-function experiments support independent roles for Nrg1 and Nrg3</title><p>To strengthen the interesting observation of specific and non-overlapping synaptic deficits in <italic>Nrg1</italic> and <italic>Nrg3</italic> conditional mutant mice, we performed gain-of-function experiments by electroporating plasmids encoding <italic>Nrg1</italic> or <italic>Nrg3</italic> into pyramidal cell progenitors in embryonic day (E) 14.5 mouse embryos. We used Type III Neuregulin 1 (hereafter referred to as Nrg1), because it is the most abundant Nrg1 isoform in the cerebral cortex during synaptogenesis (<xref ref-type="bibr" rid="bib15">Fazzari et al., 2010</xref>; <xref ref-type="bibr" rid="bib30">Longart et al., 2004</xref>). Pyramidal neurons born from the electroporated progenitor cells were labeled by GFP, which was expressed from the same plasmids (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). We observed that overexpression of Nrg1 or Nrg3 in embryonic pyramidal cells did not impair their migration and allocation into the cortex at P30 (data not shown). We next quantified the densities of inhibitory and excitatory synapses made onto or by GFP+ pyramidal cells at P30. To this end, we selected ROIs within layer 2/3 of the somatosensory cortex of electroporated mice that exhibit comparable densities of GFP+ pyramidal cells (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Of note, our ability to detect synaptic clusters via immunofluorescence was comparable among the different experimental conditions (<xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>). We observed that overexpression of Nrg1 resulted in a significant increase of somatic GAD65+/CB1R+ boutons innervating pyramidal cells, while Nrg3 overexpression did not change the density of these synaptic inputs (<xref ref-type="fig" rid="fig2">Figure 2B–C</xref>). In contrast, axonal excitatory synapses that pyramidal cells form onto PV+ interneurons were specifically increased by overexpression of Nrg3, but not Nrg1 (<xref ref-type="fig" rid="fig2">Figure 2D–E</xref>). These experiments add further support to the notion that Nrg1 and Nrg3 function in cortical pyramidal cells to induce the formation of inhibitory and excitatory synapses, respectively.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Gain-of-function experiments show the specificity of Nrg1 and Nrg3 in inhibitory and excitatory synapse formation.</title><p>(<bold>A</bold>) Schematic of experimental design. In utero electroporation of <italic>pSyn-Gfp</italic> (control), <italic>pSyn-Nrg1-pSyn-Gfp</italic>, or <italic>pSyn-Nrg3-pSyn-Gfp</italic> plasmids into pyramidal cell progenitors was performed at E14.5 mouse embryos, and the density of synapses was analyzed in cortical superficial layers at P30: inhibitory synapses formed by CCK+ basket cells onto the soma of pyramidal cells (GAD65, CB1R), and excitatory synapses made by pyramidal cells onto PV+ interneurons (VGlut1, PSD95). (<bold>B</bold>) Confocal images (top three panels) and binary images (bottom panel) illustrating presynaptic GABAergic boutons co-labeled with GAD65 (magenta) and CB1R (cyan) contacting the soma of GFP+ pyramidal cells (gray) in electroporated mice. (<bold>C</bold>) Quantification of the density of GAD65+/CB1R+ boutons formed onto GFP+ pyramidal cell somas in gain-of-function experiments. One-way ANOVA: <italic>F</italic> = 11.100, p&lt;0.01. Tukey’s range test for post hoc comparison between control and experimental groups: for <italic>pSyn-Nrg1-pSyn-Gfp</italic>, **p&lt;0.01; for <italic>pSyn-Nrg3-pSyn-Gfp</italic>, p=0.976; n = 5 mice (80 cells) for <italic>pSyn-Gfp</italic> (control), 4 mice (61 cells) for <italic>pSyn-Nrg1-pSyn-Gfp</italic>, and 5 mice (87 cells) for <italic>pSyn-Nrg3-pSyn-Gfp</italic>. (<bold>D</bold>) Confocal images (top three panels) and binary images (bottom panel) illustrating presynaptic VGlut1+ puncta (blue) in GFP+ axons (green) of pyramidal cells located in close apposition to PSD95+ clusters (red) in PV+ interneurons (gray) in electroporated mice. (<bold>E</bold>) Quantification of the density of VGlut1+/PSD95+/GFP+ synapses contacting PV+ interneurons in gain-of-function experiments. One-way ANOVA: <italic>F</italic> = 22.120, p&lt;0.001. Tukey’s range test for post hoc comparison between control and experimental groups: for <italic>pSyn-Nrg1-pSyn-Gfp</italic>, p=0.999; for <italic>pSyn-Nrg3-pSyn-Gfp</italic>, ***p&lt;0.001; n = 8 mice (147 cells) for <italic>pSyn-Gfp</italic>, 5 mice (116 cells) for <italic>pSyn-Nrg1-pSyn-Gfp</italic>, and 6 mice (101 cells) for <italic>pSyn-Nrg3-pSyn-Gfp</italic>. Scale bars, 1 µm (<bold>B, D</bold>). Data represent mean ± s.e.m. The averages per animal and genotype are represented in bar graphs, and the distributions of values per cell are shown in cumulative frequency plots. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig2sdata1">Figure 2—source data 1</xref>.</p><p> <supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Numerical data of inhibitory and excitatory synapses in gain-of-function experiments.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig2-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Density of electroporated cortical pyramidal cells in gain-of-function experiments, related to <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title><p>(<bold>A</bold>) Schematic of experimental design. Gain-of-function experiments were performed by in utero electroporation of the somatosensory cortex at E14.5 and analysis at P30. The coronal section illustrates the expression of GFP in a typical experiment. (<bold>B</bold>) Quantification of the density of GFP+ cells in the somatosensory cortex of mice following electroporation of control and wild-type neuregulin-expressing plasmids. One-way ANOVA, <italic>F</italic> = 0.026, p=0.975; <italic>n</italic> = 8 mice (24 regions of interest, ROIs) for <italic>pSyn-Gfp</italic> (control), 5 mice (16 ROIs) for <italic>pSyn-Nrg1-pSyn-Gfp</italic>, and 5 mice (16 ROIs) for <italic>pSyn-Nrg3-pSyn-Gfp</italic>. (<bold>C</bold>) Quantification of the density of GFP+ cells in the somatosensory cortex of mice following electroporation of control and chimeric neuregulin-expressing plasmids. One-way ANOVA, <italic>F</italic> = 0.054, p=0.994; <italic>n</italic> = 8 mice (30 ROIs) for <italic>pSyn-Gfp</italic> (control), 7 mice (24 ROIs) for <italic>pSyn-Nrg1<sup>Ct:Nrg3</sup>-pSyn-Gfp</italic>, 7 mice (24 ROIs) for <italic>pSyn-Nrg3<sup>Ct:Nrg1</sup>-pSyn-Gfp</italic>, 6 mice (22 ROIs) for <italic>pSyn-Nrg1<sup>EGF:Nrg3</sup>-pSyn-Gfp</italic>, and 6 mice (22 ROIs) for <italic>pSyn-Nrg3<sup>EGF:Nrg1</sup>-pSyn-Gfp</italic>. Scale bar, 400 µm. Data are shown as mean ± s.e.m. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig2s1sdata1">Figure 2—figure supplement 1—source data 1</xref>.</p><p> <supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Numerical data of GFP+ cell densities in gain-of-function experiments.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig2-figsupp1-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Extended view of synaptic labelling and analysis in brain slices from wild-type and electroporated mice.</title><p>(<bold>A</bold>) Coronal sections through the somatosensory cortex processed for immunohistochemistry against GAD65 (magenta) and CB1R (cyan) in control and conditional neuregulin mutant mice. The arrowhead indicates the localization of the synaptic puncta shown in the high magnification image. (<bold>B</bold>) Quantification of the proportion of CB1R+ puncta that are co-labeled with GAD65. One-way ANOVA: <italic>F</italic> = 0.860, p=0.455. For <italic>pSyn-Gfp</italic> (control), n = 4 mice (40 ROIs); for <italic>pSyn-Nrg1-pSyn-Gfp</italic>, four4 mice (40 ROIs); for <italic>pSyn-Nrg3<sup>EGF:Nrg1</sup>-pSyn-Gfp</italic>, 4 mice (40 ROIs). (<bold>C</bold>) Coronal sections through the somatosensory cortex processed for immunohistochemistry against VGlut1 (green) and PSD95 (red) in control and conditional neuregulin mutant mice. The arrowhead indicates the localization of the synaptic puncta shown in the high=magnification image. (<bold>D</bold>) Quantification of the proportion of VGlut1+ puncta that are co-labeled with PSD95. One-way ANOVA: <italic>F</italic> = 1.324, p=0.313. For <italic>pSyn-Gfp</italic> (control), n = 4 mice (40 ROIs); for <italic>pSyn-Nrg1-pSyn-Gfp</italic>, 4 mice (40 ROIs); for <italic>pSyn-Nrg3<sup>EGF:Nrg1</sup>-pSyn-Gfp</italic>, 4 mice (40 ROIs). Scale bars, 5 µm (<bold>A, C</bold>) and 0.5 µm (high magnifications). Data from distributions of ROIs are shown as box plots, and the adjacent data points and lines represent the averages per animal and averaged mean per group, respectively. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig2s2sdata1">Figure 2—figure supplement 2—source data 1</xref>.</p><p> <supplementary-material id="fig2s2sdata1"><label>Figure 2—figure supplement 2—source data 1.</label><caption><title>Numerical data of synaptic colocalizations in gain-of-function experiments.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig2-figsupp2-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig2-figsupp2-v2.tif"/></fig></fig-group></sec><sec id="s2-3"><title>Differential subcellular localization of neuregulins in pyramidal cells</title><p>We hypothesized that Nrg1 and Nrg3 differentially control the development of inhibitory and excitatory synapses in cortical circuits because they are targeted to different subcellular compartments in pyramidal cells. To explore this possibility, we performed another series of in utero electroporation experiments in which we expressed HA-tagged constructs of Nrg1 and Nrg3 in pyramidal cells (<xref ref-type="fig" rid="fig3">Figure 3A</xref>) and monitored the localization of both proteins at specific synapses. We found that Nrg1 and Nrg3 exhibit differential subcellular localization in pyramidal cells: whereas Nrg1 is spatially restricted to the perisomatic compartment of pyramidal cells, Nrg3 is highly enriched in the neuropil (<xref ref-type="fig" rid="fig3">Figure 3B–C</xref>). Analysis of endogenous protein expression by immunohistochemistry, using <italic>Nrg1</italic> and <italic>Nrg3</italic> conditional mutant as controls, confirmed these findings. For example, we observed the highest density of Nrg1+ puncta in the stratum pyramidale—the targeting layer of inhibitory somatic synapses in the hippocampus—in close apposition to GAD65+ inhibitory boutons (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). In contrast, Nrg3+ clusters were found to be particularly abundant within VGlut1+ presynaptic boutons coating the somatodendritic compartment of PV+ interneurons both in the hippocampus and neocortex (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>), a finding consistent with previous studies (<xref ref-type="bibr" rid="bib34">Müller et al., 2018</xref>). Altogether, these results revealed that Nrg1 and Nrg3 are differentially distributed across distinct subcellular compartments in pyramidal cells.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Nrg1 and Nrg3 have distinct subcellular distribution in pyramidal cells.</title><p>(<bold>A</bold>) Schematic of experimental design. Plasmids encoding HA-tagged neuregulins and GFP were electroporated in pyramidal cell progenitors at E14.5, and the subcellular localization of neuregulins was analyzed at P21. The schematics depict the protein structure of neuregulins indicating the insertion of the HA tag in the extracellular. N, N-terminal domain; EGF, EGF-like domain; TMD, transmembrane domain; C, C-terminal domain. (<bold>B</bold>) Coronal sections through somatosensory cortex of P21 mice following in utero electroporation of <italic>pSyn-Nrg1-pSyn-Gfp</italic> or <italic>pSyn-Nrg3-pSyn-Gfp</italic> plasmids at E14.5. Sections were processed for immunohistochemistry against GFP (green) and HA (magenta) and counterstained with DAPI (gray). The high magnification images illustrate the localization of HA-tagged neuregulins in GFP+ pyramidal cells. The bottom panel depicts HA staining in a color-inverted image. Dotted squares indicate the localization of the cells shown in the high magnification images. (<bold>C</bold>) Quantification of the localization of HA+ neuregulin in the soma and neuropil of GFP+ pyramidal cells. Soma: Two-tailed Student’s <italic>t</italic>-test, ***p&lt;0.001; <italic>n</italic> = 4 mice (32 regions of interest, ROIs) for <italic>pSyn-Nrg1-pSyn-Gfp</italic>, <italic>n</italic> = 4 mice (32 ROIs) for <italic>pSyn-Nrg3-pSyn-Gfp</italic>. Neuropil: Two-tailed Student’s <italic>t</italic>-test, ***p&lt;0.001; <italic>n</italic> = 4 mice (32 ROIs) for <italic>pSyn-Nrg1-pSyn-Gfp</italic>, <italic>n</italic> = 4 mice (32 ROIs) for <italic>pSyn-Nrg3-pSyn-Gfp</italic>. (<bold>D</bold>) Localization of neuregulins with synaptic markers. Somatic Nrg1+ clusters (magenta) co-localize with Gephyrin (cyan) in the soma of pyramidal cells (green) in close proximity to presynaptic GABAergic boutons co-labeled by GAD65 (cyan). Nrg3+ clusters (magenta) co-localize with VGlut1+ (yellow) in presynaptic GFP+ axon terminals of pyramidal cells in close proximity to postsynaptic PSD95 clusters (yellow) in PV+ interneurons (gray). Dotted squares indicate the localization of the synaptic puncta shown in the high-magnification images. (<bold>E</bold>) Schematic illustrating the subcellular localization of Nrg1, Nrg3, and ErbB4 in cortical circuits. Scale bars, 50 µm (<bold>B</bold>) and 20 µm (high magnifications), and 2 µm (<bold>D</bold>) and 1 µm (high magnifications). Data from the distributions of ROIs are shown as box plots, and the adjacent data points and lines represent the averages per animal and averaged mean per group, respectively. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>.</p><p> <supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Numerical data of subcellular localization of HA-tagged neuregulin constructs in electroporated pyramidal cells.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig3-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Localization of endogenous Nrg1 in somas of cortical neurons, and specific targeting to inhibitory GABAergic clusters.</title><p>(<bold>A</bold>) Expression of endogenous Nrg1 protein (magenta) in the hippocampus of wild-type mice at P30, co-stained with NeuN marker (green) to label the cell bodies of neurons. The bottom panel depicts Nrg1 staining in a color-inverted image. Note the intense expression of Nrg1 along the Stratum Pyramidale in CA1 region, where the somas of pyramidal cells reside. (B–C) Coronal sections through CA1 region of <italic>Neurod6<sup>+/+</sup>;Nrg1<sup>F/F</sup></italic> (<bold>B</bold>) and <italic>Neurod6<sup>Cre/+</sup>;Nrg1<sup>F/F</sup></italic> (<bold>C</bold>) mice at P30. Sections were processed for immunohistochemistry against Nrg1 (magenta) and NeuN (green). The high-magnification images illustrate Nrg1+ puncta expression within the Stratum Pyramidale and Stratum Radiatum. Note that endogenous Nrg1 protein is abundantly expressed in the Stratum Pyramidale, where the somas of pyramidal cells are located. (<bold>D</bold>) Quantification of the density of Nrg1+ clusters in regions of interest (ROIs) in both the Stratum Pyramidale and Stratum Radiatum of conditional mutant mice and wild-type littermates. Stratum Pyramidale: Two-tailed Student’s <italic>t</italic>-test, ***p&lt;0.001, n = 4 mice (40 ROIs) for <italic>Neurod6<sup>+/+</sup>;Nrg1<sup>F/F</sup></italic>, n = 4 mice (40 ROIs) for <italic>Neurod6<sup>Cre/+</sup>;Nrg1<sup>F/F</sup></italic>. Stratum Radiatum: Two-tailed Student’s <italic>t</italic>-test, p=0.980, n = 4 mice (40 ROIs) for <italic>Neurod6<sup>+/+</sup>;Nrg1<sup>F/F</sup></italic>, n = 4 mice (40 ROIs) for <italic>Neurod6<sup>Cre/+</sup>;Nrg1<sup>F/F</sup></italic>. Two-tailed Student’s <italic>t</italic>-test between Stratum Pyramidale and Stratum Radiatum in wild-type mice, ***p&lt;0.001. (<bold>E</bold>) Schematic illustrating the synaptic innervation of GABAergic boutons (labeled with the presynaptic marker GAD65) onto the somatic compartment of cortical pyramidal cells. (<bold>F</bold>) Co-localization of endogenous Nrg1 (magenta) with GAD65 (cyan) in the soma of NeuN+ cells in both the cerebral cortex (left) and the hippocampus (right). Scale bar, 100 µm (<bold>A</bold>), 20 µm (<bold>B–C</bold>) and 10 µm (high magnifications), and 2 µm (<bold>F</bold>) and 0.5 µm (high magnifications). Data are shown as mean ± s.e.m. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig3s1sdata1">Figure 3—figure supplement 1—source data 1</xref>.</p><p> <supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Numerical data of puncta density of endogenous Nrg1 protein in the cerebral cortex.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig3-figsupp1-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Localization of endogenous Nrg3 in the neuropil of the neocortex, and specific targeting to excitatory presynaptic boutons innervating PV+ interneurons.</title><p>(<bold>A</bold>) Coronal sections through CA1 region (top) and cerebral cortex (bottom) of <italic>Neurod6<sup>+/+</sup>;Nrg3<sup>F/F</sup></italic> and <italic>Neurod6<sup>Cre/+</sup>;Nrg3<sup>F/F</sup></italic> mice at P30. Sections were processed for immunohistochemistry against Nrg3 (magenta) and PV (green). Endogenous Nrg3 protein is primarily found as a punctate pattern in close apposition to PV+ cell bodies. Note that the conditional deletion of Nrg3 is driven by the transgenic line <italic>Neurod6<sup>Cre</sup></italic>, which only recombines the LoxP site-flanked Nrg3 allele in pyramidal cells. Therefore, Nrg3 expression by PV+ cells can still be appreciated in the neocortex of this conditional KO model. (<bold>B</bold>) Quantification of the total density of Nrg3+ clusters in regions of interest (ROIs) in the CA1 region of conditional mutant mice and wild-type littermates, and quantification of the density of Nrg3+ clusters in apposition to, or not in contact with, PV+ cell bodies. All clusters: Two-tailed Student’s <italic>t</italic>-test, ***p&lt;0.001, n = 3 mice (36 ROIs) for <italic>Neurod6<sup>+/+</sup>;Nrg3<sup>F/F</sup></italic>, n = 3 mice (36 ROIs) for <italic>Neurod6<sup>Cre/+</sup>;Nrg3<sup>F/F</sup></italic>. In contact with PV+ cells: Two-tailed Student’s <italic>t</italic>-test, ***p&lt;0.001, n = 3 mice (44 ROIs) for <italic>Neurod6<sup>+/+</sup>;Nrg1<sup>F/F</sup></italic>, n = 3 mice (36 ROIs) for <italic>Neurod6<sup>Cre/+</sup>;Nrg1<sup>F/F</sup></italic>. Not in contact with PV+ cells: Two-tailed Student’s <italic>t</italic>-test, **p&lt;0.01, n = 3 mice (36 ROIs) for <italic>Neurod6<sup>+/+</sup>;Nrg3<sup>F/F</sup></italic>, n = 3 mice (36 ROIs) for <italic>Neurod6<sup>Cre/+</sup>;Nrg3<sup>F/F</sup></italic>. (<bold>C</bold>) Quantification of the total density of Nrg3+ clusters in regions of interest (ROIs) in the cerebral cortex of conditional mutant mice and wild-type littermates, and quantification of the density of Nrg3+ clusters in apposition to, or not in contact with, PV+ cell bodies. All clusters: Two-tailed Student’s <italic>t</italic>-test, ***p&lt;0.001, n = 3 mice (36 ROIs) for <italic>Neurod6<sup>+/+</sup>;Nrg3<sup>F/F</sup></italic>, n = 3 mice (36 ROIs) for <italic>Neurod6<sup>Cre/+</sup>;Nrg3<sup>F/F</sup></italic>. In contact with PV+ cells: Two-tailed Student’s <italic>t</italic>-test, ***p&lt;0.001, n = 3 mice (36 ROIs) for <italic>Neurod6<sup>+/+</sup>;Nrg1<sup>F/F</sup></italic>, n = 3 mice (36 ROIs) for <italic>Neurod6<sup>Cre/+</sup>;Nrg1<sup>F/F</sup></italic>. Not in contact with PV+ cells: Two-tailed Student’s <italic>t</italic>-test, p=0.269, n = 3 mice (36 ROIs) for <italic>Neurod6<sup>+/+</sup>;Nrg3<sup>F/F</sup></italic>, n = 3 mice (36 ROIs) for <italic>Neurod6<sup>Cre/+</sup>;Nrg3<sup>F/F</sup></italic>. (<bold>D</bold>) Schematic illustrating the synaptic innervation of glutamatergic boutons (labeled with the presynaptic marker VGlut1) onto cortical PV+ interneurons. (<bold>E</bold>) Co-localization of endogenous Nrg3 (magenta) with VGlut1 (green) within excitatory inputs innervating PV+ interneurons in the neocortex. Scale bar, 10 µm (<bold>A</bold>), 5 µm (<bold>E</bold>) and 0.5 µm (high magnifications). Data are shown as mean ± s.e.m. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig3s2sdata1">Figure 3—figure supplement 2—source data 1</xref>.</p><p> <supplementary-material id="fig3s2sdata1"><label>Figure 3—figure supplement 2—source data 1.</label><caption><title>Numerical data of puncta density of endogenous Nrg3 protein in the cerebral cortex.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig3-figsupp2-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>Subcellular localization and targeting of HA-tagged Nrg1 to inhibitory perisomatic inputs of cortical pyramidal cells.</title><p>(<bold>A</bold>) Co-localization of HA-tagged Nrg1 (left) and HA-tagged Nrg3 (right) (magenta) with soma-targeting GAD65+ boutons (cyan) in electroporated GFP+ pyramidal cells (green). The bottom panel depicts HA staining in a color-inverted image. The high magnification images illustrate the localization of HA-tagged neuregulins contacted by presynaptic GAD65+ boutons. (<bold>B</bold>) Quantification of the proportion of GAD65+ boutons that co-localize with HA-tagged Nrg clusters in the soma of electroporated GFP+ pyramidal cells. Two-tailed Student’s <italic>t</italic>-test: ***p&lt;0.001; n = 4 mice (34 cells) for <italic>pSyn-Nrg1-pSyn-Gfp</italic>, n = 4 mice (32 cells) for <italic>pSyn-Nrg3-pSyn-Gfp</italic>. (<bold>C</bold>) Co-localization of HA-tagged Nrg1 (left) and HA-tagged Nrg3 (right) (magenta) with soma-targeting GAD65+ boutons (cyan) in electroporated GFP+ pyramidal cells (green). The bottom panel depicts HA staining in a color-inverted image. The high-magnification images illustrate the localization of HA-tagged neuregulins contacted by presynaptic GAD65+ boutons. (<bold>D</bold>) Quantification of the proportion of GAD65+ boutons that co-localize with HA-tagged Nrg clusters in the soma of non-electroporated NeuN+/GFP– pyramidal cells. Two-tailed Student’s <italic>t</italic>-test: p=0.861; n = 4 mice (32 cells) for <italic>pSyn-Nrg1-pSyn-Gfp</italic>, n = 4 mice (32 cells) for <italic>pSyn-Nrg3-pSyn-Gfp</italic>. (<bold>E</bold>) Nrg1+ clusters (magenta) are found in the soma of pyramidal cells (green) opposed to CB1R+ terminals (cyan) from basket cells. The schematic depicts the corresponding synapse. (<bold>F</bold>) Nrg1+ clusters (magenta) are found in the axon initial segment of pyramidal cells (green), identified by expression of pIκBα (cyan). The schematic depicts the corresponding synapse. BC, basket cell; ChC, chandelier cell; PC, pyramidal cells. Scale bars, 2 µm (<bold>A, C, E, F</bold>) and 0.5 µm (high magnifications). Data in synaptic quantifications represent mean ± s.e.m. The averages per animal and electroporation condition are shown in bar graphs. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig3s3sdata1">Figure 3—figure supplement 3—source data 1</xref>.</p><p> <supplementary-material id="fig3s3sdata1"><label>Figure 3—figure supplement 3—source data 1.</label><caption><title>Numerical data of synaptic targeting of HA-tagged neuregulin constructs in electroporated (GFP+) and non-electroporated (GFP–) pyramidal cells.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig3-figsupp3-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig3-figsupp3-v2.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 4.</label><caption><title>Synaptic targeting of wild-type neuregulin constructs to excitatory presynaptic boutons innervating PV+ interneurons.</title><p>(<bold>A</bold>) Co-localization of HA-tagged Nrg1 (left) and HA-tagged Nrg3 (right) (red) with presynaptic VGlut1+ boutons (blue) in GFP+ pyramidal cell axons (green) contacting PV+ interneurons. The bottom panel depicts HA staining in a color-inverted image. The high-magnification images illustrate the co-localization of HA-tagged neuregulins with excitatory VGlut1+ boutons. (<bold>B</bold>) Quantification of the proportion of VGlut1+ boutons that co-localize with HA-tagged Nrg clusters in axon terminals of electroporated GFP+ pyramidal cells. Two-tailed Student’s <italic>t</italic>-test: ***p&lt;0.001; n = 4 mice (40 cells) for <italic>pSyn-Nrg1-pSyn-Gfp</italic>, n = 4 mice (50 cells) for <italic>pSyn-Nrg3-pSyn-Gfp</italic>. Scale bars, 2 μm (<bold>A</bold>) and 0.5 μm (high magnifications). Data in synaptic quantifications represent mean ± s.e.m. The averages per animal and electroporation condition are shown in bar graphs. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig3s4sdata1">Figure 3—figure supplement 4—source data 1</xref>.</p><p> <supplementary-material id="fig3s4sdata1"><label>Figure 3—figure supplement 4—source data 1.</label><caption><title>Numerical data of synaptic targeting of HA-tagged neuregulin constructs in axon terminals innervating PV+ interneurons.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig3-figsupp4-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig3-figsupp4-v2.tif"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 5.</label><caption><title>Targeting of HA-tagged Nrg3 to axon terminals innervating PV+ interneurons in layer 5 of the cerebral cortex.</title><p>(<bold>A</bold>) Schematic illustrating the axonal targeting of superficial pyramidal cells onto PV+ interneurons in cortical layer 5 (<bold>L5</bold>). (<bold>B</bold>) Coronal sections through somatosensory cortex of P21 following in utero electroporation of <italic>pSyn-Nrg1-pSyn-Gfp</italic> or <italic>pSyn-Nrg3-pSyn-Gfp</italic> at E14.5. Sections were processed for immunohistochemistry against GFP (green) and HA (magenta) and counterstained with DAPI (gray). (<bold>C</bold>) Confocal images showing co-localization of GFP+ axon terminals (green) from electroporated pyramidal cells with HA-tagged Nrg1 or HA-tagged Nrg3 (red) in L5. (<bold>D</bold>) Quantification of the localization of HA-tagged neuregulin clusters in axon terminals of GFP+ pyramidal cells. Two-tailed Student’s <italic>t</italic>-test: ***p&lt;0.001; n = 4 mice (36 ROIs) for <italic>pSyn-Nrg1-pSyn-Gfp</italic>, n = 4 mice (36 ROIs) for <italic>pSyn-Nrg3-pSyn-Gfp</italic>. (<bold>E</bold>) Co-localization of HA-tagged Nrg1 (left) and HA-tagged Nrg3 (right) (red) with presynaptic VGlut1+ boutons (blue) in GFP+ pyramidal cell axons (green) contacting PV+ interneurons (gray). The color-inverted image corresponds to HA staining and illustrates the localization of HA-tagged Nrg clusters opposed to PV+ cell bodies in L5. The high-magnification images illustrate the co-localization of HA-tagged neuregulins with excitatory VGlut1+ boutons. (<bold>F</bold>) Quantification of the proportion of VGlut1+ boutons that co-localize with HA-tagged neuregulin clusters in axon terminals of electroporated GFP+ pyramidal cells contacting L5 PV+ interneurons. Two-tailed Student’s <italic>t</italic>-test: ***p&lt;0.001; n = 4 mice (42 cells) for <italic>pSyn-Nrg1-pSyn-Gfp</italic>, n = 4 mice (34 cells) for <italic>pSyn-Nrg3-pSyn-Gfp</italic>. Scale bars, 50 μm (<bold>B</bold>), 10 μm (<bold>C</bold>), and 2 μm (<bold>E</bold>) and 0.5 μm (high magnifications). Data from distributions of ROIs are shown as box plots, and the adjacent data points and lines represent the averages per animal and averaged mean per group, respectively. Data in synaptic quantifications represent mean ± s.e.m. The averages per animal and electroporation condition are shown in bar graphs. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig3s5sdata1">Figure 3—figure supplement 5—source data 1</xref> and <xref ref-type="supplementary-material" rid="fig3s5sdata2">Figure 3—figure supplement 5—source data 2</xref>.</p><p> <supplementary-material id="fig3s5sdata1"><label>Figure 3—figure supplement 5—source data 1.</label><caption><title>Numerical data of neuropil colocalization of HA-tagged neuregulin constructs in layer 5.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig3-figsupp5-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig3s5sdata2"><label>Figure 3—figure supplement 5—source data 2.</label><caption><title>Numerical data of synaptic targeting of HA-tagged neuregulin constructs in axon terminals innervating PV+ interneurons in layer 5.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig3-figsupp5-data2-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig3-figsupp5-v2.tif"/></fig><fig id="fig3s6" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 6.</label><caption><title>Synaptic targeting of HA-tagged Nrg3 construct to presynaptic terminals that contact ErbB4 postsynaptic clusters in PV+ interneurons.</title><p>(<bold>A</bold>) Localization of HA-tagged Nrg3 (blue) within GFP+ axon terminals (green) from pyramidal cells in close apposition to postsynaptic ErbB4+ clusters (red) of PV+ interneurons (gray). The bottom panel depicts HA staining in a color-inverted image. The high-magnification images illustrate the co-localization of HA-tagged Nrg3 with ErbB4+ clusters. (<bold>B</bold>) Quantifications of the density of ErbB4+ clusters (left) within the cell body of PV+ interneurons, the density of HA+/GFP+/ErbB4+ contacts (middle), and the proportion of ErbB4+ clusters that are contacted by HA+/GFP+ terminals (right), in superficial layers of the somatosensory cortex in electroporation experiments of a plasmid encoding for the HA-tagged Nrg3 construct. N = 4 mice (40 cells). Scale bars, 2 μm (<bold>A</bold>) and 0.5 μm (high magnifications). Data represent mean ± s.e.m. The averages per animal and electroporation condition are shown in bar graphs. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig3s6sdata1">Figure 3—figure supplement 6—source data 1</xref>.</p><p> <supplementary-material id="fig3s6sdata1"><label>Figure 3—figure supplement 6—source data 1.</label><caption><title>Numerical data of co-localization of HA-tagged Nrg3 construct and ErbB4+ clusters in PV+ interneurons.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig3-figsupp6-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig3-figsupp6-v2.tif"/></fig></fig-group><p>We next explored the localization of Nrg1 and Nrg3 with markers of inhibitory and excitatory synapses. We observed that Nrg1 puncta colocalize in synaptic clusters with Gephyrin, a scaffolding protein present in the postsynaptic membrane of inhibitory synapses (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). These Nrg1 puncta were often opposed to presynaptic markers of inhibitory cells, such as GAD65 and CB1R, targeting the soma of pyramidal cells, and Nrg1 puncta were also observed within the AIS (<xref ref-type="fig" rid="fig3">Figure 3D</xref> and <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3</xref>). In contrast, we found that Nrg3 colocalizes to clusters contacting PV+ interneurons and the excitatory presynaptic marker VGlut1 (<xref ref-type="fig" rid="fig3">Figure 3D</xref> and <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4</xref>). We also detected Nrg3 puncta opposed to clusters expressing PSD95 (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). In addition, we observed that GFP+ axon terminals from electroporated layer 2/3 pyramidal cells express HA-tagged Nrg3 in their presynaptic boutons innervating layer 5 PV+ interneurons, a target of superficial pyramidal cells in the cerebral cortex (<xref ref-type="fig" rid="fig3s5">Figure 3—figure supplement 5</xref>). Altogether, our results revealed a striking segregation in the subcellular distribution of neuregulins in pyramidal cells: Nrg1 is enriched in the postsynaptic compartment of inhibitory synapses targeting the soma of pyramidal cells whereas Nrg3 is mostly restricted to excitatory presynaptic terminals contacting interneurons (<xref ref-type="fig" rid="fig3">Figure 3E</xref>).</p></sec><sec id="s2-4"><title>The EGF-like domain of neuregulins does not mediate synapse specificity</title><p>The signaling capacity of neuregulins depends on their extracellular EGF-like domain, which binds to their receptors to trigger several intracellular signaling cascades (<xref ref-type="bibr" rid="bib33">Mei and Xiong, 2008</xref>). To test whether the EGF-like domain of Nrg1 and Nrg3 is involved in the synaptic specificity exhibited by these molecules, we generated HA-tagged constructs of Nrg1 and Nrg3 in which we swapped their EGF-like domains and performed in utero electroporation to express them in pyramidal cells. We observed no differences in the subcellular localization of these chimeric constructs compared to wild-type Nrg1 and Nrg3: Nrg1 carrying the EGF-like domain of Nrg3 (Nrg1<sup>EGF:Nrg3</sup>) localized to the soma, whereas Nrg3 carrying the EGF-like domain of Nrg1 (Nrg3<sup>EGF:Nrg1</sup>) localized to the neuropil (<xref ref-type="fig" rid="fig4">Figure 4A–B</xref>). Synaptic targeting of Nrg1<sup>EGF:Nrg3</sup> to inhibitory postsynapses and of Nrg3<sup>EGF:Nrg1</sup> to excitatory presynaptic boutons was similar to that observed with Nrg1 and Nrg3 wild-type constructs (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref> and <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Neuregulin-dependent synapse formation and localization is not specified by the EGF-like domain.</title><p>(<bold>A</bold>) Coronal sections through somatosensory cortex of P30 mice following in utero electroporation of <italic>pSyn-Nrg1<sup>EGF:Nrg3</sup>-pSyn-Gfp</italic> or <italic>pSyn-Nrg3<sup>EGF:Nrg1</sup>-pSyn-Gfp</italic> plasmids at E14.5. Sections were processed for immunohistochemistry against GFP (green) and HA (magenta) and counterstained with DAPI (gray). The high-magnification images illustrate the localization of HA-tagged neuregulins in GFP+ pyramidal cells. The bottom panel depicts HA staining in a color-inverted image. Dotted squares indicate the localization of the cells shown in the high-magnification images. The schematics illustrate the structure of chimeric neuregulins in which the EGF-like domain was swapped between Nrg1 and Nrg3. (<bold>B</bold>) Quantification of the localization of HA+ neuregulin in the soma and neuropil of GFP+ pyramidal cells. Soma: Two-tailed Student’s <italic>t</italic>-test, ***p&lt;0.001; <italic>n</italic> = 5 mice (40 regions of interest, ROIs) for <italic>pSyn-Nrg1<sup>EGF:Nrg3</sup>-pSyn-Gfp</italic>, <italic>n</italic> = 5 mice (40 ROIs) for <italic>pSyn-Nrg3<sup>EGF:Nrg1</sup>-pSyn-Gfp</italic>. Neuropil: Two-tailed Student’s <italic>t</italic>-test, ***p&lt;0.001; <italic>n</italic> = 5 mice (40 ROIs) for <italic>pSyn-Nrg1<sup>EGF:Nrg3</sup>-pSyn-Gfp</italic>, <italic>n</italic> = 5 mice (40 ROIs) for <italic>pSyn-Nrg3<sup>EGF:Nrg1</sup>-pSyn-Gfp</italic>. (<bold>C</bold>) Confocal images (top three panels) and binary images (bottom panel) illustrating presynaptic boutons co-labeled with GAD65 (magenta) and CB1R (cyan) innervating the soma of GFP+ pyramidal cells (gray) in EGF-like domain swapping experiments. (<bold>D</bold>) Quantification of the density of GAD65+/CB1R+ boutons contacting GFP+ pyramidal cells in gain-of-function chimera experiments. One-way ANOVA: <italic>F</italic> = 26.790, p&lt;0.001. Tukey’s range test for post hoc comparison between control and experimental groups: for <italic>pSyn-Nrg1<sup>EGF:Nrg3</sup>-pSyn-Gfp</italic>, ***p&lt;0.001; for <italic>pSyn-Nrg3<sup>EGF:Nrg1</sup>-pSyn-Gfp</italic>, p=0.968; n = 6 mice (120 cells) for <italic>pSyn-Gfp</italic> (control), 6 mice (110 cells) for <italic>pSyn-Nrg1<sup>EGF:Nrg3</sup>-pSyn-Gfp</italic>, 5 mice (88 cells) for <italic>pSyn-Nrg3<sup>EGF:Nrg1</sup>-pSyn-Gfp</italic>. (<bold>E</bold>) Confocal images (top three panels) and binary images (bottom panel) illustrating presynaptic VGlut1+ puncta (blue) in GFP+ axons (green) of pyramidal cells located in close apposition to PSD95+ clusters (red) in PV+ interneurons (gray) in EGF-like domain swapping experiments. (<bold>F</bold>) Quantification of the density of VGlut1+/PSD95+/GFP+ synapses contacting PV+ interneurons in gain-of-function chimera experiments. One-way ANOVA: <italic>F</italic> = 21.820, p&lt;0.001. Tukey’s range test for post hoc comparison between control and experimental groups: for <italic>pSyn-Nrg1<sup>EGF:Nrg3</sup>-pSyn-Gfp</italic>, p=0.982, for <italic>pSyn-Nrg3<sup>EGF:Nrg1</sup>-pSyn-Gfp</italic>, ***p&lt;0.001; n = 9 mice (167 cells) for <italic>pSyn-Gfp</italic> (control), 6 mice (94 cells) for <italic>pSyn-Nrg1<sup>EGF:Nrg3</sup>-pSyn-Gfp</italic>, 6 mice (96 cells) for <italic>pSyn-Nrg3<sup>EGF:Nrg1</sup>-pSyn-Gfp</italic>. Data from the distributions of ROIs are shown as box plots, and the adjacent data points and lines represent the averages per animal and averaged mean per group, respectively. Scale bars, 50 μm (<bold>A</bold>) and 20 μm (high magnification), and 1 μm (<bold>C, E</bold>). Data in synaptic quantifications represent mean ± s.e.m. The averages per animal and electroporation condition are represented in bar graphs, and the distributions of values per cell are shown in cumulative frequency plots. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig4sdata1">Figure 4—source data 1</xref>, and <xref ref-type="supplementary-material" rid="fig4sdata2">Figure 4—source data 2</xref>.</p><p> <supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Numerical data of subcellular localization in gain-of-function experiments with EGF-like domain chimeric neuregulin constructs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig4-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig4sdata2"><label>Figure 4—source data 2.</label><caption><title>Numerical data of inhibitory and excitatory synapses in gain-of-function experiments with EGF-like domain chimeric neuregulin constructs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig4-data2-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Synaptic targeting of EGF-like domain-swapping neuregulin constructs to inhibitory postsynaptic clusters in the somatic compartment of cortical pyramidal cells.</title><p>(<bold>A</bold>) Co-localization of HA-tagged chimeric Nrg1<sup>EGF:Nrg3</sup> (left) and HA-tagged chimeric Nrg3<sup>EGF:Nrg1</sup> (right) (magenta) with soma-targeting GAD65+ boutons (cyan) in electroporated GFP+ pyramidal cells (green). The bottom panel depicts HA staining in a color-inverted image. The high-magnification images illustrate the localization of HA-tagged neuregulins contacted by presynaptic GAD65+ boutons. (<bold>B</bold>) Quantification of the proportion of GAD65+ boutons that co-localize with HA-tagged Nrg clusters in the soma of electroporated GFP+ pyramidal cells. Tukey’s range test for post hoc comparison between wild-type Nrg1 construct and chimeric Nrg constructs: p=0.745, n = 4 mice (32 cells) for <italic>pSyn-Nrg1<sup>EGF:Nrg3</sup>-pSyn-Gfp</italic>; ***p&lt;0.001, n = 4 mice (32 cells) for <italic>pSyn-Nrg3<sup>EGF:Nrg1</sup>-pSyn-Gfp</italic>; ***p&lt;0.001, for comparison between chimeric Nrg constructs. Note that data for Nrg1 and Nrg3 wild-type constructs is the same data shown in <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3B</xref>. Scale bars, 2 μm (<bold>A</bold>) and 0.5 μm (high magnifications). Data in synaptic quantifications represent mean ± s.e.m. The averages per animal and electroporation condition are shown in bar graphs. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig4s1sdata1">Figure 4—figure supplement 1—source data 1</xref>.</p><p> <supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Numerical data of synaptic targeting of EGF-like domain chimeric neuregulin constructs in GFP+ electroporated pyramidal cells.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig4-figsupp1-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Targeting of EGF-like domain-swapping neuregulin constructs to excitatory presynaptic boutons innervating PV+ interneurons.</title><p>(<bold>A</bold>) Co-localization of HA-tagged chimeric Nrg1<sup>EGF:Nrg3</sup> (left) and HA-tagged chimeric Nrg3<sup>EGF:Nrg1</sup> (red) with presynaptic VGlut1+ boutons (blue) in GFP+ pyramidal cell axons (green) contacting PV+ interneurons (gray). The bottom panel depicts HA staining in a color-inverted image. The high-magnification images illustrate the co-localization of HA-tagged neuregulins with excitatory VGlut1+ boutons. (<bold>B</bold>) Quantification of the proportion of VGlut1+ boutons that co-localize with HA-tagged Nrg clusters in axon terminals of electroporated GFP+ pyramidal cells. Tukey’s range test for post hoc comparison between wild-type Nrg3 construct and chimeric Nrg constructs: ***p&lt;0.001, n = 4 mice (42 cells) for <italic>pSyn-Nrg1<sup>EGF:Nrg3</sup>-pSyn-Gfp; p</italic>=0.775, n = 4 mice (39 cells) for <italic>pSyn-Nrg3<sup>EGF:Nrg1</sup>-pSyn-Gfp</italic>; ***p&lt;0.001, for comparison between chimeric Nrg constructs. Note that data for Nrg1 and Nrg3 wild-type constructs is the same data shown in <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4B</xref>. Scale bars, 2 μm (<bold>A</bold>) and 0.5 μm (high magnifications). Data in synaptic quantifications represent mean ± s.e.m. The averages per animal and electroporation condition are shown in bar graphs. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig4s2sdata1">Figure 4—figure supplement 2—source data 1</xref>.</p><p> <supplementary-material id="fig4s2sdata1"><label>Figure 4—figure supplement 2—source data 1.</label><caption><title>Numerical data of synaptic targeting of EGF-like domain chimeric neuregulin constructs in axon terminals innervating PV+ interneurons.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig4-figsupp2-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig4-figsupp2-v2.tif"/></fig></fig-group><p>We then examined how expression of these constructs influenced inhibitory synaptic inputs and excitatory synaptic outputs in electroporated pyramidal cells. Consistent with its somatic localization, we found that the receptor-binding chimeric construct of Nrg1 (Nrg1<sup>EGF:Nrg3</sup>) increased the density of CCK+ presynaptic boutons innervating the soma of GFP+ pyramidal cells, as visualized by GAD65/CB1R colocalization, in similar quantities than wild-type Nrg1 (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig4">Figure 4C–D</xref>). However, overexpression of the receptor-binding chimeric construct of Nrg3 (Nrg3<sup>EGF:Nrg1</sup>), which is efficiently targeted to the axonal compartment, did not result in significant changes in CCK+ bouton density (<xref ref-type="fig" rid="fig4">Figure 4C–D</xref>).</p><p>To examine the synaptogenic properties of neuregulin chimeric constructs in the axonal compartment, we measured VGlut1+/PSD95+ synapse density within GFP+ pyramidal cell axons targeting PV+ interneurons. The receptor-binding chimeric construct of Nrg3 (Nrg3<sup>EGF:Nrg1</sup>) significantly augmented the density of axonal excitatory synapses that electroporated pyramidal cells made onto PV+ interneurons, at comparable levels than wild-type Nrg3 (<xref ref-type="fig" rid="fig2">Figure 2E</xref> and <xref ref-type="fig" rid="fig4">Figure 4E–F</xref>). In contrast, overexpression of the receptor-binding chimeric construct of Nrg1 (Nrg1<sup>EGF:Nrg3</sup>), which is targeted to the perisomatic region, did not change excitatory synapse densities in axon terminals (<xref ref-type="fig" rid="fig4">Figure 4E–F</xref>). Thus, chimeric neuregulins containing the EGF-like domain of the homologous neuregulin member can recapitulate the specific synaptic functions of wild-type Nrg1 and Nrg3 in vivo. These findings demonstrate that Nrg1 and Nrg3 function in inhibitory and excitatory synapse formation does not depend on their differential binding properties to their receptors, but on their selective sorting to the somatic and axonal compartment, respectively.</p></sec><sec id="s2-5"><title>Structural differences mediate the subcellular distribution of neuregulins</title><p>Since the extracellular EGF-like domain of Nrg1 and Nrg3 is not responsible for the differential functions of these two family-related synaptic molecules, we hypothesized that the intracellular region (C-terminal) of these proteins might be important for their localization and therefore differential physiological roles (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). To test this idea, we engineered HA-tagged constructs in which the intracellular domains (C-terminal) were swapped between both neuregulins and used in utero electroporation to express them in pyramidal cells. We observed that the C-terminal domain of Nrg3 was sufficient to re-route some Nrg1 from the soma to the neuropil (Nrg1<sup>Ct:Nrg3</sup>; <xref ref-type="fig" rid="fig5">Figure 5A–B</xref>), although with limited efficiency compared to full-length Nrg3 (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Accordingly, the proportion of VGlut1+/GFP+ boutons innervating PV+ interneurons that express the chimeric Nrg1<sup>Ct:Nrg3</sup> protein was significantly reduced compared to Nrg3 wild-type protein, which suggested that this chimeric protein is less efficiently expressed and/or targeted to axonal excitatory synapses than the wild-type form (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). We also found that the intracellular domain of Nrg1 is sufficient to sequester a large fraction of Nrg3 in the soma, dramatically decreasing its normal targeting to the neuropil (Nrg3<sup>Ct:Nrg1</sup>; <xref ref-type="fig" rid="fig5">Figure 5A–B</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). Remarkably, the chimeric Nrg3<sup>Ct:Nrg1</sup> proteins found in the soma of electroporated GFP+ pyramidal cells were precisely located in postsynaptic clusters adjacent to inhibitory inputs (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>). These results suggest that the intracellular, C-terminal domains of Nrg1 and Nrg3 contain unique sequences that influence the subcellular trafficking of both neuregulins.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>The C-terminal domain of Nrg1 and Nrg3 determines subcellular sorting to input and output synapses in pyramidal cells.</title><p>(<bold>A</bold>) Coronal sections through somatosensory cortex of P30 mice following in utero electroporation of <italic>pSyn-Nrg1<sup>Ct:Nrg3</sup>-pSyn-Gfp</italic> or <italic>pSyn-Nrg3<sup>Ct:Nrg1</sup>-pSyn-Gfp</italic> plasmids at E14.5. Sections were processed for immunohistochemistry against GFP (green) and HA (magenta) and counterstained with DAPI (gray). The high-magnification images illustrate the localization of HA-tagged neuregulins in GFP+ pyramidal cells. The bottom panel depicts HA staining in a color-inverted image. Dotted squares indicate the localization of the cells shown in the high-magnification images. The schematics illustrate the structure of chimeric neuregulins in which the intracellular, C-terminal domain was swapped between Nrg1 and Nrg3. (<bold>B</bold>) Quantification of the localization of HA+ neuregulin in the soma and neuropil of GFP+ pyramidal cells. Soma: Two-tailed Student’s <italic>t</italic>-test, ***p&lt;0.001; <italic>n</italic> = 5 mice (40 regions of interest, ROIs) for <italic>pSyn-Nrg1<sup>Ct:Nrg3</sup>-pSyn-Gfp</italic>, <italic>n</italic> = 5 mice (40 ROIs) for <italic>pSyn-Nrg3<sup>Ct:Nrg1</sup>-pSyn-Gfp</italic>. Neuropil: Two-tailed Student’s <italic>t</italic>-test, *p&lt;0.05; <italic>n</italic> = 5 mice (40 ROIs) for <italic>pSyn-Nrg1<sup>Ct:Nrg3</sup>-pSyn-Gfp</italic>, <italic>n</italic> = 5 mice (40 ROIs) for <italic>pSyn-Nrg3<sup>Ct:Nrg1</sup>-pSyn-Gfp</italic>. (<bold>C</bold>) Confocal images (top three panels) and binary images (bottom panel) illustrating presynaptic boutons co-labeled with GAD65 (magenta) and CB1R (cyan) innervating the soma of GFP+ pyramidal cells (gray) in C-terminal domain swapping experiments. (<bold>D</bold>) Quantification of the density of GAD65+/CB1R+ boutons contacting GFP+ pyramidal cells in gain-of-function chimera experiments. One-way ANOVA: <italic>F</italic> = 15.640, p&lt;0.001. Tukey’s range test for post hoc comparison between control and experimental groups: for <italic>pSyn-Nrg1<sup>Ct:Nrg3</sup>-pSyn-Gfp</italic>, p=0.632; for <italic>pSyn-Nrg3<sup>Ct:Nrg1</sup>-pSyn-Gfp</italic>, ***p&lt;0.001; n = 6 mice (120 cells) for <italic>pSyn-Gfp</italic> (control), 6 mice (136 cells) for <italic>pSyn-Nrg1<sup>Ct:Nrg3</sup>-pSyn-Gfp</italic>, 6 mice (127 cells) for <italic>pSyn-Nrg3<sup>Ct:Nrg1</sup>-pSyn-Gfp</italic>. (<bold>E</bold>) Confocal images (top three panels) and binary images (bottom panel) illustrating presynaptic VGlut1+ puncta (blue) in GFP+ axons (green) of pyramidal cells located in close apposition to PSD95+ clusters (red) in PV+ interneurons (gray) in C-terminal domain swapping experiments. (<bold>F</bold>) Quantification of the density of VGlut1+/PSD95+/GFP+ synapses contacting PV+ interneurons in gain-of-function chimera experiments. One-way ANOVA: <italic>F</italic> = 0.679, p=0.519. Tukey’s range test for post hoc comparison between control and experimental groups: for <italic>pSyn-Nrg1<sup>Ct:Nrg3</sup>-pSyn-Gfp</italic>, p=0.489, for <italic>pSyn-Nrg3<sup>Ct:Nrg1</sup>-pSyn-Gfp</italic>, p=0.909; n = 9 mice (167 cells) for <italic>pSyn-Gfp</italic> (control), 7 mice (121 cells) for <italic>pSyn-Nrg1<sup>Ct:Nrg3</sup>-pSyn-Gfp</italic>, 7 mice (135 cells) for <italic>pSyn-Nrg3<sup>Ct:Nrg1</sup>-pSyn-Gfp</italic>. Scale bars, 50 μm (<bold>A</bold>) and 20 μm (high magnification), and 1 μm (<bold>C, E</bold>). Data from the distributions of ROIs are shown as box plots, and the adjacent data points and lines represent the averages per animal and averaged mean per group, respectively. Data in synaptic quantifications represent mean ± s.e.m. The averages per animal and electroporation condition are represented in bar graphs, and the distributions of values per cell are shown in cumulative frequency plots. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig5sdata1">Figure 5—source data 1</xref>, and <xref ref-type="supplementary-material" rid="fig5sdata2">Figure 5—source data 2</xref>.</p><p> <supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Numerical data of subcellular localization in gain-of-function experiments with C-terminal domain chimeric neuregulin constructs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig5-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Numerical data of inhibitory and excitatory synapses in gain-of-function experiments with C-terminal domain chimeric neuregulin constructs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig5-data2-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Comparison of amino acid sequences of the EGF-like domain and the C-terminal domains of Nrg1 and Nrg3.</title><p>(<bold>A</bold>) Schematic representation of genomic sequences for <italic>Nrg1</italic> and <italic>Nrg3</italic> loci. Numbers correspond to exons. The specific gene isoform for <italic>Nrg1</italic> and <italic>Nrg3</italic> are indicated (right). (<bold>B</bold>) Sequence alignments of Nrg1 and Nrg3 for exons 2–3, which correspond to the EGF-like domain, and exons 6–10, which correspond to the C-terminal domain. Ct: C-terminal domain; EGF: EGF-like domain; TMD: transmembrane domain.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Targeting of C-terminal domain-swapping neuregulin constructs to excitatory presynaptic boutons innervating PV+ interneurons.</title><p>(<bold>A</bold>) Co-localization of HA-tagged chimeric Nrg1<sup>EGF:Nrg3</sup> (left) and HA-tagged chimeric Nrg3<sup>EGF:Nrg1</sup> (right) (red) with presynaptic VGlut1+ boutons (blue) in GFP+ pyramidal cell axons (green) contacting PV+ interneurons (gray). The bottom panel depicts HA staining in a color-inverted image. The high-magnification images illustrate the co-localization of HA-tagged neuregulins with excitatory VGlut1+ boutons. (<bold>B</bold>) Quantification of the proportion of VGlut1+ boutons that co-localize with HA-tagged Nrg clusters in axon terminals of electroporated GFP+ pyramidal cells. Tukey’s range test for post hoc comparison between wild-type Nrg3 construct and chimeric Nrg constructs: ***p&lt;0.001, n = 4 mice (50 cells) for <italic>pSyn-Nrg1<sup>Ct:Nrg3</sup>-pSyn-Gfp</italic>; ***p&lt;0.001, n = 4 mice (42 cells) for <italic>pSyn-Nrg3<sup>Ct:Nrg1</sup>-pSyn-Gfp</italic>; ***p&lt;0.001, for comparison between chimeric Nrg constructs. Note that data for Nrg1 and Nrg3 wild-type constructs is the same data shown in <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4B</xref>. (<bold>C</bold>) Quantification of the intensity of HA+ clusters within VGlut1+/GFP+ terminals innervating cortical PV+ interneurons. Tukey’s range test for post hoc comparison between wild-type Nrg3 construct and chimeric Nrg constructs: ***p&lt;0.001, n = 4 mice (50 cells) for <italic>pSyn-Nrg1<sup>Ct:Nrg3</sup>-pSyn-Gfp</italic>; ***p&lt;0.001, n = 4 mice (42 cells) for <italic>pSyn-Nrg3<sup>Ct:Nrg1</sup>-pSyn-Gfp</italic>; *p&lt;0.05, for comparison between chimeric Nrg constructs. Scale bars, 2 μm (<bold>A</bold>) and 0.5 μm (high magnifications). Data in synaptic quantifications represent mean ± s.e.m. The averages per animal and electroporation condition are shown in bar graphs. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig5s2sdata1">Figure 5—figure supplement 2—source data 1</xref>.</p><p> <supplementary-material id="fig5s2sdata1"><label>Figure 5—figure supplement 2—source data 1.</label><caption><title>Numerical data of synaptic targeting of C-terminal domain chimeric neuregulin constructs in axon terminals innervating PV+ interneurons.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig5-figsupp2-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig5-figsupp2-v2.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>Synaptic targeting of C-terminal domain-swapping neuregulin constructs to inhibitory postsynaptic clusters in the somatic compartment of cortical pyramidal cells.</title><p>(<bold>A</bold>) Co-localization of HA-tagged chimeric Nrg1<sup>Ct:Nrg3</sup> (left) and HA-tagged chimeric Nrg3<sup>Ct:Nrg1</sup> (right) (magenta) with soma-targeting GAD65+ boutons (cyan) in electroporated GFP+ pyramidal cells (green). The bottom panel depicts HA staining in a color-inverted image. The high-magnification images illustrate the localization of HA-tagged neuregulins contacted by presynaptic GAD65+ boutons. (<bold>B</bold>) Quantification of the proportion of GAD65+ boutons that co-localize with HA-tagged Nrg clusters in the soma of electroporated GFP+ pyramidal cells. Tukey’s range test for post hoc comparison between wild-type Nrg1 construct and chimeric Nrg constructs: ***p&lt;0.001, n = 4 mice (32 cells) for <italic>pSyn-Nrg1<sup>Ct:Nrg3</sup>-pSyn-Gfp; p</italic>=0.077, n = 4 mice (34 cells) for <italic>pSyn-Nrg3<sup>Ct:Nrg1</sup>-pSyn-Gfp</italic>; ***p&lt;0.001, for comparison between chimeric Nrg constructs. Note that data for Nrg1 and Nrg3 wild-type constructs is the same data shown in <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3B</xref>. Scale bars, 2 μm (<bold>A</bold>) and 0.5 μm (high magnifications). Data in synaptic quantifications represent mean ± s.e.m. The averages per animal and electroporation condition are shown in bar graphs. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig5s3sdata1">Figure 5—figure supplement 3—source data 1</xref>.</p><p> <supplementary-material id="fig5s3sdata1"><label>Figure 5—figure supplement 3—source data 1.</label><caption><title>Numerical data of synaptic targeting of C-terminal domain chimeric neuregulin constructs in GFP+ electroporated pyramidal cells.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig5-figsupp3-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig5-figsupp3-v2.tif"/></fig></fig-group><p>The previous experiments suggested that C-terminal domain-dependent subcellular sorting may determine the specificity of neuregulin signaling in inhibitory and excitatory synapse formation. To test this hypothesis, we first quantified the density of CCK+ somatic inputs in pyramidal cells expressing the C-terminal domain-swapping neuregulin proteins. Consistent with its inefficient retention in the soma (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref> and <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>), we observed that overexpression of a chimeric Nrg1 protein containing the C-terminal domain of Nrg3 (Nrg1<sup>Ct:Nrg3</sup>) does not increase the number of CB1R+/GAD65+ presynaptic boutons contacting electroporated pyramidal cells (<xref ref-type="fig" rid="fig5">Figure 5C–D</xref>). In contrast, overexpression of a chimeric Nrg3 protein carrying the C-terminal domain of Nrg1 (Nrg3<sup>Ct:Nrg1</sup>), which is abnormally retained in the soma of pyramidal cells (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref> and <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>), led to a significant increase in the density of these GABAergic inputs (<xref ref-type="fig" rid="fig5">Figure 5C–D</xref>). Secondly, we measured the ability of these chimeric constructs to influence the formation of excitatory synapses onto PV+ interneurons. Consistent with their inefficient transport to the neuropil compared to wild-type Nrg3 (<xref ref-type="fig" rid="fig5">Figure 5A–B</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>), neither Nrg1<sup>Ct:Nrg3</sup> nor Nrg3<sup>Ct:Nrg1</sup> caused a significant change in the number of VGlut1+/PSD95+ puncta within GFP+ axon terminals contacting PV+ interneurons (<xref ref-type="fig" rid="fig5">Figure 5E–F</xref>). These experiments confirmed that the efficient targeting of neuregulins to specific subcellular compartments in pyramidal cells mediates their function in synapse formation. They also revealed that the C-terminal domain of neuregulins is essential for the specificity of this process.</p><p>To add further support to this idea, we performed a final series of experiments in which we electroporated plasmids encoding truncated forms of Nrg1 and Nrg3 that lack the entire intracellular region, the C-terminal domain. We found that both Nrg1 and Nrg3 lacking the C-terminal domain (Nrg1<sup>ΔCt</sup> and Nrg3<sup>ΔCt</sup>) lose the specific subcellular distribution found in wild-type Nrg1 and Nrg3 (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>). Specifically, we observed that Nrg1<sup>ΔCt</sup> was no longer restricted to the somatic compartment of pyramidal cells and was in turn abundantly found throughout the neuropil, both in dendrites and axon terminals (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>). On the other hand, we observed that Nrg3<sup>ΔCt</sup> was no longer restricted to axons as it is the case for wild-type Nrg3: it was also abundantly found in the somatodendritic compartment of pyramidal cells (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>). Consistently, both Nrg1<sup>ΔCt</sup> and Nrg3<sup>ΔCt</sup> were observed in somatic inhibitory synapses as well as axonal excitatory synapses in electroporated GFP+ pyramidal cells (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplements 1</xref>–<xref ref-type="fig" rid="fig6s2">2</xref>). This finding reinforced the idea that the specific localization of Nrg1 and Nrg3 in the somatic and axonal compartments, respectively, requires sequences encoded in their C-terminal domain.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Subcellular segregation of neuregulins is encoded in the C-terminal domain.</title><p>(<bold>A</bold>) Coronal sections through somatosensory cortex of P30 mice following in utero electroporation of <italic>pSyn-Nrg1<sup>ΔCt</sup>-pSyn-Gfp</italic> or <italic>pSyn-Nrg3<sup>ΔCt</sup>-pSyn-Gfp</italic> plasmids at E14.5. Sections were processed for immunohistochemistry against GFP (green) and HA (magenta) and counterstained with DAPI (gray). The high-magnification images illustrate the localization of HA-tagged neuregulins in GFP+ pyramidal cells. The bottom panel depicts HA staining in a color-inverted image. Dotted squares indicate the localization of the cells shown in the high-magnification images. The schematics illustrate the structure of truncated neuregulins in which the C-terminal domain was removed. (<bold>B</bold>) Quantification of the localization of HA+ neuregulin in the soma and neuropil of GFP+ pyramidal cells. Soma: Mann-Whitney <italic>U</italic>-test, p=0.093; <italic>n</italic> = 6 mice (66 regions of interest, ROIs) for <italic>pSyn-Nrg1<sup>ΔCt</sup>-pSyn-Gfp</italic>, <italic>n</italic> = 6 mice (66 ROIs) for <italic>pSyn-Nrg3<sup>ΔCt</sup>-pSyn-Gfp</italic>. Neuropil: Two-tailed Student’s <italic>t</italic>-test, p=0.589; <italic>n</italic> = 6 mice (58 ROIs) for <italic>pSyn-Nrg1<sup>ΔCt</sup>-pSyn-Gfp</italic>, <italic>n</italic> = 6 mice (58 ROIs) for <italic>pSyn-Nrg1<sup>ΔCt</sup>-pSyn-Gfp</italic>. (<bold>C</bold>) Confocal images (top three panels) and binary images (bottom panel) illustrating presynaptic boutons co-labeled with GAD65 (magenta) and CB1R (cyan) innervating the soma of GFP+ pyramidal cells (gray) in C-terminal domain deletion experiments. (<bold>D</bold>) Quantification of the density of GAD65+/CB1R+ boutons contacting GFP+ pyramidal cells in gain-of-function truncation experiments. One-way ANOVA: <italic>F</italic> = 5.325, p&lt;0.05. Tukey’s range test for post hoc comparison between control and experimental groups: for <italic>pSyn-Nrg1<sup>ΔCt</sup>-pSyn-Gfp</italic>, *p&lt;0.05; for <italic>pSyn-Nrg3<sup>ΔCt</sup>-pSyn-Gfp</italic>, *p&lt;0.05; n = 6 mice (120 cells) for <italic>pSyn-Gfp</italic> (control), six mice (145 cells) for <italic>pSyn-Nrg1<sup>ΔCt</sup>-pSyn-Gfp</italic>, six mice (138 cells) for <italic>pSyn-Nrg3<sup>ΔCt</sup>-pSyn-Gfp</italic>. (<bold>E</bold>) Confocal images (top three panels) and binary images (bottom panel) illustrating presynaptic VGlut1+ puncta (blue) in GFP+ axons (green) of pyramidal cells located in close apposition to PSD95+ clusters (red) in PV+ interneurons (gray) in C-terminal domain deletion experiments. (<bold>F</bold>) Quantification of the density of VGlut1+/PSD95+/GFP+ synapses contacting PV+ interneurons in gain-of-function truncation experiments. One-way ANOVA: <italic>F</italic> = 19.500, p&lt;0.001. Tukey’s range test for post hoc comparison between control and experimental groups: for <italic>pSyn-Nrg1<sup>ΔCt</sup>-pSyn-Gfp</italic>, ***p&lt;0.001, for <italic>pSyn-Nrg3<sup>ΔCt</sup>-pSyn-Gfp</italic>, ***p&lt;0.001; n = 9 mice (167 cells) for <italic>pSyn-Gfp</italic> (control), 5 mice (107 cells) for <italic>pSyn-Nrg1<sup>ΔCt</sup>-pSyn-Gfp</italic>, 5 mice (111 cells) for <italic>pSyn-Nrg3<sup>ΔCt</sup>-pSyn-Gfp</italic>. Scale bars, 50 μm (<bold>A</bold>) and 20 μm (high magnification), and 1 μm (<bold>C, E</bold>). Data from the distributions of ROIs are shown as box plots, and the adjacent data points and lines represent the averages per animal and averaged mean per group, respectively. Data in synaptic quantifications represent mean ± s.e.m. The averages per animal and electroporation condition are represented in bar graphs, and the distributions of values per cell are shown in cumulative frequency plots. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig6sdata1">Figure 6—source data 1</xref>, and <xref ref-type="supplementary-material" rid="fig6sdata2">Figure 6—source data 2</xref>.</p><p> <supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Numerical data of subcellular localization in gain-of-function experiments with C-terminal domain truncated neuregulin constructs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig6-data1-v2.xlsx"/></supplementary-material> </p><p> <supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Numerical data of inhibitory and excitatory synapses in gain-of-function experiments with C-terminal domain truncated neuregulin constructs.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig6-data2-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Synaptic targeting of C-terminal domain-lacking neuregulin constructs to inhibitory postsynaptic clusters in the somatic compartment of cortical pyramidal cells.</title><p>(<bold>A</bold>) Co-localization of HA-tagged truncated Nrg1<sup>ΔCt</sup> (left) and HA-tagged truncated Nrg3<sup>ΔCt</sup> (right) (magenta) with soma-targeting GAD65+ boutons (cyan) in electroporated GFP+ pyramidal cells (green). The bottom panel depicts HA staining in a color-inverted image. The high-magnification images illustrate the localization of HA-tagged neuregulins contacted by presynaptic GAD65+ boutons. (<bold>B</bold>) Quantification of the proportion of GAD65+ boutons that co-localize with HA-tagged Nrg clusters in the soma of electroporated GFP+ pyramidal cells. Tukey’s range test for post hoc comparison between wild-type Nrg1 construct and chimeric Nrg constructs: **p&lt;0.01, n = 4 mice (34 cells) for <italic>pSyn-Nrg1<sup>ΔCt</sup>-pSyn-Gfp</italic>; ***p&lt;0.001, n = 5 mice (43 cells) for <italic>pSyn-Nrg3<sup>ΔCt</sup>-pSyn-Gfp; p</italic>=0.739, for comparison between chimeric Nrg constructs. Note that data for Nrg1 and Nrg3 wild-type constructs is the same data shown in <xref ref-type="fig" rid="fig3s3">Figure 3—figure supplement 3B</xref>. Scale bars, 2 μm (<bold>A</bold>) and 0.5 μm (high magnifications). Data in synaptic quantifications represent mean ± s.e.m. The averages per animal and electroporation condition are shown in bar graphs. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig6s1sdata1">Figure 6—figure supplement 1—source data 1</xref>.</p><p> <supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Numerical data of synaptic targeting of C-terminal domain truncated neuregulin constructs in GFP+ electroporated pyramidal cells.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig6-figsupp1-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig6-figsupp1-v2.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Targeting of C-terminal domain-lacking neuregulin constructs to excitatory presynaptic boutons innervating PV+ interneurons.</title><p>(<bold>A</bold>) Co-localization of HA-tagged truncated Nrg1<sup>ΔCt</sup> (left) and HA-tagged truncated Nrg3<sup>ΔCt</sup> (right) (red) with presynaptic VGlut1+ boutons (blue) in GFP+ pyramidal cell axons (green) contacting PV+ interneurons (gray). The bottom panel depicts HA staining in a color-inverted image. The high-magnification images illustrate the co-localization of HA-tagged neuregulins with excitatory VGlut1+ boutons. (<bold>B</bold>) Quantification of the proportion of VGlut1+ boutons that co-localize with HA-tagged Nrg clusters in axon terminals of electroporated GFP+ pyramidal cells. Tukey’s range test for post hoc comparison between wild-type Nrg3 construct and chimeric Nrg constructs: p=0.689, n = 5 mice (38 cells) for <italic>pSyn-Nrg1<sup>ΔCt</sup>-pSyn-Gfp; p</italic>=0.928, n = 5 mice (36 cells) for <italic>pSyn-Nrg3<sup>ΔCt</sup>-pSyn-Gfp; p</italic>=0.304, for comparison between chimeric Nrg constructs. Note that data for Nrg1 and Nrg3 wild-type constructs is the same data shown in <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplement 4B</xref>. Scale bars, 2 μm (<bold>A</bold>) and 0.5 μm (high magnifications). Data in synaptic quantifications represent mean ± s.e.m. The averages per animal and electroporation condition are shown in bar graphs. Data used for quantitative analyses are available in <xref ref-type="supplementary-material" rid="fig6s2sdata1">Figure 6—figure supplement 2—source data 1</xref>.</p><p> <supplementary-material id="fig6s2sdata1"><label>Figure 6—figure supplement 2—source data 1.</label><caption><title>Numerical data of synaptic targeting of C-terminal domain truncated neuregulin constructs in axon terminals innervating PV+ interneurons.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-57000-fig6-figsupp2-data1-v2.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-57000-fig6-figsupp2-v2.tif"/></fig></fig-group><p>We examined how the lack of specificity in the distribution of neuregulins would impact the formation of inhibitory inputs and excitatory outputs in pyramidal cells. First, we assessed the effect of Nrg1 and Nrg3 proteins lacking the C-terminal domain in inducing the formation of GABAergic boutons from CCK+ basket cells onto the soma of pyramidal neurons. Strikingly, overexpression of truncated forms of Nrg1 and Nrg3 resulted in a significant increase in the density of GAD65+/CB1R+ boutons innervating electroporated pyramidal cells (<xref ref-type="fig" rid="fig6">Figure 6C–D</xref>). Of note, these phenotypes appeared to be moderate as compared to overexpression experiments of wild-type Nrg1 protein (<xref ref-type="fig" rid="fig2">Figure 2B–C</xref>), probably due to the fact that the targeting of both neuregulins lacking the C-terminal domain to the somatic compartment is less efficient than the wild-type Nrg1 protein (<xref ref-type="fig" rid="fig3">Figure 3B–C</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>). Second, we quantified excitatory synaptic inputs contacting PV+ interneurons from pyramidal cells expressing the truncated forms of Nrg1 and Nrg3. Overexpression of these truncated proteins robustly induced the formation of VGlut1+/PSD95+ synaptic contacts within GFP+ axon terminals innervating PV+ interneurons (<xref ref-type="fig" rid="fig6">Figure 6E–F</xref>). Altogether, the ability of neuregulins lacking their C-terminal domains to induce synapse formation in vivo suggests that their synaptogenic function does not depend on intracellular signaling pathways but rather on the role mediated by the extracellular domain at the synaptic membrane. These results are consistent with the hypothesis that the selective subcellular segregation of Nrg1 and Nrg3 in cortical pyramidal cells controls their specific function in inhibitory and excitatory synapses, respectively.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our findings unveil how subcellular sorting of synaptic proteins orchestrates the assembly of excitatory and inhibitory synapses in cortical circuits. Previous studies have shown that the tyrosine kinase receptor ErbB4 is required for the wiring of specific types of cortical interneurons, in which it contributes to the formation of both inhibitory outputs and excitatory inputs. Here we demonstrate that Nrg1 and Nrg3, two different members of the neuregulin family of trophic factors co-expressed by pyramidal cells, mediate the development of inhibitory synapses made and excitatory synapses received, respectively, by ErbB4-expressing cortical interneurons. Our study highlights the crucial role of polarized protein trafficking for synaptic specificity in the formation of neuronal circuits.</p><p>Proteins are synthesized in the rough endoplasmic reticulum, modified through the Golgi complex, and packaged into carrier vesicles for their transport to different subcellular domains. The efficient targeting of membrane proteins to distinct subcellular compartments relies on specific protein-protein interactions that regulate vesicle trafficking. In particular, membrane proteins are sorted into different pools of vesicles for selective delivery to the somatodendritic or axonal compartments while being transported through the trans-Golgi network (<xref ref-type="bibr" rid="bib36">Ribeiro et al., 2018</xref>). Our study demonstrates that the C-terminal domains of Nrg1 and Nrg3 are essential for the sorting of these synaptic proteins into the somatic and axonal compartments, respectively (<xref ref-type="fig" rid="fig5">Figure 5</xref> and <xref ref-type="fig" rid="fig6">Figure 6</xref>). This is consistent with the existence of amino acid sequences in the cytoplasmic domain of other transmembrane proteins that are required for their accurate subcellular sorting (<xref ref-type="bibr" rid="bib11">Farías et al., 2012</xref>; <xref ref-type="bibr" rid="bib22">Gu, 2003</xref>; <xref ref-type="bibr" rid="bib29">Li et al., 2016</xref>; <xref ref-type="bibr" rid="bib38">Rivera et al., 2003</xref>). Our experiments also indicate that the C-terminal, intracellular domains of neuregulins are indispensable for the specific formation of inhibitory and excitatory synapses in pyramidal cells in vivo. Our data suggest that, while the C-terminal domain plays critical roles in specifying the selective subcellular localization of Nrg1 and Nrg3, their extracellular domain might be sufficient to bind and activate their receptor at the pre- and postsynaptic sites, respectively, to induce synaptogenesis. This is in contrast with the mechanisms of action of postsynaptic Neuroligin-1, whose varied functions at the synapse rely on signaling pathways associated with both its intra- and extracellular domains (<xref ref-type="bibr" rid="bib52">Wu et al., 2019</xref>).</p><p>ErbB4 is the most likely receptor mediating the effect on Nrg1 and Nrg3 in the wiring of cortical interneurons. ErbB4 is a classical binding partner of both neuregulins (<xref ref-type="bibr" rid="bib32">Mei and Nave, 2014</xref>) and is exclusively expressed in the postnatal cortex by several types of cortical interneurons (<xref ref-type="bibr" rid="bib15">Fazzari et al., 2010</xref>; <xref ref-type="bibr" rid="bib46">Vullhorst et al., 2009</xref>). Using electron microscopy, we have previously shown that ErbB4 is very abundant in the postsynaptic density of excitatory synapses received by interneurons (<xref ref-type="bibr" rid="bib15">Fazzari et al., 2010</xref>). In addition, ErbB4 is also found, albeit at lower density (i.e. relatively fewer immunogold particles compared to those found in postsynaptic densities), in inhibitory axo-somatic and axo-axonic terminals. At the light microscopy level, Nrg3 and ErbB4 colocalize extensively in excitatory synaptic puncta contacting PV+ interneurons (<xref ref-type="fig" rid="fig3s6">Figure 3—figure supplement 6</xref>), which is consistent with a role for this ligand-receptor pair in the formation of these synapses. In contrast, the relatively low levels of ErbB4 in the axon terminals of CCK+ basket cells and chandelier cells prevent their detection at the light microscopy level (<xref ref-type="bibr" rid="bib15">Fazzari et al., 2010</xref>), which precludes the assessment of Nrg1-ErbB4 colocalization in the same synapses. Although it is formally possible that Nrg1 function in inhibitory synapse formation is mediated by a yet unidentified receptor, the complementary phenotypes observed in conditional <italic>Nrg1</italic>, <italic>Nrg3</italic> and <italic>ErbB4</italic> mutants strongly suggests otherwise. Loss of ErbB4 leads to a decrease in the number of excitatory synapses received by PV+ basket cells and in the number of inhibitory synapses made by CCK+ basket cells and chandelier cells (<xref ref-type="bibr" rid="bib9">Del Pino et al., 2017</xref>; <xref ref-type="bibr" rid="bib8">Del Pino et al., 2013</xref>; <xref ref-type="bibr" rid="bib15">Fazzari et al., 2010</xref>; <xref ref-type="bibr" rid="bib44">Ting et al., 2011</xref>; <xref ref-type="bibr" rid="bib54">Yang et al., 2013</xref>), and these synaptic defects are recapitulated by the summation of those reported in this study in conditional <italic>Nrg1</italic> and <italic>Nrg3</italic> mutants: loss of Nrg1 causes a decrease in the number of inhibitory synapses made by CCK+ basket cells and chandelier cells on pyramidal cells (<xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>), whereas loss of Nrg3 leads to a reduction in the number of excitatory synapses received by PV+ interneurons (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Previous in vitro studies have suggested a role for Type III Nrg1 in axonal terminals of pyramidal cells (<xref ref-type="bibr" rid="bib4">Chen et al., 2010</xref>; <xref ref-type="bibr" rid="bib25">Huang et al., 2000</xref>; <xref ref-type="bibr" rid="bib47">Vullhorst et al., 2017</xref>). These conclusions were based on the finding that exogenous Nrg1 protein expressed in cultured neurons was present in axons. The discrepancy with our results is most likely due to an abnormal subcellular distribution when exogenous constructs are expressed in neurons cultured in vitro. Our experiments reveal that only Nrg3 is transported to axon terminals of pyramidal cells in vivo, while Nrg1 is selectively retained in the somatic compartment (<xref ref-type="fig" rid="fig3">Figure 3</xref>). This is consistent with the observation that Nrg1 is required for the development of inhibitory synapses but is dispensable for the formation of excitatory synapses onto interneurons, whereas the converse occurs for Nrg3 (<xref ref-type="fig" rid="fig2">Figure 2</xref> and <xref ref-type="bibr" rid="bib34">Müller et al., 2018</xref>). Together, these results demonstrate segregated functions for Nrg1 and Nrg3 in synapse development during the orchestration of cortical circuits. In the peripheral nervous system, Type III Nrg1 mediates the clustering of nicotinic acetylcholine receptors in nerve terminals through a mechanism that involves backward signaling via the phosphatidyl-inositol 3-kinase pathway (<xref ref-type="bibr" rid="bib24">Hancock et al., 2008</xref>; <xref ref-type="bibr" rid="bib51">Wolpowitz et al., 2000</xref>). This presynaptic function of Nrg1 suggests that the subcellular targeting of Nrg1 in peripheral sensory neurons and cortical pyramidal cells require different sorting mechanisms. It is worth noting that the conditional <italic>Nrg1</italic> mutant allele used in our studies lacks the EGF domain in all <italic>Nrg1</italic> isoforms following Cre-mediated recombination. Nevertheless, since overexpression of Type III <italic>Nrg1</italic> causes complementary phenotypes to those found in <italic>Nrg1</italic> conditional mutant mice, our results suggest that the loss of inhibitory synapses in these mice is exclusively due to the absence of Type III <italic>Nrg1.</italic></p><p>A surprising finding in our study is the striking restriction of Nrg1 to the perisomatic region of pyramidal cells, as opposed to a wider somatodendritic distribution characteristic of other polarized proteins (<xref ref-type="bibr" rid="bib11">Farías et al., 2012</xref>). Its specific subcellular distribution is consistent with the unique synaptic targeting of GABAergic cortical interneurons to different subcellular compartments, and in particular, the essential role of Nrg1 in perisomatic GABAergic innervation of pyramidal cells (<xref ref-type="fig" rid="fig1">Figure 1</xref> and <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>). In addition to the critical role of Nrg1 C-terminal domain in somatic targeting (<xref ref-type="fig" rid="fig5">Figure 5</xref> and <xref ref-type="fig" rid="fig6">Figure 6</xref>), there could be additional amino acid motifs in the Nrg1 sequence that coordinately participate in this peculiar sorting to confine the protein to pyramidal cell somas. A potential candidate region is the N-terminal domain of Nrg1 containing the cysteine-rich domain (CRD), which is also located in the cytoplasmic space due to the stretch of hydrophobic amino acids that conforms a second transmembrane domain to anchor the mature protein to the membrane (<xref ref-type="bibr" rid="bib49">Wang et al., 2001</xref>). Interestingly, we did not observe deficits in the density of PV+ basket cell synapses contacting the soma of pyramidal cells in <italic>Nrg1</italic> mutant mice (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5</xref>), which is consistent with the lack of a phenotype in these synapses in mice lacking ErbB4 from interneurons (<xref ref-type="bibr" rid="bib8">Del Pino et al., 2013</xref>; <xref ref-type="bibr" rid="bib54">Yang et al., 2013</xref>). Together, these data suggest that the development of specific subsets of GABAergic synapses might be controlled by the localization of Nrg1 present in the perisomatic compartment of pyramidal cells.</p><p>Axons from pyramidal cells form abundant synaptic contacts onto cortical PV+ interneurons, a process that is regulated by Nrg3 (this study and <xref ref-type="bibr" rid="bib15">Fazzari et al., 2010</xref>; <xref ref-type="bibr" rid="bib34">Müller et al., 2018</xref>). Accordingly, Nrg3 was found to be specifically targeted to presynaptic boutons contacting PV+ interneurons across layers of the cerebral cortex (<xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="fig" rid="fig3s4">Figure 3—figure supplements 4</xref>–<xref ref-type="fig" rid="fig3s5">5</xref>), and similarly in the hippocampal CA1 circuitry (<xref ref-type="bibr" rid="bib34">Müller et al., 2018</xref>). Further, our experiments showed that the specific subcellular distribution of Nrg3 depends on an intracellular mechanism whereby the cytoplasmic C-terminal domain effectively mediate the targeting of the protein to axon terminals in pyramidal cells. This raises the question of the underlying mechanisms for selective axonal sorting. One possibility is that Nrg3 C-terminal domain harbors conserved amino acid sequences that mediate a direct transport pathway to these specific presynaptic boutons through selective vesicle loading and trafficking. Since the C-terminal domain of neuregulins constitutes a large portion of the entire protein (over 350 amino acids), the identification of structural determinants potentially responsible for subcellular sorting will require further efforts. An alternative mechanism could rely on lateral diffusion and relocation to the appropriate synaptic contacts after unspecific axonal sorting, possibly mediated through binding to synaptic interacting partners (<xref ref-type="bibr" rid="bib18">Fu and Huang, 2010</xref>). The co-existence of multiple mechanisms for selective axonal sorting cannot be ruled out, as it has been shown for other proteins (<xref ref-type="bibr" rid="bib39">Sampo et al., 2003</xref>; <xref ref-type="bibr" rid="bib50">Wisco et al., 2003</xref>; <xref ref-type="bibr" rid="bib55">Yap et al., 2008</xref>).</p><p>Neuregulin binding to tyrosine kinase receptors of the ErbB family activates multiple pathways of signal transduction (<xref ref-type="bibr" rid="bib6">Citri and Yarden, 2006</xref>), and previous studies have indicated that the EGF-like domain of Nrg1 is a more potent effector to trigger ErbB4 activation than Nrg3 in phosphorylation assays in vitro (<xref ref-type="bibr" rid="bib34">Müller et al., 2018</xref>). Interestingly, our structure-function experiments suggest that the ErbB4-binding, EGF-like domain of both Nrg1 and Nrg3 are equally suitable to promote inhibitory and excitatory synapse formation in pyramidal cells in vivo (<xref ref-type="fig" rid="fig4">Figure 4</xref>). This observation indicates that the function of neuregulins in cortical circuit development is primarily controlled through their precise subcellular targeting, and suggests the existence of an exquisite ligand-receptor program that orchestrates the assembly of specific cortical circuits through the integration of specific inhibitory inputs and excitatory outputs in pyramidal cells. This may also provide pyramidal cells with a mechanism to independently regulate the strength of particular synapses in the adult cortex through the differential control of the expression of each neuregulin protein. Considering the strong association of neuregulin signaling with cognition and schizophrenia (<xref ref-type="bibr" rid="bib27">Kasnauskiene et al., 2013</xref>; <xref ref-type="bibr" rid="bib32">Mei and Nave, 2014</xref>; <xref ref-type="bibr" rid="bib48">Walsh et al., 2008</xref>), our findings reinforce the idea that genetic dysfunction of interneuron-pyramidal cell connectivity might be at the core of neurodevelopmental disorders.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type (species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">Antibody</td><td valign="top">Anti-Parvalbumin (polyclonal chicken)</td><td valign="top">Synaptic Systems</td><td valign="top">Cat# 195 006, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2619887">AB_2619887</ext-link></td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-CB1 (polyclonal goat)</td><td valign="top">Frontier Institute</td><td valign="top">Cat# CB1-Go-Af450, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2571592">AB_2571592</ext-link></td><td valign="top">IHC(1:400)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Nrg3 (polyclonal goat)</td><td valign="top">Neuromics</td><td valign="top">Cat# GT15220</td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-VGlut1 (polyclonal guinea pig)</td><td valign="top">Merck Millipore</td><td valign="top">Cat# AB5905, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2301751">AB_2301751</ext-link></td><td valign="top">IHC(1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-GAD65 (monoclonal mouse, IgG2a)</td><td valign="top">Merck Millipore</td><td valign="top">Cat# MAB351R, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_94905">AB_94905</ext-link></td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-GAD67 (monoclonal mouse, IgG2a)</td><td valign="top">Merck Millipore</td><td valign="top">Cat# MAB5406, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2278725">AB_2278725</ext-link></td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Gephyrin (monoclonal mouse, IgG1)</td><td valign="top">Synaptic Systems</td><td valign="top">Cat# 147 011, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_887717">AB_887717</ext-link></td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-HA (monoclonal mouse, IgG1)</td><td valign="top">BioLegend</td><td valign="top">Cat# 901502, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2565007">AB_2565007</ext-link></td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-PSD95 (monoclonal mouse, IgG2a)</td><td valign="top">NeuroMab</td><td valign="top">Cat# 70–028, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2307331">AB_2307331</ext-link></td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Synaptotagmin-2 (monoclonal mouse, IgG2a)</td><td valign="top">ZFIN</td><td valign="top">Cat# ZDB-ATB-081002–25, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10013783">AB_10013783</ext-link></td><td valign="top">IHC(1:250)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-DsRed (polyclonal rabbit)</td><td valign="top">Clontech, Takara Bio</td><td valign="top">Cat# 632496, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10013483">AB_10013483</ext-link></td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-HA (polyclonal rabbit)</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat# 3724, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1549585">AB_1549585</ext-link></td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Nrg1 (polyclonal rabbit)</td><td valign="top">Abcam</td><td valign="top">Cat# ab23248, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2154667">AB_2154667</ext-link></td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-Parvalbumin (polyclonal rabbit)</td><td valign="top">Swant</td><td valign="top">Cat# PV27, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2631173">AB_2631173</ext-link></td><td valign="top">IHC(1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-pIκBα (polyclonal rabbit)</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat# 2859, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_561111">AB_561111</ext-link></td><td valign="top">IHC(1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-chicken-DyLight 405 (donkey)</td><td valign="top">Jackson Immuno Research Europe Ltd.</td><td valign="top">Cat# 703-475-155, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2340373">AB_2340373</ext-link></td><td valign="top">IHC(1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-guinea pig-647 (donkey)</td><td valign="top">Jackson Immuno Research Europe Ltd.</td><td valign="top">Cat# 706-605-148, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2340476">AB_2340476</ext-link></td><td valign="top">IHC(1:250)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-goat-Alexa 647 (donkey)</td><td valign="top">Molecular Probes</td><td valign="top">Cat# A-21447, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2535864">AB_2535864</ext-link></td><td valign="top">IHC(1:400)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-mouse-Alexa 488 (donkey)</td><td valign="top">Molecular Probes</td><td valign="top">Cat# A-21202, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_141607">AB_141607</ext-link></td><td valign="top">IHC(1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-rabbit-Alexa 647 (donkey)</td><td valign="top">Molecular Probes</td><td valign="top">Cat# A-31573, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2536183">AB_2536183</ext-link></td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-rabbit-Cy3 (donkey)</td><td valign="top">Jackson Immuno Research Europe Ltd.</td><td valign="top">Cat# 711-165-152, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2307443">AB_2307443</ext-link></td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-chicken-Alexa 488 (goat)</td><td valign="top">Molecular Probes</td><td valign="top">Cat# A-11039, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2534096">AB_2534096</ext-link></td><td valign="top">IHC(1:600)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-mouse IgG1-Alexa 488 (goat)</td><td valign="top">Molecular Probes</td><td valign="top">Cat# A-21121, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2535764">AB_2535764</ext-link></td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-mouse IgG1-Alexa 555 (goat)</td><td valign="top">Molecular Probes</td><td valign="top">Cat# A-21127, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2535769">AB_2535769</ext-link></td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-mouse IgG1-Alexa 647 (goat)</td><td valign="top">Molecular Probes</td><td valign="top">Cat# A-21240, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2535809">AB_2535809</ext-link></td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Anti-mouse IgG2a-Alexa 647 (goat)</td><td valign="top">Molecular Probes</td><td valign="top">Cat# A-21241, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2535810">AB_2535810</ext-link></td><td valign="top">IHC(1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Biotinylated anti-rabbit (goat)</td><td valign="top">Vector Laboratories</td><td valign="top">Cat# BA-1000, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2313606">AB_2313606</ext-link></td><td valign="top">IHC(1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Biotinylated anti-rat (goat)</td><td valign="top">Vector Laboratories</td><td valign="top">Cat# BA-9400, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2336202">AB_2336202</ext-link></td><td valign="top">IHC(1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Biotinylated anti-mouse (horse)</td><td valign="top">Vector Laboratories</td><td valign="top">Cat# BA-2000, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2313581">AB_2313581</ext-link></td><td valign="top">IHC(1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Biotinylated anti-mouse IgG1 (rat)</td><td valign="top">BioLegend</td><td valign="top">Cat# 406603, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_315062">AB_315062</ext-link></td><td valign="top">IHC(1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Streptavidin-Alexa 488</td><td valign="top">Thermo Fisher Scientific</td><td valign="top">Cat# S11223, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2336881">AB_2336881</ext-link></td><td valign="top">IHC(1:400)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Streptavidin-Alexa 555</td><td valign="top">Thermo Fisher Scientific</td><td valign="top">Cat# S32355, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2571525">AB_2571525</ext-link></td><td valign="top">IHC(1:400)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Streptavidin-Alexa 647</td><td valign="top">Jackson Immuno Research Europe Ltd.</td><td valign="top">Cat# 016-600-084, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2341101">AB_2341101</ext-link></td><td valign="top">IHC(1:200)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Streptavidin-DyLight 405</td><td valign="top">Jackson Immuno Research Europe Ltd.</td><td valign="top">Cat# 016-470-084, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2337248">AB_2337248</ext-link></td><td valign="top">IHC(1:400)</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">DAPI stain</td><td valign="top">Invitrogen</td><td valign="top">Cat# D9542</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Fast green</td><td valign="top">Roche</td><td valign="top">Cat# 06402712001</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Paraformaldehye</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# 441244</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Ritrodrine hydrochloride</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# R0758-1G</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Tamoxifen</td><td valign="top">Invitrogen</td><td valign="top">Cat# D9542</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Triton X-100</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat# T8787-100ML</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">RNAscope Probe - Mm-Nrg1</td><td valign="top">ACDBio</td><td valign="top">Cat# 418181</td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">RNAscope Probe - Mm-Nrg3</td><td valign="top">ACDBio</td><td valign="top">Cat# 441831</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">RNAscope Multiplex Fluorescent Assay</td><td valign="top">ACDBio</td><td valign="top">Cat# 323110</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (<italic>Mus musculus</italic>)</td><td valign="top"><italic>Neurod6<sup>Cre</sup></italic> (<italic>Neurod6<sup>tm1(cre)Kan</sup></italic>)</td><td valign="top"><xref ref-type="bibr" rid="bib21">Goebbels et al., 2006</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/17146780">17146780</ext-link></td><td valign="top"/><td valign="top">Dr Klaus Nave (MPI-EM)</td></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Neurod6<sup>CreERT2</sup></italic> (<italic>Neurod6<sup>tm2.1(cre/ERT2</sup></italic><sup>)<italic>Kan</italic></sup>)</td><td valign="top"><xref ref-type="bibr" rid="bib1">Agarwal et al., 2012</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/21880656">21880656</ext-link></td><td valign="top"/><td valign="top">Dr Klaus Nave (MPI-EM)</td></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Nrg1<sup>floxed</sup></italic> (<italic>Nrg1<sup>tm3Cbm</sup></italic>)</td><td valign="top"><xref ref-type="bibr" rid="bib53">Yang et al., 2001</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/11395002">11395002</ext-link></td><td valign="top"/><td valign="top">Dr Carmen Birchmeier (MDC)</td></tr><tr><td valign="top">Genetic reagent (<italic>M. musculus</italic>)</td><td valign="top"><italic>Nrg3<sup>floxed</sup></italic> (<italic>Nrg3<sup>tm1a(KOMP)Mbp</sup></italic>)</td><td valign="top"><xref ref-type="bibr" rid="bib3">Bartolini et al., 2017</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/28147272">28147272</ext-link></td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Genetic regent (<italic>M. musculus</italic>)</td><td valign="top"><italic>RCL<sup>tdT</sup></italic> or Ai9 (<italic>Gt(ROSA)26Sor<sup>tm9(CAGtdTomato)Hze</sup>/J</italic>)</td><td valign="top"><xref ref-type="bibr" rid="bib31">Madisen et al., 2010</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/20023653">20023653</ext-link> Jackson Laboratory</td><td valign="top">Stock: 007905, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:007905">IMSR_JAX:007905</ext-link></td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>M. musculus</italic>)</td><td valign="top">C57BL/6J</td><td valign="top">Jackson Laboratory</td><td valign="top">Stock: 000664, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_JAX:000664">IMSR_JAX:000664</ext-link></td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>M. musculus</italic>)</td><td valign="top">Crl:CD1(ICR)</td><td valign="top">Charles River Laboratories</td><td valign="top">Stock: 022, RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/IMSR_CRL:022">IMSR_CRL:022</ext-link></td><td valign="top"/></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Nex-4</td><td valign="top"><xref ref-type="bibr" rid="bib21">Goebbels et al., 2006</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/17146780">17146780</ext-link></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">GAGTCCTGGAATCAGTCTTTTTC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Nex-5</td><td valign="top"><xref ref-type="bibr" rid="bib21">Goebbels et al., 2006</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/17146780">17146780</ext-link></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">AGAATGTGGAGTAGGGTGAC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Nex-6</td><td valign="top"><xref ref-type="bibr" rid="bib21">Goebbels et al., 2006</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/17146780">17146780</ext-link></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">CCGCATAACCAGTGAAACAG</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Exon1-S</td><td valign="top"><xref ref-type="bibr" rid="bib1">Agarwal et al., 2012</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/21880656">21880656</ext-link></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">GAGTCCTGGAATCAGTGTTTTTC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Nex-ORF-as</td><td valign="top"><xref ref-type="bibr" rid="bib1">Agarwal et al., 2012</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/21880656">21880656</ext-link></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">AGAATGTGGAGTAGGGTGAC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Cre-as</td><td valign="top"><xref ref-type="bibr" rid="bib1">Agarwal et al., 2012</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/21880656">21880656</ext-link></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">CCGCATAACCAGTGAAACAG</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">Nco-1</td><td valign="top"><xref ref-type="bibr" rid="bib53">Yang et al., 2001</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/11395002">11395002</ext-link></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">TCCTTTTGTGTGTGTTCAGCACCGG</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">M7-As</td><td valign="top"><xref ref-type="bibr" rid="bib53">Yang et al., 2001</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/11395002">11395002</ext-link></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">GCACCAAGTGGTTGCGATTGTTGCT</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">wt-F</td><td valign="top"><xref ref-type="bibr" rid="bib3">Bartolini et al., 2017</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/28147272">28147272</ext-link></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">AGAGGGAGAATGGAAAACAATGAGC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">wt-R</td><td valign="top"><xref ref-type="bibr" rid="bib3">Bartolini et al., 2017</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/28147272">28147272</ext-link></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">AGATGCCAGTGTCTCTTGTTTAGGG</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">131</td><td valign="top"><xref ref-type="bibr" rid="bib31">Madisen et al., 2010</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/20023653">20023653</ext-link></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">AAGGGAGCTGCAGTGGAGTA</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">132</td><td valign="top"><xref ref-type="bibr" rid="bib31">Madisen et al., 2010</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/20023653">20023653</ext-link></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">CCGAAAATCTGTGGGAAGTC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">133</td><td valign="top"><xref ref-type="bibr" rid="bib31">Madisen et al., 2010</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/20023653">20023653</ext-link></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">GGCATTAAAGCAGCGTATCC</named-content></td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">134</td><td valign="top"><xref ref-type="bibr" rid="bib31">Madisen et al., 2010</xref>, PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/20023653">20023653</ext-link></td><td valign="top">PCR primers</td><td valign="top"><named-content content-type="sequence">CTGTTCCTGTACGGCATGG</named-content></td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top"><italic>pSyn-Gfp</italic> (plasmid)</td><td valign="top">this paper</td><td valign="top"/><td valign="top">See Materials and methods, Section 2.</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top"><italic>pSyn-HANrg1-pSyn-Gfp</italic> (plasmid)</td><td valign="top">this paper</td><td valign="top"/><td valign="top">See Materials and methods, Section 2.</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top"><italic>pSyn-HANrg3-pSyn-Gfp</italic> (plasmid)</td><td valign="top">this paper</td><td valign="top"/><td valign="top">See Materials and methods, Section 2.</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top"><italic>pSyn-HANrg1<sup>Ct:Nrg3</sup>-pSyn-Gfp</italic> (plasmid)</td><td valign="top">this paper</td><td valign="top"/><td valign="top">See Materials and methods, Section 2.</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top"><italic>pSyn-HANrg3<sup>Ct:Nrg1</sup>-pSyn-Gfp</italic> (plasmid)</td><td valign="top">this paper</td><td valign="top"/><td valign="top">See Materials and methods, Section 2.</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top"><italic>pSyn-HANrg1<sup>EGF:Nrg3</sup>-pSyn-Gfp</italic> (plasmid)</td><td valign="top">this paper</td><td valign="top"/><td valign="top">See Materials and methods, Section 2.</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top"><italic>pSyn-HANrg3<sup>EGF:Nrg1</sup>-pSyn-Gfp</italic> (plasmid)</td><td valign="top">this paper</td><td valign="top"/><td valign="top">See Materials and methods, Section 2.</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top"><italic>pSyn-HANrg1<sup>ΔCt</sup>-pSyn-Gfp</italic> (plasmid)</td><td valign="top">this paper</td><td valign="top"/><td valign="top">See Materials and methods, Section 2.</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top"><italic>pSyn-HANrg3<sup>ΔCt</sup>-pSyn-Gfp</italic> (plasmid)</td><td valign="top">this paper</td><td valign="top"/><td valign="top">See Materials and methods, Section 2.</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">FIJI (ImageJ)</td><td valign="top">National Institute of Health</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002285">SCR_002285</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">MATLAB</td><td valign="top">MathWorks</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001622">SCR_001622</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">LAS AF</td><td valign="top">Leica Microsystems</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_013673">SCR_013673</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Bioconductor</td><td valign="top">open source</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_006442">SCR_006442</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">R Project for Statistical Computing</td><td valign="top">open source</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_001905">SCR_001905</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">RStudio</td><td valign="top">open source</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_000432">SCR_000432</ext-link></td><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>The mouse lines <italic>Neurod6<sup>CreERT2</sup></italic> (<italic>Neurod6<sup>tm2.1(cre/ERT2)Kan</sup></italic>) (<xref ref-type="bibr" rid="bib1">Agarwal et al., 2012</xref>), <italic>Neurod6<sup>Cre</sup></italic> (<italic>Neurod6<sup>tm1(cre)Kan</sup></italic>) (<xref ref-type="bibr" rid="bib21">Goebbels et al., 2006</xref>), <italic>Nrg1<sup>floxed</sup></italic> (<italic>Nrg1<sup>tm3Cbm</sup></italic>) (<xref ref-type="bibr" rid="bib53">Yang et al., 2001</xref>), <italic>Nrg3<sup>floxed</sup></italic> (<italic>Nrg3<sup>tm1a(KOMP)Mbp</sup></italic>) (<xref ref-type="bibr" rid="bib3">Bartolini et al., 2017</xref>), and <italic>RCL<sup>tdT</sup></italic> (<italic>Gt(ROSA)26Sor<sup>tm9(CAG-tdTomato)Hze</sup></italic>) (<xref ref-type="bibr" rid="bib31">Madisen et al., 2010</xref>) were maintained in a C57BL/6J background (Jackson Laboratories, #000664). CD-1 [Crl:CD1(ICR)] mice (Charles River, #022) were used for in utero electroporation (IUE) experiments. Animals were housed in groups of up to five littermates and maintained under standard, temperature controlled, laboratory conditions. Mice were kept on a 12:12 light/dark cycle and received water and food ad libitum. All animal procedures were approved by the ethical committee (King’s College London) and conducted in accordance with European regulations, and Home Office personal and project licenses under the UK Animals (Scientific Procedures) 1986 Act.</p><p>The following primer sequences were used for routine genotyping: <italic>Neurod6<sup>CreERT2</sup></italic> (5’ - <named-content content-type="sequence">GAGTCCTGGAATCAGTGTTTTTC</named-content> - 3’; 5’ - <named-content content-type="sequence">AGAATGTGGAGTAGGGTGAC</named-content> - 3’; 5’ - <named-content content-type="sequence">CCGCATAACCAGTGAAACAG</named-content> - 3’), <italic>Neurod6<sup>Cre</sup></italic> (5’ - <named-content content-type="sequence">GAGTCCTGGAATCAGTCTTTTTC</named-content> - 3’; 5’ - <named-content content-type="sequence">AGAATGTGGAGTAGGGTGAC</named-content> - 3’; 5’ - <named-content content-type="sequence">CCGCATAACCAGTGAAACAG</named-content> - 3’), <italic>Nrg1<sup>floxed</sup></italic> (5’ - <named-content content-type="sequence">TCCTTTTGTGTGTGTTCAGCACCGG</named-content> - 3’; 5’ - <named-content content-type="sequence">GCACCAAGTGGTTGCGATTGTTGCT</named-content> - 3’), <italic>Nrg3<sup>floxed</sup></italic> (5’ - <named-content content-type="sequence">AGAGGGAGAATGGAAAACAATGAGC</named-content> - 3’; 5’ - <named-content content-type="sequence">AGATGCCAGTGTCTCTTGTTTAGGG</named-content> - 3’), and <italic>RCL<sup>tdT</sup></italic> (5’ - <named-content content-type="sequence">AAGGGAGCTGCAGTGGAGTA</named-content> - 3’; 5’ - <named-content content-type="sequence">CCGAAAATCTGTGGGAAGTC</named-content> - 3’; 5’ - <named-content content-type="sequence">GGCATTAAAGCAGCGTATCC</named-content> - 3’; 5’ - <named-content content-type="sequence">CTGTTCCTGTACGGCATGG</named-content> - 3’).</p></sec><sec id="s4-2"><title>Generation of DNA constructs</title><p>Neuregulin constructs were generated by standard molecular biology procedures. We used the DNA sequences of the predominant isoforms for <italic>Nrg1</italic> (GenBank: NM_178591, Ensembl Transcript ID: ENSMUST00000073884.5) and <italic>Nrg3</italic> (GenBank: NM_008734, Ensembl Transcript ID: ENSMUST00000166968.8). The neuregulin sequences lacked the 5’- and 3’-untranslated regions (UTR) and were preceded by the Kozak consensus sequence. The different neuregulin inserts were cloned into an expression vector plasmid containing the synapsin promoter (<italic>pSyn</italic>) using the restriction enzymes NotI/EcoRI. These plasmids contained an additional <italic>pSyn</italic> promoter followed by a green fluorescent protein (GFP) as a reporter to label the electroporated cells (<xref ref-type="bibr" rid="bib20">Gascón et al., 2008</xref>). For control experiments, we used the <italic>pSyn-Gfp</italic> plasmid lacking any neuregulin insert.</p><p>To identify the subcellular localization of neuregulins, constructs harbored a human influenza hemagglutinin (HA) epitope tag upstream of the EGF-like domain (exon 2). It has been previously reported that this tag insertion site in neuregulin loci does not alter their function (<xref ref-type="bibr" rid="bib49">Wang et al., 2001</xref>). The HA tag was inserted between amino acids 222 (Leucine, L) and 223 (Serine, S) for Nrg1 protein, and between amino acids 277 (Histidine, H) and 278 (Threonine, T) for Nrg3 protein.</p><p>For EGF-like domain swapping experiments, the chimeric neuregulins were generated by replacing the EGF-like domain of a neuregulin member by the corresponding domain from its homologous gene. First, the EGF-like domain of Nrg1 (amino acids 223 to 286, corresponding to exons 2 and 3) was replaced by the EGF-like domain of Nrg3 (amino acids 278 to 346, corresponding to exons 2 and 3); this chimeric protein was named Nrg1<sup>EGF:Nrg3</sup>. Second, the EGF-like domain of Nrg3 (amino acids 278 to 346) was replaced by the EGF-like domain of Nrg1 (amino acids 223 to 286); this chimeric protein was named Nrg3<sup>EGF:Nrg1</sup>.</p><p>For C-terminal domain swapping experiments, the chimeric neuregulins were generated by replacing the C-terminal domain of a neuregulin member by the corresponding domain from its homologous gene. First, the C-terminal domain of Nrg1 (amino acids 326–700, corresponding to exons 6–9) was replaced by the C-terminal domain of Nrg3 (amino acids 384–713, corresponding to exons 6–10); this chimeric protein was named Nrg1<sup>Ct:Nrg3</sup>. Second, the C-terminal domain of Nrg3 (amino acids 384–713) was replaced by the C-terminal domain of Nrg1 (amino acids 326–700); this chimeric protein was named Nrg3<sup>Ct:Nrg1</sup>.</p><p>For C-terminal domain deletion experiments, the truncated neuregulins were generated by deleting the C-terminal domain of each neuregulin and inserting a stop codon downstream of the transmembrane domain of the protein. First, the C-terminal domain of Nrg1 (amino acids 329–700) was deleted and a stop codon was inserted after amino acid 328 (Lysine, K); this truncated protein was named Nrg1<sup>ΔCt</sup>. Second, the C-terminal domain of Nrg3 (amino acids 389–713) was deleted and a stop codon was inserted after amino acid 388 (Lysine, K); this truncated protein was named Nrg3<sup>ΔCt</sup>.</p><p>For in utero electroporation (IUE), neuregulin expression plasmids were used at a concentration of 1 μg/μl. DNA solution was mixed with Fast Green (Roche, Cat# 06402712001) and 1–2 μl of the solution was injected into the lateral ventricle of E14.5 embryos.</p><p>To estimate the similarity between homologous protein domains of Nrg1 and Nrg3, we used the online-based Basic Local Alignment Search Tool (BLAST) from NCBI (<ext-link ext-link-type="uri" xlink:href="https://blast.ncbi.nlm.nih.gov/Blast.cgi">https://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link>). Amino acid sequences were compared for exons 2–3 of both neuregulins—corresponding to the EGF-like domains—, and exons 6–9 and exons 6–10 of Nrg1 and Nrg3, respectively—corresponding to the C-terminal domains.</p></sec><sec id="s4-3"><title>In utero electroporation</title><p>In utero electroporation (IUE) was performed as described before (<xref ref-type="bibr" rid="bib3">Bartolini et al., 2017</xref>). CD-1 [Crl:CD1(ICR)] mice (Charles River, #022) were used for all IUE experiments. Timed-pregnant females were deeply anesthetized with isoflurane (Piramal Critical Care Limited). Buprenorphine (Vetergesic, Ceva Animal Health Ltd) was administered for analgesia via subcutaneous injection, and ritodrine hydrochloride (Sigma-Aldrich, Cat# R0758) was applied to the exposed uterine horns to relax the myometrium. DNA solution was mixed with Fast Green (Roche, Cat# 06402712001) and 1–2 μl of the solution was injected into the lateral ventricle of embryos at E14.5. Forceps-shaped electrodes (CUY650P3, Nepa Gene) connected to an electroporator (NEPA21 Super Electroporator, Nepa Gene) were used to deliver five electric pulses (45 V for 50 ms, with 950 ms intervals). The electrodes were positioned to target cortical pyramidal cell progenitors in the subventricular zone.</p></sec><sec id="s4-4"><title>Tamoxifen injection</title><p>Tamoxifen (Sigma-Aldrich, Cat# 85256) was dissolved in corn oil (Sigma-Aldrich, Cat# C8267) (10 mg/ml) at 37°C with constant agitation. Tamoxifen at a dose of 1 mg/10 g of body weight was administered via intragastric injection into P0 postnatal <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdT</sup>;Nrg3<sup>floxed</sup></italic> or <italic>Neurod6<sup>CreERT2</sup>;RCL<sup>tdT</sup>;Nrg3<sup>floxed</sup></italic> mouse pups to conditionally knock-out the corresponding neuregulin gene in cortical pyramidal cells during postnatal development.</p></sec><sec id="s4-5"><title>Histology and immunohistochemistry</title><p>Mice were deeply anesthetized with pentobarbital sodium (Euthatal, Merial Animal Health Ltd) by intraperitoneal injection, and transcardially perfused with sodium chloride solution (Sigma-Aldrich, Cat# S76530) followed by 4% paraformaldehyde (PFA) (Sigma-Aldrich, Cat# 441244) in phosphatase-buffered saline (PBS). Dissected brains were post-fixed for 2 hr at 4°C, cryoprotected in 30% sucrose (Sigma-Aldrich, Cat# S0389) in PBS, and cut frozen on a sliding microtome (Leica SM2010 R) at 40 μm. Free-floating brain slices were permeabilized with 0.2% Triton X-100 (Sigma-Aldrich, Cat# T8787) in PBS for 1 hr, and blocked for 2 hr in a solution containing 0.3% Triton X-100, 1% serum, and 5% bovine serum albumin (BSA) (Sigma-Aldrich, Cat# A8806). Then, brain slices were incubated overnight at 4°C with primary antibodies. For immunostaining using antibodies against Nrgs, heat-induced antigen retrieval (H-AR) was performed before the permeabilization step. For H-AR, brain slices were incubated in target retrieval buffer solution containing 0.01M sodium citrate and 10% glycerol (pH 6) at 70°C for 1 hr. After H-AR, brain slices were washed in PBS. The next day, the tissue was repeatedly rinsed in PBS and incubated with secondary antibodies for 2 hr at room temperature. When required, brain slices were counterstained with 5 μM 4’,6-diamidine-2’-phenylindole dihydrochloride (DAPI) (Sigma-Aldrich, Cat# D9542) in PBS. All primary and secondary antibodies were diluted in 0.3% Triton X-100, 1% serum and 2% BSA. The following primary antibodies were used: chicken anti-parvalbumin (1:500, Synaptic Systems, #195 006), goat anti-CB1 (1:400, Frontier Institute, #CB1-Go-Af450), guinea pig anti-VGlut1 (1:2000, Merck Millipore, #AB5905), mouse IgG2a anti-GAD65 (1:500, Merck Millipore, #MAB351R), mouse IgG2a anti-GAD67 (1:5,000, Merck Millipore, #MAB5406), mouse IgG1 anti-gephyrin (1:500, Synaptic Systems, #147 011), mouse anti-HA (1:500, BioLegend, #901502), mouse anti-PSD95 (1:500, NeuroMab, #70–028), mouse IgG2a anti-Synaptotagmin-2 (1:250, ZFIN, #ZDB-ATB-081002–25), rabbit anti-DsRed (1:500, Clontech, #632496), rabbit anti-HA (1:500, Cell Signaling Technology, #3724), rabbit anti-parvalbumin (1:2000, Swant, #PV27), and rabbit anti-pIκBα (1:200, Cell Signaling Technology, #2859). The following secondary antibodies were used: donkey anti-chicken-DyLight 405 (1:200, Jackson ImmunoResearch Europe Ltd., #703-475-155), donkey anti-guinea pig-647 (1:250, Jackson ImmunoResearch Europe Ltd., #706-605-148), donkey anti-goat-Alexa 647 (1:400, Molecular Probes, #A-21447), donkey anti-mouse-Alexa 488 (1:200, Molecular Probes, A-21202), donkey anti-rabbit-Alexa 647 (1:500, Molecular Probes, #A-31573), donkey anti-rabbit-Cy3 (1:500, Jackson ImmunoResearch Europe Ltd., #711-165-152), goat anti-chicken-Alexa 488 (1:600, Molecular Probes, #A-11039), goat anti-mouse IgG1-Alexa 488 (1:500, Molecular Probes, #A-21121), goat anti-mouse IgG1-Alexa 555 (1:500, Molecular Probes, #A-21127), goat anti-mouse IgG1-Alexa 647 (1:500, Molecular Probes, #A-21240), goat anti-mouse IgG2a-Alexa 647 (1:500, Molecular Probes, #A-21241), biotinylated goat anti-rabbit (1:200, Vector Laboratories, #BA-1000), biotinylated goat anti-rat (1:200, Vector Laboratories, #BA-9400), biotinylated horse anti-mouse (1:200, Vector Laboratories, #BA-2000), biotinylated rat anti-mouse IgG1 (1:200, BioLegend, #406603), streptavidin-Alexa 488 (1:400, Thermo Fisher Scientific, #S11223), streptavidin-Alexa 555 (1:400, Thermo Fisher Scientific, #S32355), streptavidin-Alexa 647 (1:200, Jackson ImmunoResearch Europe Ltd., #016-600-084), and streptavidin-DyLight 405 (1:400, Jackson ImmunoResearch Europe Ltd., #016-470-084).</p></sec><sec id="s4-6"><title>Single-molecule fluorescence in situ hybridization</title><p>Mice were perfused as described above, and brains were postfixed overnight in 4% PFA in PBS followed by cryoprotection in 30% sucrose-RNase free PBS. Brains were sectioned frozen on sliding microtome at 30 μm. Fluorescent in situ hybridization on brain slices was performed according to manufacturer’s protocol (ACDBio, RNAscope Multiplex Fluorescent Assay v2, Cat# 323110). The following probes from the RNAscope catalogue were used in this study: Nrg1-C3 (ACDBio, Cat# 418181), and Nrg3-C1 (ACDBio, Cat# 441831).</p></sec><sec id="s4-7"><title>Image acquisition and image analysis</title><p>Images were acquired at 1024 × 1024 pixel resolution in an inverted Leica TCS-SP8 confocal microscope. Imaging for cell density and synapse density analyses was performed at 8-bit depth, and imaging for subcellular compartment analysis was performed at 12-bit depth. Tile scan images of brain slices were acquired in a ZEISS Apotome2. Samples from the same experiment were imaged and analyzed in parallel, using the same laser power, photomultiplier gain and detection filter settings.</p><p>For subcellular compartment analysis, images were acquired with 20X/0.50 (Magnification/Numerical Aperture) objective, and 0.75 digital zoom at 200 Hz acquisition speed. Analysis of HA-tagged neuregulin localization in somas and neuropil was performed in MatLab (MathWorks). First, single-channel images positive for GFP, corresponding to pyramidal cell bodies, were normalized to a reference image by using a histogram matching function to allow the detection of soma and neuropil across samples using intensity-based thresholding with the same parameters. Images from the same experiment were normalized to the same reference image. For somatic compartment analysis, pyramidal cell somas—that show higher intensity of GFP+ signal compared to neuropil—were masked using a low threshold. Masks of neuregulin expression in somas were generated by thresholding of single-channel images positive for HA. The GFP+ and HA+ masks were merged, and the number of GFP-masked somas containing HA+ signal was automatically quantified. Somatic neuregulin expression was represented as the percentage of HA/GFP double-positive somas per region of interest (ROI). For neuropil compartment analysis, the neuropil of pyramidal cells was masked from the single-channel images positive for GFP using a high threshold and an additional subtraction of the area of the soma identified with a low threshold. The image thresholding method ‘IsoData’ was used to detect and generate masks of HA expression in the neuropil. After merging the GFP+ mask and the HA+ mask, the quantification of the percentage of HA+/GFP+ colocalization was used to estimate neuregulin expression in the neuropil of a given ROI. Imaging was performed in 3–4 slices of the somatosensory cortex, and 4–10 ROIs were quantified and averaged per animal.</p><p>For cell density analysis, images were acquired with 10X/0.30 or 20X/0.50 objectives, and 0.75 digital zoom at 200 Hz acquisition speed. Analysis of PV+ interneuron density was performed in FIJI (ImageJ) software. The number of PV+ cells was manually counted across layers in the somatosensory cortex. This number was then divided by area (μm<sup>2</sup>) of cortex to estimate the density of cells. A minimum of six brain slices were quantified and averaged per animal. For quantification of tdTomato- or GFP-labeled pyramidal cells, the cell density analyses were performed in upper layers of the somatosensory cortex of 3–4 slices that contain the ROIs used in synaptic analyses.</p><p>For synapse density analysis, images were acquired with 100X/1.44 objective and 2.2 digital zoom at 200 Hz acquisition speed. To estimate the relative position of each neuron within the L2/3 of the cortex, we then took images of the same cells with 40X/1.40 objective and 0.75 digital zoom to measure the depth from the border between L1 and L2. Analysis of bouton/synapse densities was performed using a custom macro in FIJI (ImageJ) software, as described previously (<xref ref-type="bibr" rid="bib12">Favuzzi et al., 2017</xref>). Processing of surface and synaptic single-channel images included background subtraction, Gaussian blurring, smoothing, and contrast enhancement. For quantification of somatic synaptic contacts, the PV+ or tdTomato (tdT)+ soma was detected based on intensity levels and automatically drawn to create a mask representing the surface of the cell body and to measure its perimeter. Similarly, for quantification of axo-axonic synaptic contacts, a mask of the AIS was created from pIκBα+ structure and its length measured. For presynaptic boutons and postsynaptic clusters, a threshold of intensity was used to automatically detect putative synaptic puncta while excluding any background. The thresholds for the different synaptic markers were unbiasedly selected in a set of random images prior to quantification, and the same threshold was applied to all images from the same experiment. The ‘Analyze Particles’ (circularity 0.00–1.00) and ‘Watershed’ tools were applied to the synaptic channels, and a mask was generated. The minimum sizes for particles were defined as follows: 0.06 for GAD67+, GAD65+ and CB1R+ boutons; and 0.05 for Syt2+ and VGlut1+ boutons and Geph+ and PSD95+ clusters. Finally, a merged image of the surface and synaptic masks was created to automatically quantify the number of contacts opposed to the soma or AIS structures. The criterion to identify presynaptic boutons (GAD67+, GAD65+, CB1R+, Syt2+, or VGlut1+) contacting the surface border of a soma or AIS was that ≥0.04 μm<sup>2</sup> of the puncta area in the synaptic mask was colocalizing with the mask of the soma or AIS. The criterion to identify postsynaptic clusters (Geph+, or PSD95+) contained inside a defined soma was that ≥0.04 μm<sup>2</sup> of the puncta area in the synaptic mask was colocalizing with the mask of the soma. Synapses (Syt2+/Geph+, or VGlut1+/PSD95+) were identified when a presynaptic bouton and a postsynaptic cluster were contacting each other, with a colocalization area of ≥0.03 μm<sup>2</sup> of their corresponding masks. VGlut1+/PSD95+ synaptic contacts were considered to originate from tdT- or GFP-labeled axon terminals when ≥ 0.025 μm<sup>2</sup> of their area were colocalizing with the mask of tdT+ or GFP+ processes.</p><p>For the analysis of the density of endogenous Nrg puncta, images were acquired with 100X/1.44 objective and 0.75 digital zoom at 200 Hz acquisition speed, and quantitative analyses were performed using a custom macro in FIJI (ImageJ) software. For Nrg1 puncta density, ROIs (2000 μm<sup>2</sup>) were analyzed in both the stratum pyramidale and stratum radiatum, distinguished by the location of neuronal somas labeled with NeuN. Intensity-based threshold for Nrg1 signal was unbiasedly selected in a set of random images to detect putative puncta, and the same threshold was applied to all images from the same experiment. For Nrg3 puncta density, images were processed similarly to Nrg1 density analysis, using the same criteria to detect and analyze the number of Nrg3+ clusters per ROI (24,025 μm<sup>2</sup>). In addition, to quantitatively estimate and distinguish between Nrg3+ clusters that are in close apposition to PV+ cells—putatively representing Nrg3-labeled presynaptic excitatory inputs onto interneurons—and Nrg3+ clusters that are not in contact with PV+ cells, we used PV immunostaining to generate masks representing the cell bodies of PV+ interneurons. ROIs with similar proportion of PV+ cell body masks across genotypes were used (average, 8561.4 μm<sup>2</sup>).</p></sec><sec id="s4-8"><title>Quantification and statistical analysis</title><p>All statistical analyses were performed using R Project for Statistical Computing (<ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/">https://www.r-project.org/</ext-link>). For data analysis and visualization, we used the ‘ggplot2’ package in RStudio (<ext-link ext-link-type="uri" xlink:href="https://www.rstudio.com/">https://www.rstudio.com/</ext-link>). Shapiro-Wilk test was used as a normality test to compare the empirical distribution function of the data sets with a normal probability distribution. To test the null hypothesis that the difference between two independent and parametric data samples measured in control and experimental conditions has a mean value of zero we used two-tailed Student’s <italic>t</italic>-test. Mann-Whitney <italic>U</italic>-test was used as the non-parametric alternative test. To analyze the differences among multiple experimental groups, we used one- or two-way analysis of variance (ANOVA) test followed by Tukey's range test as a post hoc comparison test. Kruskal-Wallis test was used as the non-parametric alternative test. Statistical significance was considered at p-values&lt;0.05. Data are presented as mean ± SEM. Number of cells or ROIs analyzed and number of animals for each experiment are described in each figure legend. Cumulative frequencies of synaptic densities are used to show the diversity of synaptic densities across all cells analyzed, further supporting the observed significant alterations in synaptic densities by depicting the general change of the entire pool of cells per experimental condition.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank I Andrew and L Doglio for excellent technical assistance and E F Maraver for image analysis; C Birchmeier (Max-Delbrueck-Centrum, Berlin) for conditional <italic>Nrg1</italic> mice, and K Nave (Max Planck Institute of Experimental Medicine, Göttingen) for <italic>Nex-Cre</italic> and <italic>Nex-Cre<sup>ERT2</sup></italic> mice. Supported by grants from the Medical Research Council (MRC Programme Grant, MR/S010785/1) and European Union’s Horizon 2020 research and innovation programme under grant agreement (AIMS-2-TRIALS, 777394) to BR and OM, and Fondation Roger de Spoelberch to OM. DE-A was supported by a ‘la Caixa’ Foundation Graduate Fellowship.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing, DE-A performed the majority of experiments described in this manuscript</p></fn><fn fn-type="con" id="con2"><p>Investigation, Methodology, CO performed initial experiments establishing the differential function of Neuregulins</p></fn><fn fn-type="con" id="con3"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Investigation, SP performed early pilot experiments with Nrg3</p></fn><fn fn-type="con" id="con5"><p>Investigation, ID performed early pilot experiments with Nrg3</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Resources, Supervision, Funding acquisition, Validation, Investigation, Visualization, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Resources, Supervision, Funding acquisition, Validation, Investigation, Visualization, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals in accordance with European regulations, and Home Office personal and project licenses (PPL 0808-2004-2019, PPL PD025E9BC-2019-2024) under the UK Animals (Scientific Procedures) 1986 Act. The experiments performed in this study, have been designed to follow the 3R's rules whenever possible.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-57000-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for the figures and figure supplements.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agarwal</surname> <given-names>A</given-names></name><name><surname>Dibaj</surname> <given-names>P</given-names></name><name><surname>Kassmann</surname> <given-names>CM</given-names></name><name><surname>Goebbels</surname> <given-names>S</given-names></name><name><surname>Nave</surname> <given-names>KA</given-names></name><name><surname>Schwab</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>In vivo imaging and noninvasive ablation of pyramidal neurons in adult NEX-CreERT2 mice</article-title><source>Cerebral Cortex</source><volume>22</volume><fpage>1473</fpage><lpage>1486</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhr214</pub-id><pub-id pub-id-type="pmid">21880656</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apóstolo</surname> <given-names>N</given-names></name><name><surname>de Wit</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Compartmentalized distributions of neuronal and glial cell-surface proteins pattern the synaptic network</article-title><source>Current Opinion in Neurobiology</source><volume>57</volume><fpage>126</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2019.01.025</pub-id><pub-id pub-id-type="pmid">30826628</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartolini</surname> <given-names>G</given-names></name><name><surname>Sánchez-Alcañiz</surname> <given-names>JA</given-names></name><name><surname>Osório</surname> <given-names>C</given-names></name><name><surname>Valiente</surname> <given-names>M</given-names></name><name><surname>García-Frigola</surname> <given-names>C</given-names></name><name><surname>Marín</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Neuregulin 3 mediates cortical plate invasion and laminar allocation of GABAergic interneurons</article-title><source>Cell Reports</source><volume>18</volume><fpage>1157</fpage><lpage>1170</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.12.089</pub-id><pub-id pub-id-type="pmid">28147272</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>YJ</given-names></name><name><surname>Zhang</surname> <given-names>M</given-names></name><name><surname>Yin</surname> <given-names>DM</given-names></name><name><surname>Wen</surname> <given-names>L</given-names></name><name><surname>Ting</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>P</given-names></name><name><surname>Lu</surname> <given-names>YS</given-names></name><name><surname>Zhu</surname> <given-names>XH</given-names></name><name><surname>Li</surname> <given-names>SJ</given-names></name><name><surname>Wu</surname> <given-names>CY</given-names></name><name><surname>Wang</surname> <given-names>XM</given-names></name><name><surname>Lai</surname> <given-names>C</given-names></name><name><surname>Xiong</surname> <given-names>WC</given-names></name><name><surname>Mei</surname> <given-names>L</given-names></name><name><surname>Gao</surname> <given-names>TM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation</article-title><source>PNAS</source><volume>107</volume><fpage>21818</fpage><lpage>21823</lpage><pub-id pub-id-type="doi">10.1073/pnas.1010669107</pub-id><pub-id pub-id-type="pmid">21106764</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cioni</surname> <given-names>JM</given-names></name><name><surname>Lin</surname> <given-names>JQ</given-names></name><name><surname>Holtermann</surname> <given-names>AV</given-names></name><name><surname>Koppers</surname> <given-names>M</given-names></name><name><surname>Jakobs</surname> <given-names>MAH</given-names></name><name><surname>Azizi</surname> <given-names>A</given-names></name><name><surname>Turner-Bridger</surname> <given-names>B</given-names></name><name><surname>Shigeoka</surname> <given-names>T</given-names></name><name><surname>Franze</surname> <given-names>K</given-names></name><name><surname>Harris</surname> <given-names>WA</given-names></name><name><surname>Holt</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Late endosomes act as mRNA translation platforms and sustain mitochondria in axons</article-title><source>Cell</source><volume>176</volume><fpage>56</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.11.030</pub-id><pub-id pub-id-type="pmid">30612743</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Citri</surname> <given-names>A</given-names></name><name><surname>Yarden</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>EGF–ERBB signalling: towards the systems level</article-title><source>Nature Reviews Molecular Cell Biology</source><volume>7</volume><fpage>505</fpage><lpage>516</lpage><pub-id pub-id-type="doi">10.1038/nrm1962</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Wit</surname> <given-names>J</given-names></name><name><surname>Ghosh</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Specification of synaptic connectivity by cell surface interactions</article-title><source>Nature Reviews Neuroscience</source><volume>17</volume><fpage>4</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1038/nrn.2015.3</pub-id><pub-id pub-id-type="pmid">26656254</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Pino</surname> <given-names>I</given-names></name><name><surname>García-Frigola</surname> <given-names>C</given-names></name><name><surname>Dehorter</surname> <given-names>N</given-names></name><name><surname>Brotons-Mas</surname> <given-names>JR</given-names></name><name><surname>Alvarez-Salvado</surname> <given-names>E</given-names></name><name><surname>Martínez de Lagrán</surname> <given-names>M</given-names></name><name><surname>Ciceri</surname> <given-names>G</given-names></name><name><surname>Gabaldón</surname> <given-names>MV</given-names></name><name><surname>Moratal</surname> <given-names>D</given-names></name><name><surname>Dierssen</surname> <given-names>M</given-names></name><name><surname>Canals</surname> <given-names>S</given-names></name><name><surname>Marín</surname> <given-names>O</given-names></name><name><surname>Rico</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Erbb4 deletion from fast-spiking interneurons causes schizophrenia-like phenotypes</article-title><source>Neuron</source><volume>79</volume><fpage>1152</fpage><lpage>1168</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.07.010</pub-id><pub-id pub-id-type="pmid">24050403</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Pino</surname> <given-names>I</given-names></name><name><surname>Brotons-Mas</surname> <given-names>JR</given-names></name><name><surname>Marques-Smith</surname> <given-names>A</given-names></name><name><surname>Marighetto</surname> <given-names>A</given-names></name><name><surname>Frick</surname> <given-names>A</given-names></name><name><surname>Marín</surname> <given-names>O</given-names></name><name><surname>Rico</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Abnormal wiring of CCK<sup>+</sup> basket cells disrupts spatial information coding</article-title><source>Nature Neuroscience</source><volume>20</volume><fpage>784</fpage><lpage>792</lpage><pub-id pub-id-type="doi">10.1038/nn.4544</pub-id><pub-id pub-id-type="pmid">28394324</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Pino</surname> <given-names>I</given-names></name><name><surname>Rico</surname> <given-names>B</given-names></name><name><surname>Marín</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neural circuit dysfunction in mouse models of neurodevelopmental disorders</article-title><source>Current Opinion in Neurobiology</source><volume>48</volume><fpage>174</fpage><lpage>182</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2017.12.013</pub-id><pub-id pub-id-type="pmid">29329089</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farías</surname> <given-names>GG</given-names></name><name><surname>Cuitino</surname> <given-names>L</given-names></name><name><surname>Guo</surname> <given-names>X</given-names></name><name><surname>Ren</surname> <given-names>X</given-names></name><name><surname>Jarnik</surname> <given-names>M</given-names></name><name><surname>Mattera</surname> <given-names>R</given-names></name><name><surname>Bonifacino</surname> <given-names>JS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Signal-mediated, AP-1/clathrin-dependent sorting of transmembrane receptors to the somatodendritic domain of hippocampal neurons</article-title><source>Neuron</source><volume>75</volume><fpage>810</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.07.007</pub-id><pub-id pub-id-type="pmid">22958822</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favuzzi</surname> <given-names>E</given-names></name><name><surname>Marques-Smith</surname> <given-names>A</given-names></name><name><surname>Deogracias</surname> <given-names>R</given-names></name><name><surname>Winterflood</surname> <given-names>CM</given-names></name><name><surname>Sánchez-Aguilera</surname> <given-names>A</given-names></name><name><surname>Mantoan</surname> <given-names>L</given-names></name><name><surname>Maeso</surname> <given-names>P</given-names></name><name><surname>Fernandes</surname> <given-names>C</given-names></name><name><surname>Ewers</surname> <given-names>H</given-names></name><name><surname>Rico</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Activity-Dependent gating of parvalbumin interneuron function by the perineuronal net protein brevican</article-title><source>Neuron</source><volume>95</volume><fpage>639</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.06.028</pub-id><pub-id pub-id-type="pmid">28712654</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favuzzi</surname> <given-names>E</given-names></name><name><surname>Deogracias</surname> <given-names>R</given-names></name><name><surname>Marques-Smith</surname> <given-names>A</given-names></name><name><surname>Maeso</surname> <given-names>P</given-names></name><name><surname>Jezequel</surname> <given-names>J</given-names></name><name><surname>Exposito-Alonso</surname> <given-names>D</given-names></name><name><surname>Balia</surname> <given-names>M</given-names></name><name><surname>Kroon</surname> <given-names>T</given-names></name><name><surname>Hinojosa</surname> <given-names>AJ</given-names></name><name><surname>F Maraver</surname> <given-names>E</given-names></name><name><surname>Rico</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Distinct molecular programs regulate synapse specificity in cortical inhibitory circuits</article-title><source>Science</source><volume>363</volume><fpage>413</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1126/science.aau8977</pub-id><pub-id pub-id-type="pmid">30679375</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favuzzi</surname> <given-names>E</given-names></name><name><surname>Rico</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Molecular diversity underlying cortical excitatory and inhibitory synapse development</article-title><source>Current Opinion in Neurobiology</source><volume>53</volume><fpage>8</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2018.03.011</pub-id><pub-id pub-id-type="pmid">29704699</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fazzari</surname> <given-names>P</given-names></name><name><surname>Paternain</surname> <given-names>AV</given-names></name><name><surname>Valiente</surname> <given-names>M</given-names></name><name><surname>Pla</surname> <given-names>R</given-names></name><name><surname>Luján</surname> <given-names>R</given-names></name><name><surname>Lloyd</surname> <given-names>K</given-names></name><name><surname>Lerma</surname> <given-names>J</given-names></name><name><surname>Marín</surname> <given-names>O</given-names></name><name><surname>Rico</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling</article-title><source>Nature</source><volume>464</volume><fpage>1376</fpage><lpage>1380</lpage><pub-id pub-id-type="doi">10.1038/nature08928</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fish</surname> <given-names>KN</given-names></name><name><surname>Sweet</surname> <given-names>RA</given-names></name><name><surname>Lewis</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Differential distribution of proteins regulating GABA synthesis and reuptake in axon boutons of subpopulations of cortical interneurons</article-title><source>Cerebral Cortex</source><volume>21</volume><fpage>2450</fpage><lpage>2460</lpage><pub-id pub-id-type="doi">10.1093/cercor/bhr007</pub-id><pub-id pub-id-type="pmid">21422269</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flames</surname> <given-names>N</given-names></name><name><surname>Long</surname> <given-names>JE</given-names></name><name><surname>Garratt</surname> <given-names>AN</given-names></name><name><surname>Fischer</surname> <given-names>TM</given-names></name><name><surname>Gassmann</surname> <given-names>M</given-names></name><name><surname>Birchmeier</surname> <given-names>C</given-names></name><name><surname>Lai</surname> <given-names>C</given-names></name><name><surname>Rubenstein</surname> <given-names>JL</given-names></name><name><surname>Marín</surname> <given-names>O</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1</article-title><source>Neuron</source><volume>44</volume><fpage>251</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2004.09.028</pub-id><pub-id pub-id-type="pmid">15473965</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname> <given-names>Y</given-names></name><name><surname>Huang</surname> <given-names>ZJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Differential dynamics and activity-dependent regulation of alpha- and beta-neurexins at developing GABAergic synapses</article-title><source>PNAS</source><volume>107</volume><fpage>22699</fpage><lpage>22704</lpage><pub-id pub-id-type="doi">10.1073/pnas.1011233108</pub-id><pub-id pub-id-type="pmid">21149722</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuccillo</surname> <given-names>MV</given-names></name><name><surname>Földy</surname> <given-names>C</given-names></name><name><surname>Gökce</surname> <given-names>Ö</given-names></name><name><surname>Rothwell</surname> <given-names>PE</given-names></name><name><surname>Sun</surname> <given-names>GL</given-names></name><name><surname>Malenka</surname> <given-names>RC</given-names></name><name><surname>Südhof</surname> <given-names>TC</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Single-Cell mRNA profiling reveals Cell-Type-Specific expression of neurexin isoforms</article-title><source>Neuron</source><volume>87</volume><fpage>326</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.06.028</pub-id><pub-id pub-id-type="pmid">26182417</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gascón</surname> <given-names>S</given-names></name><name><surname>Paez-Gomez</surname> <given-names>JA</given-names></name><name><surname>Díaz-Guerra</surname> <given-names>M</given-names></name><name><surname>Scheiffele</surname> <given-names>P</given-names></name><name><surname>Scholl</surname> <given-names>FG</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Dual-promoter lentiviral vectors for constitutive and regulated gene expression in neurons</article-title><source>Journal of Neuroscience Methods</source><volume>168</volume><fpage>104</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.jneumeth.2007.09.023</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goebbels</surname> <given-names>S</given-names></name><name><surname>Bormuth</surname> <given-names>I</given-names></name><name><surname>Bode</surname> <given-names>U</given-names></name><name><surname>Hermanson</surname> <given-names>O</given-names></name><name><surname>Schwab</surname> <given-names>MH</given-names></name><name><surname>Nave</surname> <given-names>K-A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Genetic targeting of principal neurons in neocortex and hippocampus of NEX-Cre mice</article-title><source>Genesis</source><volume>44</volume><fpage>611</fpage><lpage>621</lpage><pub-id pub-id-type="doi">10.1002/dvg.20256</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>A conserved domain in axonal targeting of Kv1 (Shaker) Voltage-Gated potassium channels</article-title><source>Science</source><volume>301</volume><fpage>646</fpage><lpage>649</lpage><pub-id pub-id-type="doi">10.1126/science.1086998</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gumy</surname> <given-names>LF</given-names></name><name><surname>Hoogenraad</surname> <given-names>CC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Local mechanisms regulating selective cargo entry and long-range trafficking in axons</article-title><source>Current Opinion in Neurobiology</source><volume>51</volume><fpage>23</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2018.02.007</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hancock</surname> <given-names>ML</given-names></name><name><surname>Canetta</surname> <given-names>SE</given-names></name><name><surname>Role</surname> <given-names>LW</given-names></name><name><surname>Talmage</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Presynaptic type III Neuregulin1-ErbB signaling targets α7 nicotinic acetylcholine receptors to axons</article-title><source>Journal of Cell Biology</source><volume>181</volume><fpage>511</fpage><lpage>521</lpage><pub-id pub-id-type="doi">10.1083/jcb.200710037</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>YZ</given-names></name><name><surname>Won</surname> <given-names>S</given-names></name><name><surname>Ali</surname> <given-names>DW</given-names></name><name><surname>Wang</surname> <given-names>Q</given-names></name><name><surname>Tanowitz</surname> <given-names>M</given-names></name><name><surname>Du</surname> <given-names>QS</given-names></name><name><surname>Pelkey</surname> <given-names>KA</given-names></name><name><surname>Yang</surname> <given-names>DJ</given-names></name><name><surname>Xiong</surname> <given-names>WC</given-names></name><name><surname>Salter</surname> <given-names>MW</given-names></name><name><surname>Mei</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses</article-title><source>Neuron</source><volume>26</volume><fpage>443</fpage><lpage>455</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)81176-9</pub-id><pub-id pub-id-type="pmid">10839362</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iijima</surname> <given-names>T</given-names></name><name><surname>Wu</surname> <given-names>K</given-names></name><name><surname>Witte</surname> <given-names>H</given-names></name><name><surname>Hanno-Iijima</surname> <given-names>Y</given-names></name><name><surname>Glatter</surname> <given-names>T</given-names></name><name><surname>Richard</surname> <given-names>S</given-names></name><name><surname>Scheiffele</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>SAM68 regulates neuronal activity-dependent alternative splicing of neurexin-1</article-title><source>Cell</source><volume>147</volume><fpage>1601</fpage><lpage>1614</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.11.028</pub-id><pub-id pub-id-type="pmid">22196734</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasnauskiene</surname> <given-names>J</given-names></name><name><surname>Ciuladaite</surname> <given-names>Z</given-names></name><name><surname>Preiksaitiene</surname> <given-names>E</given-names></name><name><surname>Utkus</surname> <given-names>A</given-names></name><name><surname>Peciulyte</surname> <given-names>A</given-names></name><name><surname>Kučinskas</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A new single gene deletion on 2q34: <italic>ERBB4</italic> is associated with intellectual disability</article-title><source>American Journal of Medical Genetics Part A</source><volume>161</volume><fpage>1487</fpage><lpage>1490</lpage><pub-id pub-id-type="doi">10.1002/ajmg.a.35911</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katona</surname> <given-names>I</given-names></name><name><surname>Sperlágh</surname> <given-names>B</given-names></name><name><surname>Sík</surname> <given-names>A</given-names></name><name><surname>Käfalvi</surname> <given-names>A</given-names></name><name><surname>Vizi</surname> <given-names>ES</given-names></name><name><surname>Mackie</surname> <given-names>K</given-names></name><name><surname>Freund</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons</article-title><source>The Journal of Neuroscience</source><volume>19</volume><fpage>4544</fpage><lpage>4558</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-11-04544.1999</pub-id><pub-id pub-id-type="pmid">10341254</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>P</given-names></name><name><surname>Merrill</surname> <given-names>SA</given-names></name><name><surname>Jorgensen</surname> <given-names>EM</given-names></name><name><surname>Shen</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Two clathrin adaptor protein complexes instruct Axon-Dendrite polarity</article-title><source>Neuron</source><volume>90</volume><fpage>564</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.04.020</pub-id><pub-id pub-id-type="pmid">27151641</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longart</surname> <given-names>M</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Karavanova</surname> <given-names>I</given-names></name><name><surname>Buonanno</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Neuregulin-2 is developmentally regulated and targeted to dendrites of central neurons</article-title><source>The Journal of Comparative Neurology</source><volume>472</volume><fpage>156</fpage><lpage>172</lpage><pub-id pub-id-type="doi">10.1002/cne.20016</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madisen</surname> <given-names>L</given-names></name><name><surname>Zwingman</surname> <given-names>TA</given-names></name><name><surname>Sunkin</surname> <given-names>SM</given-names></name><name><surname>Oh</surname> <given-names>SW</given-names></name><name><surname>Zariwala</surname> <given-names>HA</given-names></name><name><surname>Gu</surname> <given-names>H</given-names></name><name><surname>Ng</surname> <given-names>LL</given-names></name><name><surname>Palmiter</surname> <given-names>RD</given-names></name><name><surname>Hawrylycz</surname> <given-names>MJ</given-names></name><name><surname>Jones</surname> <given-names>AR</given-names></name><name><surname>Lein</surname> <given-names>ES</given-names></name><name><surname>Zeng</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A robust and high-throughput Cre reporting and characterization system for the whole mouse brain</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1038/nn.2467</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mei</surname> <given-names>L</given-names></name><name><surname>Nave</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases</article-title><source>Neuron</source><volume>83</volume><fpage>27</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.06.007</pub-id><pub-id pub-id-type="pmid">24991953</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mei</surname> <given-names>L</given-names></name><name><surname>Xiong</surname> <given-names>WC</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Neuregulin 1 in neural development, synaptic plasticity and schizophrenia</article-title><source>Nature Reviews Neuroscience</source><volume>9</volume><fpage>437</fpage><lpage>452</lpage><pub-id pub-id-type="doi">10.1038/nrn2392</pub-id><pub-id pub-id-type="pmid">18478032</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname> <given-names>T</given-names></name><name><surname>Braud</surname> <given-names>S</given-names></name><name><surname>Jüttner</surname> <given-names>R</given-names></name><name><surname>Voigt</surname> <given-names>BC</given-names></name><name><surname>Paulick</surname> <given-names>K</given-names></name><name><surname>Sheean</surname> <given-names>ME</given-names></name><name><surname>Klisch</surname> <given-names>C</given-names></name><name><surname>Gueneykaya</surname> <given-names>D</given-names></name><name><surname>Rathjen</surname> <given-names>FG</given-names></name><name><surname>Geiger</surname> <given-names>JR</given-names></name><name><surname>Poulet</surname> <given-names>JF</given-names></name><name><surname>Birchmeier</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Neuregulin 3 promotes excitatory synapse formation on hippocampal interneurons</article-title><source>The EMBO Journal</source><volume>37</volume><elocation-id>e98858</elocation-id><pub-id pub-id-type="doi">10.15252/embj.201798858</pub-id><pub-id pub-id-type="pmid">30049711</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname> <given-names>A</given-names></name><name><surname>Weber</surname> <given-names>J</given-names></name><name><surname>Labin</surname> <given-names>E</given-names></name><name><surname>Lai</surname> <given-names>C</given-names></name><name><surname>Prieto</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Developmental expression of neuregulin‐3 in the rat central nervous system</article-title><source>Journal of Comparative Neurology</source><volume>527</volume><fpage>797</fpage><lpage>817</lpage><pub-id pub-id-type="doi">10.1002/cne.24559</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname> <given-names>LF</given-names></name><name><surname>Verpoort</surname> <given-names>B</given-names></name><name><surname>de Wit</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Trafficking mechanisms of synaptogenic cell adhesion molecules</article-title><source>Molecular and Cellular Neuroscience</source><volume>91</volume><fpage>34</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2018.04.003</pub-id><pub-id pub-id-type="pmid">29631018</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ribeiro</surname> <given-names>LF</given-names></name><name><surname>Verpoort</surname> <given-names>B</given-names></name><name><surname>Nys</surname> <given-names>J</given-names></name><name><surname>Vennekens</surname> <given-names>KM</given-names></name><name><surname>Wierda</surname> <given-names>KD</given-names></name><name><surname>de Wit</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>SorCS1-mediated sorting in dendrites maintains neurexin axonal surface polarization required for synaptic function</article-title><source>PLOS Biology</source><volume>17</volume><elocation-id>e3000466</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3000466</pub-id><pub-id pub-id-type="pmid">31658245</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera</surname> <given-names>JF</given-names></name><name><surname>Ahmad</surname> <given-names>S</given-names></name><name><surname>Quick</surname> <given-names>MW</given-names></name><name><surname>Liman</surname> <given-names>ER</given-names></name><name><surname>Arnold</surname> <given-names>DB</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>An evolutionarily conserved dileucine motif in shal K+ channels mediates dendritic targeting</article-title><source>Nature Neuroscience</source><volume>6</volume><fpage>243</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1038/nn1020</pub-id><pub-id pub-id-type="pmid">12592409</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampo</surname> <given-names>B</given-names></name><name><surname>Kaech</surname> <given-names>S</given-names></name><name><surname>Kunz</surname> <given-names>S</given-names></name><name><surname>Banker</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Two distinct mechanisms target membrane proteins to the axonal surface</article-title><source>Neuron</source><volume>37</volume><fpage>611</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(03)00058-8</pub-id><pub-id pub-id-type="pmid">12597859</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sando</surname> <given-names>R</given-names></name><name><surname>Jiang</surname> <given-names>X</given-names></name><name><surname>Südhof</surname> <given-names>TC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Latrophilin GPCRs direct synapse specificity by coincident binding of FLRTs and teneurins</article-title><source>Science</source><volume>363</volume><elocation-id>eaav7969</elocation-id><pub-id pub-id-type="doi">10.1126/science.aav7969</pub-id><pub-id pub-id-type="pmid">30792275</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sommeijer</surname> <given-names>JP</given-names></name><name><surname>Levelt</surname> <given-names>CN</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Synaptotagmin-2 is a reliable marker for parvalbumin positive inhibitory boutons in the mouse visual cortex</article-title><source>PLOS ONE</source><volume>7</volume><elocation-id>e35323</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0035323</pub-id><pub-id pub-id-type="pmid">22539967</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Südhof</surname> <given-names>TC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Towards an understanding of synapse formation</article-title><source>Neuron</source><volume>100</volume><fpage>276</fpage><lpage>293</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.09.040</pub-id><pub-id pub-id-type="pmid">30359597</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thu</surname> <given-names>CA</given-names></name><name><surname>Chen</surname> <given-names>WV</given-names></name><name><surname>Rubinstein</surname> <given-names>R</given-names></name><name><surname>Chevee</surname> <given-names>M</given-names></name><name><surname>Wolcott</surname> <given-names>HN</given-names></name><name><surname>Felsovalyi</surname> <given-names>KO</given-names></name><name><surname>Tapia</surname> <given-names>JC</given-names></name><name><surname>Shapiro</surname> <given-names>L</given-names></name><name><surname>Honig</surname> <given-names>B</given-names></name><name><surname>Maniatis</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Single-cell identity generated by combinatorial homophilic interactions between α, β, and γ protocadherins</article-title><source>Cell</source><volume>158</volume><fpage>1045</fpage><lpage>1059</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2014.07.012</pub-id><pub-id pub-id-type="pmid">25171406</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ting</surname> <given-names>AK</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Wen</surname> <given-names>L</given-names></name><name><surname>Yin</surname> <given-names>DM</given-names></name><name><surname>Shen</surname> <given-names>C</given-names></name><name><surname>Tao</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Xiong</surname> <given-names>WC</given-names></name><name><surname>Mei</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons</article-title><source>Journal of Neuroscience</source><volume>31</volume><fpage>15</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2538-10.2011</pub-id><pub-id pub-id-type="pmid">21209185</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tushev</surname> <given-names>G</given-names></name><name><surname>Glock</surname> <given-names>C</given-names></name><name><surname>Heumüller</surname> <given-names>M</given-names></name><name><surname>Biever</surname> <given-names>A</given-names></name><name><surname>Jovanovic</surname> <given-names>M</given-names></name><name><surname>Schuman</surname> <given-names>EM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Alternative 3' UTRs modify the localization, regulatory potential, stability, and plasticity of mRNAs in neuronal compartments</article-title><source>Neuron</source><volume>98</volume><fpage>495</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2018.03.030</pub-id><pub-id pub-id-type="pmid">29656876</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vullhorst</surname> <given-names>D</given-names></name><name><surname>Neddens</surname> <given-names>J</given-names></name><name><surname>Karavanova</surname> <given-names>I</given-names></name><name><surname>Tricoire</surname> <given-names>L</given-names></name><name><surname>Petralia</surname> <given-names>RS</given-names></name><name><surname>McBain</surname> <given-names>CJ</given-names></name><name><surname>Buonanno</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent Hippocampus</article-title><source>Journal of Neuroscience</source><volume>29</volume><fpage>12255</fpage><lpage>12264</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2454-09.2009</pub-id><pub-id pub-id-type="pmid">19793984</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vullhorst</surname> <given-names>D</given-names></name><name><surname>Ahmad</surname> <given-names>T</given-names></name><name><surname>Karavanova</surname> <given-names>I</given-names></name><name><surname>Keating</surname> <given-names>C</given-names></name><name><surname>Buonanno</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Structural similarities between neuregulin 1-3 isoforms determine their subcellular distribution and signaling mode in central neurons</article-title><source>The Journal of Neuroscience</source><volume>37</volume><fpage>5232</fpage><lpage>5249</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2630-16.2017</pub-id><pub-id pub-id-type="pmid">28432142</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walsh</surname> <given-names>T</given-names></name><name><surname>McClellan</surname> <given-names>JM</given-names></name><name><surname>McCarthy</surname> <given-names>SE</given-names></name><name><surname>Addington</surname> <given-names>AM</given-names></name><name><surname>Pierce</surname> <given-names>SB</given-names></name><name><surname>Cooper</surname> <given-names>GM</given-names></name><name><surname>Nord</surname> <given-names>AS</given-names></name><name><surname>Kusenda</surname> <given-names>M</given-names></name><name><surname>Malhotra</surname> <given-names>D</given-names></name><name><surname>Bhandari</surname> <given-names>A</given-names></name><name><surname>Stray</surname> <given-names>SM</given-names></name><name><surname>Rippey</surname> <given-names>CF</given-names></name><name><surname>Roccanova</surname> <given-names>P</given-names></name><name><surname>Makarov</surname> <given-names>V</given-names></name><name><surname>Lakshmi</surname> <given-names>B</given-names></name><name><surname>Findling</surname> <given-names>RL</given-names></name><name><surname>Sikich</surname> <given-names>L</given-names></name><name><surname>Stromberg</surname> <given-names>T</given-names></name><name><surname>Merriman</surname> <given-names>B</given-names></name><name><surname>Gogtay</surname> <given-names>N</given-names></name><name><surname>Butler</surname> <given-names>P</given-names></name><name><surname>Eckstrand</surname> <given-names>K</given-names></name><name><surname>Noory</surname> <given-names>L</given-names></name><name><surname>Gochman</surname> <given-names>P</given-names></name><name><surname>Long</surname> <given-names>R</given-names></name><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Davis</surname> <given-names>S</given-names></name><name><surname>Baker</surname> <given-names>C</given-names></name><name><surname>Eichler</surname> <given-names>EE</given-names></name><name><surname>Meltzer</surname> <given-names>PS</given-names></name><name><surname>Nelson</surname> <given-names>SF</given-names></name><name><surname>Singleton</surname> <given-names>AB</given-names></name><name><surname>Lee</surname> <given-names>MK</given-names></name><name><surname>Rapoport</surname> <given-names>JL</given-names></name><name><surname>King</surname> <given-names>MC</given-names></name><name><surname>Sebat</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia</article-title><source>Science</source><volume>320</volume><fpage>539</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1126/science.1155174</pub-id><pub-id pub-id-type="pmid">18369103</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>JY</given-names></name><name><surname>Miller</surname> <given-names>SJ</given-names></name><name><surname>Falls</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>The N-terminal region of neuregulin isoforms determines the accumulation of cell surface and released neuregulin ectodomain</article-title><source>Journal of Biological Chemistry</source><volume>276</volume><fpage>2841</fpage><lpage>2851</lpage><pub-id pub-id-type="doi">10.1074/jbc.M005700200</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wisco</surname> <given-names>D</given-names></name><name><surname>Anderson</surname> <given-names>ED</given-names></name><name><surname>Chang</surname> <given-names>MC</given-names></name><name><surname>Norden</surname> <given-names>C</given-names></name><name><surname>Boiko</surname> <given-names>T</given-names></name><name><surname>Fölsch</surname> <given-names>H</given-names></name><name><surname>Winckler</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Uncovering multiple axonal targeting pathways in hippocampal neurons</article-title><source>Journal of Cell Biology</source><volume>162</volume><fpage>1317</fpage><lpage>1328</lpage><pub-id pub-id-type="doi">10.1083/jcb.200307069</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolpowitz</surname> <given-names>D</given-names></name><name><surname>Mason</surname> <given-names>TB</given-names></name><name><surname>Dietrich</surname> <given-names>P</given-names></name><name><surname>Mendelsohn</surname> <given-names>M</given-names></name><name><surname>Talmage</surname> <given-names>DA</given-names></name><name><surname>Role</surname> <given-names>LW</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Cysteine-rich domain isoforms of the neuregulin-1 gene are required for maintenance of peripheral synapses</article-title><source>Neuron</source><volume>25</volume><fpage>79</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80873-9</pub-id><pub-id pub-id-type="pmid">10707974</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Morishita</surname> <given-names>WK</given-names></name><name><surname>Riley</surname> <given-names>AM</given-names></name><name><surname>Hale</surname> <given-names>WD</given-names></name><name><surname>Südhof</surname> <given-names>TC</given-names></name><name><surname>Malenka</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Neuroligin-1 signaling controls LTP and NMDA receptors by distinct molecular pathways</article-title><source>Neuron</source><volume>102</volume><fpage>621</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2019.02.013</pub-id><pub-id pub-id-type="pmid">30871858</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Arber</surname> <given-names>S</given-names></name><name><surname>William</surname> <given-names>C</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Tanabe</surname> <given-names>Y</given-names></name><name><surname>Jessell</surname> <given-names>TM</given-names></name><name><surname>Birchmeier</surname> <given-names>C</given-names></name><name><surname>Burden</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation</article-title><source>Neuron</source><volume>30</volume><fpage>399</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(01)00287-2</pub-id><pub-id pub-id-type="pmid">11395002</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>JM</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>XJ</given-names></name><name><surname>Geng</surname> <given-names>HY</given-names></name><name><surname>Ye</surname> <given-names>M</given-names></name><name><surname>Spitzer</surname> <given-names>NC</given-names></name><name><surname>Luo</surname> <given-names>JH</given-names></name><name><surname>Duan</surname> <given-names>SM</given-names></name><name><surname>Li</surname> <given-names>XM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Development of GABA circuitry of fast-spiking basket interneurons in the medial prefrontal cortex of erbb4-mutant mice</article-title><source>Journal of Neuroscience</source><volume>33</volume><fpage>19724</fpage><lpage>19733</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1584-13.2013</pub-id><pub-id pub-id-type="pmid">24336736</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname> <given-names>CC</given-names></name><name><surname>Nokes</surname> <given-names>RL</given-names></name><name><surname>Wisco</surname> <given-names>D</given-names></name><name><surname>Anderson</surname> <given-names>E</given-names></name><name><surname>Fölsch</surname> <given-names>H</given-names></name><name><surname>Winckler</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Pathway selection to the axon depends on multiple targeting signals in NgCAM</article-title><source>Journal of Cell Science</source><volume>121</volume><fpage>1514</fpage><lpage>1525</lpage><pub-id pub-id-type="doi">10.1242/jcs.022442</pub-id><pub-id pub-id-type="pmid">18411247</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yogev</surname> <given-names>S</given-names></name><name><surname>Shen</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Cellular and molecular mechanisms of synaptic specificity</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>30</volume><fpage>417</fpage><lpage>437</lpage><pub-id pub-id-type="doi">10.1146/annurev-cellbio-100913-012953</pub-id><pub-id pub-id-type="pmid">25150010</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.57000.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Brose</surname><given-names>Nils</given-names></name><role>Reviewing Editor</role><aff><institution>Max Planck Institute of Experimental Medicine</institution><country>Germany</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Birchmeier-Kohler</surname><given-names>Carmen</given-names> </name><role>Reviewer</role><aff><institution>Max Delbrueck Center for Molecular Medicine (MDC) in the Helmholtz Society</institution><country>Germany</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>All reviewers agree that your study provides important insights into a molecular program that governs the assembly of specific neuronal circuits – specifically a complementary role of Nrg1-ErbB4 and Nrg3-Erb4 in regulating inhibitory outputs and excitatory inputs of cortical interneurons, based on the differential sub-cellular trafficking of Nrg1 and Nrg3.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Subcellular sorting of neuregulins controls the assembly of excitatory-inhibitory cortical circuits&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Nils Brose as Reviewing Editor and John Huguenard as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Carmen Birchmeier-Kohler (Reviewer #1).</p><p>The reviewers have discussed the reviews with one another and I have drafted this decision to help you prepare a revised submission.</p><p>As the editors have judged that your manuscript is of interest, but as described below that additional experiments are required before it is published, we would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). First, because many researchers have temporarily lost access to the labs, we will give authors as much time as they need to submit revised manuscripts. We are also offering, if you choose, to post the manuscript to bioRxiv (if it is not already there) along with this decision letter and a formal designation that the manuscript is 'in revision at <italic>eLife</italic>'. Please let us know if you would like to pursue this option. (If your work is more suitable for medRxiv, you will need to post the preprint yourself, as the mechanisms for us to do so are still in development.)</p><p>All three reviewers and the Reviewing Editor agreed that your article provides very interesting new insights into the mechanisms by which different types of Nrg-ErbB4 interactions differentially control the genesis of inhibitory vs. excitatory synapses in the cerebral cortex.</p><p>On the other hand, all three reviewers raised critical issues that need to be addressed before your article can be published in <italic>eLife</italic>. Below, I am providing a digest of the corresponding comments that we regard as essential:</p><p>Essential revisions</p><p>1) Evidence that the distribution of overexpressed HA-tagged full-length Nrgs recapitulates the distribution of endogenous Nrgs is needed to support the conclusions of the study. If immunohistochemistry is challenging, the authors could consider a molecular replacement strategy by expressing HA-tagged Nrg1 and Nrg3 in the respective Nrg conditional knockout mice.</p><p>2) Related to this issue, many data (Figure 4-6) relate to analyses of chimeric and deletion constructs of Nrg. It needs to be shown that these constructs traffic normally to the cell surface. It is possible that altered protein folding and reduced surface trafficking could result in the distribution patterns shown for the chimeric and truncated Nrg constructs, e.g. due to accumulation in endoplasmic reticulum present in somata and dendrites. Further, specific inhibitory or excitatory synaptic targeting of these constructs needs to be assessed.</p><p>3) It is unclear whether the overexpressed HA-Nrg1 that is observed in clusters on GFP+ pyramidal neurons is produced by these neurons or provided in trans. This should be clarified by quantifying perisomatic HA-Nrg1 on neighboring GFP+ and GFP- somata.</p><p>4) It appears to be assumed throughout the study that ErbB4 is located pre- or postsynaptically in the respective synapse analyzed (related to axonic vs. somatic Nrg), but this is nowhere shown. Some experiments that address the mechanism of how Nrg1/Nrg3 facilitates synapse formation should be presented. Is this dependent on a long-term (persisting) Nrg1/ErbB4 or Nrg3/ErbB4 interaction? In other words, is Nrg1-GFP located at the majority of the perisomatic synaptic sites and is ErbB4 detected there? Similarly, at how many synapses in the axonal initial segment is Nrg1-GFP/ErbB4 co-localization detected? Alternatively, a persistent Nrg1/ErbB4 or Nrg3/ErbB4 localization at the synapse might not be needed, just short-term interactions could be sufficient to elicit ErbB4 signalling.</p><p>5) In Figure 3, the localization of HA-Nrg1 to the edges of somata is visible but specific colocalization with GAD65 or especially gephyrin is not clear. Localization of HA-Nrg1 to inhibitory postsynaptic sites needs to be quantified as it is an important part of the conclusions.</p><p>6) All main conclusions depend on colocalization analyses of immunofluorescence signals and expressed markers in single confocal optical sections, with no other complementary approaches, such as electron microscopy or electrophysiology. There is a concern with this approach, as to whether individual synapses belonging to specific presynaptic and postsynaptic cells can be sufficiently resolved given the limits of standard confocal imaging. In the images shown, there is no clear correspondence between GAD65 and gephyrin, nor between VGlut1 and PSD95. This is a particular concern for excitatory synapses, as antigen retrieval methods are typically used to visualize PSD95, but do not appear to have been used here, and some of the VGlut1 puncta counted do not appear to fit entirely within the relevant tdT or GFP filled axons. Further, there is a concern that individual excitatory synapses can be resolved given their high density in cortical neuropil without using super-resolution or expansion microscopy approaches, which are now available. Currently, the best way to address this issue could be for the authors to present in an extended view figure large field images of PSD95 and VGlut1, and of GAD65 and gephyrin, showing a one-to-one correspondence of presynaptic and postsynaptic antigens and demonstrating ability to resolve all individual synapses in a field.</p><p>7) The targeting of Nrg3 to excitatory presynaptic sites on axons and presynaptic function has already been reported quite thoroughly in Muller et al., 2018. This information, as well as information on Nrg1 isoforms and their trafficking and function should be presented in the Introduction (here, there is also substantial literature, such as Vulhorst et al., 2017). In essence, much of the more general introductory background is not essential, but specific background on Nrgs needs to be added.</p><p>8) In loss-of-function experiments, a conditional Nrg1 allele was used that affects all Nrg1 isoforms, whereas in the gain-of-function experiments a type III Nrg1 cDNA is used. This should be clearly stated and discussed.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><p>Thank you for resubmitting your work entitled &quot;Subcellular sorting of neuregulins controls the assembly of excitatory-inhibitory cortical circuits&quot; for further consideration by <italic>eLife</italic>. Your revised article has been evaluated by John Huguenard (Senior Editor) and a Reviewing Editor.</p><p>Overall, the three reviewers agree that the revisions have improved the manuscript substantially and regard almost all critical issues resolved. However, there is one important point that remains to be addressed:</p><p>It should be tested experimentally whether ErbB4 and Nrg1/Nrg3 are co-localized at the synapses studied, and it should be quantitatively assessed what proportion of synapses contain both, the receptor and ligand. Such colocalization is implied throughout the paper, but no corresponding data are shown, nor do previously published studies adequately resolve this issue. At this point, it would be acceptable to address this issue for the wild-type scenario. Anti-ErbB4 antibodies suitable for this purpose are available.</p><p>The reviewers regard this issue to be essential because the corresponding data will have a major impact on the overall interpretation of the study.</p><p>If this information can absolutely not be provided with acceptable effort, the claim that Nrg1/Nrg3 functions are mediated by direct and persistent interactions with the ErbB4 receptor at the synapses of interest is not sufficiently supported. Accordingly, the text would have to be partially rewritten to reflect this issue – e.g. by merely proposing that ErbB4 mediates synaptic functions (e.g. based on the similarities in phenotypes of constitutive and conditional ErbB4 mutants).</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.57000.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions</p><p>1) Evidence that the distribution of overexpressed HA-tagged full-length Nrgs recapitulates the distribution of endogenous Nrgs is needed to support the conclusions of the study. If immunohistochemistry is challenging, the authors could consider a molecular replacement strategy by expressing HA-tagged Nrg1 and Nrg3 in the respective Nrg conditional knockout mice.</p></disp-quote><p>We thank the reviewers for this important consideration. We agree that our overexpression experiments of HA-tagged neuregulins are insufficient to provide conclusive evidence regarding the endogenous localization of Nrg1 and Nrg3 in the neocortex. Following the reviewers’ advice, we have performed heat-induced antigen retrieval-based immunohistochemistry using antibodies against Nrg1 and Nrg3 to study the endogenous localization of these proteins in the neocortex. The results of these experiments reveal the presence of endogenous Nrg1 and Nrg3 clusters in the same subcellular localisations than we previously observed the HA-tagged versions of Nrg1 and Nrg3 in pyramidal cells (Nrg1: postsynaptic to inhibitory inputs; Nrg3: presynaptic in excitatory boutons), which demonstrates that the distribution of HA-tagged Nrgs recapitulates the distribution of endogenous Nrgs.</p><p>We quantified the density of Nrg1-labelled synaptic puncta in CA1 stratum pyramidale (the natural target of somatic inhibitory boutons) and stratum radiatum (as a negative targeting control). We used <italic>Nrg1</italic> conditional mutant mice to demonstrate the specificity of the antibodies. The results of these experiments are shown in Figure 3—figure supplement 1.</p><p>We quantified the density of Nrg3-labelled clusters in both the CA1 region of the hippocampus and superficial layers of the cerebral cortex. We used <italic>Nrg3</italic> conditional mutant mice to demonstrate the specificity of the antibodies. The results of these experiments are shown in Figure 3—figure supplement 2.</p><disp-quote content-type="editor-comment"><p>2) Related to this issue, many data (Figure 4-6) relate to analyses of chimeric and deletion constructs of Nrg. It needs to be shown that these constructs traffic normally to the cell surface. It is possible that altered protein folding and reduced surface trafficking could result in the distribution patterns shown for the chimeric and truncated Nrg constructs, e.g. due to accumulation in endoplasmic reticulum present in somata and dendrites. Further, specific inhibitory or excitatory synaptic targeting of these constructs needs to be assessed.</p></disp-quote><p>Following the reviewers’ suggestions, we have examined the synaptic targeting of all the chimeric and truncated Nrg constructs. We have quantified the percentage of colocalisation for all constructs with inhibitory and excitatory synaptic markers. The results of these analyses have strengthened our conclusions about the specific synaptic trafficking of these constructs.</p><p>We quantified the percentage of co-localization of EGF-like domain chimeric constructs with GAD65+ puncta targeting GFP+ somas in superficial cortical layers. The results of these analyses are shown in Figure 4—figure supplement 1.</p><p>We quantified the percentage of co-localization of EGF-like domain chimeric constructs with VGluT1<sup>+</sup>/GFP+ puncta innervating PV+ interneurons in superficial cortical layers. The results of these analyses are shown in Figure 4— figure supplement 2.</p><p>We quantified the percentage of co-localization of C-terminal domain chimeric constructs with GAD65+ puncta targeting GFP+ somas in superficial cortical layers. The results of these analyses are shown in Figure 5—figure supplement 2.</p><p>We quantified the percentage of co-localization of C-terminal domain chimeric constructs with VGluT1<sup>+</sup>/GFP+ puncta innervating PV+ interneurons in superficial cortical layers. In addition, we quantified the intensity of HA+ puncta. The results of these analyses are shown in Figure 5—figure supplement 3.</p><p>We quantified the percentage of co-localization of C-terminal domain truncated constructs with GAD65+ puncta targeting GFP+ somas in superficial cortical layers. The results of these analyses are shown in Figure 6—figure supplement 1.</p><p>We quantified the percentage of co-localization of C-terminal domain truncated constructs with VGluT1<sup>+</sup>/GFP+ puncta innervating PV+ interneurons in superficial cortical layers. The results of these analyses are shown in Figure 6— figure supplement 2.</p><disp-quote content-type="editor-comment"><p>3) It is unclear whether the overexpressed HA-Nrg1 that is observed in clusters on GFP+ pyramidal neurons is produced by these neurons or provided in trans. This should be clarified by quantifying perisomatic HA-Nrg1 on neighboring GFP+ and GFP- somata.</p></disp-quote><p>The possibility that HA-Nrg1 is provided in trans is very unlikely because pyramidal cells very rarely synapse on the soma of other pyramidal cells (there are many classical studies about this, but perhaps the recent Lascone et al., Neuron 2020 provides the most comprehensive quantification). We have nevertheless quantified HA-tagged Nrg1 and HA-tagged Nrg3 clusters in electroporated GFP+ pyramidal cell somas as well as in NeuN+/GFP- neuronal somas. The results of these analyses demonstrate that HA-Nrg1 is only present postsynaptically to inhibitory terminals contacting the soma of electroporated pyramidal cells. These results also confirmed that Nrg3 is never found in that location.</p><p>We have quantified the percentage of co-localization of HA-tagged Nrg1 and HA-tagged Nrg3 with inhibitory boutons targeting GFP+ and NeuN+/GFP- neuronal somas in superficial cortical layers. The results of these analyses are shown in Figure 3—figure supplement 3.</p><disp-quote content-type="editor-comment"><p>4) It appears to be assumed throughout the study that ErbB4 is located pre- or post-synaptically in the respective synapse analyzed (related to axonic vs. somatic Nrg), but this is nowhere shown. Some experiments that address the mechanism of how Nrg1/Nrg3 facilitates synapse formation should be presented. Is this dependent on a long-term (persisting) Nrg1/ErbB4 or Nrg3/ErbB4 interaction? In other words, is Nrg1-GFP located at the majority of the perisomatic synaptic sites and is ErbB4 detected there? Similarly, at how many synapses in the axonal initial segment is Nrg1-GFP/ErbB4 co-localization detected? Alternatively, a persistent Nrg1/ErbB4 or Nrg3/ErbB4 localization at the synapse might not be needed, just short-term interactions could be sufficient to elicit ErbB4 signalling.</p></disp-quote><p>We agree on the interest of understanding the trans-synaptic signalling pathway mediated by neuregulins and ErbB4 receptor. We and others have previously shown the specific subcellular localisation of ErbB4 in different populations of cortical interneurons. In particular, we used electron microscopy to reveal the localisation of ErbB4 at excitatory postsynaptic densities targeting the dendrites of interneurons and at inhibitory presynaptic boutons targeting the axonal initial segment and perisomatic compartment of pyramidal cells (Fazzari et al., 2010). In the present study, we have found that the subcellular localisation of Nrg1 is specifically restricted to the perisomatic compartment of pyramidal cells, whereas the subcellular localisation of Nrg3 is greatly enriched in the axon terminals of pyramidal cells innervating PV+ interneurons. Moreover, the fact that the synaptic deficits observed in <italic>Nrg1</italic> and <italic>Nrg3</italic> conditional mutants (present study) together recapitulate those previously reported for <italic>ErbB4</italic> conditional mutants (our previous work: Del Pino et al., 2013; Del Pino et al., 2017), strongly suggests that presynaptic ErbB4-postsynaptic Nrg1 signalling is involved in the formation of perisomatic inhibitory synapses, whereas presynaptic Nrg3-postsynaptic ErbB4 signalling mediates the formation of excitatory synapses contacting PV+ interneurons. Although we agree that the study of the dynamic interactions between ErbB4 and Nrgs is of great interest, we think that the experiments required to asses them fall outside the scope of the current study.</p><p>The first paragraph in the Discussion summarises the genetic evidence supporting the idea that Nrg1 and Nrg3 interact with ErbB4 for the formation of the synapses described in this study.</p><disp-quote content-type="editor-comment"><p>5) In Figure 3, the localization of HA-Nrg1 to the edges of somata is visible but specific colocalization with GAD65 or especially gephyrin is not clear. Localization of HA-Nrg1 to inhibitory postsynaptic sites needs to be quantified as it is an important part of the conclusions.</p></disp-quote><p>We do not understand what the reviewer refers to in this comment. HA-Nrg1 is expressed post-synaptically in the pyramidal cell soma, therefore it is opposed to GAD65+ presynaptic boutons and gephyrin puncta should be embedded in the HANrg1 clusters, as shown in Figure 3 and Figure 3—figure supplement 3. To strengthen this point, we have now quantified the co-localisation of HA-tagged Nrg1 and HA-tagged Nrg3 clusters with presynaptic GAD65+ boutons targeting the somas of electroporated GFP+ pyramidal cells.</p><p>We quantified the percentage of GAD65+ boutons that are in close apposition to postsynaptic clusters expressing HA-tagged Nrg1 or HA-tagged Nrg3 in electroporated GFP+ pyramidal cells. The results of these analyses are shown in Figure 3—figure supplement 3. In this figure, we added HA staining in a colour-inverted image in low and high-magnification to more clearly illustrate the localisation of HA-tagged Nrg1 at postsynaptic locations within the pyramidal cells.</p><disp-quote content-type="editor-comment"><p>6) All main conclusions depend on colocalization analyses of immunofluorescence signals and expressed markers in single confocal optical sections, with no other complementary approaches, such as electron microscopy or electrophysiology. There is a concern with this approach, as to whether individual synapses belonging to specific presynaptic and postsynaptic cells can be sufficiently resolved given the limits of standard confocal imaging. In the images shown, there is no clear correspondence between GAD65 and gephyrin, nor between VGlut1 and PSD95. This is a particular concern for excitatory synapses, as antigen retrieval methods are typically used to visualize PSD95, but do not appear to have been used here, and some of the VGlut1 puncta counted do not appear to fit entirely within the relevant tdT or GFP filled axons. Further, there is a concern that individual excitatory synapses can be resolved given their high density in cortical neuropil without using super-resolution or expansion microscopy approaches, which are now available. Currently, the best way to address this issue could be for the authors to present in an extended view figure large field images of PSD95 and VGlut1, and of GAD65 and gephyrin, showing a one-to-one correspondence of presynaptic and postsynaptic antigens and demonstrating ability to resolve all individual synapses in a field.</p></disp-quote><p>We are aware of the limitations of standard confocal imaging to resolve synaptic puncta. As suggested, we now provide large field-of-view images of the distinct synaptic markers used throughout our study for both loss- and gain-of-function experiments. In addition, we have quantified the proportion of clusters co-labelled with synaptic markers that are used for co-localisation synaptic analysis. Our analyses reveal that, independently of the experimental condition, the proportion in colocalization for both inhibitory or excitatory synaptic markers is 50-70% and, more importantly, is identical for each comparison (e.g., excitatory and inhibitory synaptic terminals in conditional <italic>Nrg1</italic> and <italic>Nrg3</italic> mutants compared to their respective controls). This suggests that, even if we may not identify all synapses using confocal microscopy, we do not have artefactual biases in our analysis because we identify the same proportion of synapses in control and experimental groups. Notwithstanding these new analyses, we would like to mention that we have done this type of synaptic analyses for more than 10 years in the context of different projects, and we have repeatedly shown that our histological data is always equivalent to electrophysiological synaptic analyses performed on the same mice (Fazzari et al., 2010; Del Pino et al., 2013; Del Pino et al., 2017; Favuzzi et al., 2017; Favuzzi et al., 2019).</p><p>We have added large field-of-view images of synaptic staining in superficial cortical layers of control and <italic>Nrg1</italic> and <italic>Nrg3</italic> conditional mutant mice in Figure 1—figure supplement 3, as well as in brain slices from electroporated mice in Figure 2—figure supplement 1.</p><p>We have quantified the extent to which synaptic markers co-localize using standard confocal imaging to show that our quantitative method can reliably detect and estimate the density of synaptic clusters in brain slices of adult mice.</p><disp-quote content-type="editor-comment"><p>7) The targeting of Nrg3 to excitatory presynaptic sites on axons and presynaptic function has already been reported quite thoroughly in Muller et al., 2018. This information, as well as information on Nrg1 isoforms and their trafficking and function should be presented in the Introduction (here, there is also substantial literature, such as Vulhorst et al., 2017). In essence, much of the more general introductory background is not essential, but specific background on Nrgs needs to be added.</p></disp-quote><p>Following the reviewers’ suggestion, we have included these studies in the Introduction. The requested citations are now included in the Introduction.</p><disp-quote content-type="editor-comment"><p>8) In loss-of-function experiments, a conditional Nrg1 allele was used that affects all Nrg1 isoforms, whereas in the gain-of-function experiments a type III Nrg1 cDNA is used. This should be clearly stated and discussed.</p></disp-quote><p>We thank the reviewers for this comment. A sentence has been added in the Results and Discussion clarifying this point.</p><p>[Editors' note: further revisions were suggested prior to acceptance, as described below.]</p><disp-quote content-type="editor-comment"><p>Overall, the three reviewers agree that the revisions have improved the manuscript substantially and regard almost all critical issues resolved. However, there is one important point that remains to be addressed:</p><p>It should be tested experimentally whether ErbB4 and Nrg1/Nrg3 are co-localized at the synapses studied, and it should be quantitatively assessed what proportion of synapses contain both, the receptor and ligand. Such colocalization is implied throughout the paper, but no corresponding data are shown, nor do previously published studies adequately resolve this issue. At this point, it would be acceptable to address this issue for the wild-type scenario. Anti-ErbB4 antibodies suitable for this purpose are available.</p><p>The reviewers regard this issue to be essential because the corresponding data will have a major impact on the overall interpretation of the study.</p><p>If this information can absolutely not be provided with acceptable effort, the claim that Nrg1/Nrg3 functions are mediated by direct and persistent interactions with the ErbB4 receptor at the synapses of interest is not sufficiently supported. Accordingly, the text would have to be partially rewritten to reflect this issue – e.g. by merely proposing that ErbB4 mediates synaptic functions (e.g. based on the similarities in phenotypes of constitutive and conditional ErbB4 mutants).</p></disp-quote><p>We were happy to learn that the three reviewers consider that our revisions have improved the manuscript substantially and that there is only one important point that remains to be addressed. Following your request, we have performed immunohistochemical experiments to assess, at the light microscopy level, whether ErbB4 co-localises with Nrg1 and Nrg3 at the synapses studied. We found that most ErbB4+ synaptic clusters found in PV+ interneurons also contain presynaptic Nrg3 (Figure 3—figure supplement 6), which reinforces the view that the role of Nrg3 in the formation of excitatory synapses contacting PV+ interneurons is mediated by ErbB4. We attempted to do a similar experiment for Nrg1, however we could not detect ErbB4 clusters at the inhibitory boutons at light microscopy, precluding the assessment of Nrg1-ErbB4 co-localisation. This result is not surprising since we have previously found using electron microscopy that the levels of ErbB4 at inhibitory synaptic terminals are two or three times lower than those found in postsynaptic densities being contacted by excitatory synapses (see Figure 1 and Supplementary Figures 2 and 6 in Fazzari et al., 2010). At this point, the only way to demonstrate that Nrg1 and ErbB4 co-localise at inhibitory synapses made by CCK<sup>+</sup> cells on the soma and by chandelier cells on the axon initial segment of pyramidal cells is to perform double labeling immunohistochemistry for Nrg1 and ErbB4 at the electron microscopy level. We hope that the editors understand that performing this additional experiment is a major effort beyond the expected in a second revision at <italic>eLife</italic>. However, since we agree with the reviewers’ criticism that our experiments do not demonstrate that the function of Nrg1 and Nrg3 in synapse formation is indeed mediated by ErbB4, we have modified the text to avoid giving the impression that this is the case. In brief, we have avoided any reference to Nrg1/ErbB4 or Nrg3/ErbB4 binding or signaling in the Abstract and Results sections, and we have edited the Discussion to reflect the reasons supporting the view that ErbB4 is the most likely receptor mediating the function of Nrg1 and Nrg3 in cortical interneurons. We think the revisions introduced in the text directly address the point raised by the reviewers.</p></body></sub-article></article>